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IL-2-inducible T cell kinase (ITK) is expressed in T lymphocytes and mast 
cells (MC), and functions as a critical signaling mediator downstream of numerous 
cell surface receptors. ITK regulates both adaptive and innate immunity, via regulation 
of cell differentiation and activation.  
Lack of ITK results in spontaneous memory acquisition in αβ T cells termed 
“innate memory phenotype (IMP) T cells”. The development and function of IMP T 
cells, and the role of ITK in their development remains unknown. This dissertation 
describes an alternative bone marrow transplantation system, which generates murine 
models with predominant naïve or IMP T cells, allowing comparative investigation of 
the functions of these cells in vivo; and demonstrates that: 1) IMP T cell development 
requires hematopoietic expression of major histocompatibility complexes; 2) IMP 
CD8+ T cells are not the result of T cell homeostatic proliferation (HP), and they can 
rapidly and potently respond to primary antigenic stimulation; and 3) IMP CD4+ T 
cells can suppress autoimmune graft-versus-host disease. In addition, this dissertation 
also investigates the T cell-intrinsic role of ITK in the development of both IMP and 
HP CD8+ T cells: 1) ITK tunes IL-4/TcR signaling synergy to regulate IMP CD8+ T 
cell differentiation; and 2) ITK suppresses CD8+ T cell HP and anti-tumor immunity. 
Loss of ITK in mice also results in hyper-production of immunoglobulin E 
 (IgE), through which MC regulate the development of allergy. Differential functions 
of ITK and the homologous Bruton's tyrosine kinase (BTK) in MC response to 
allergen/IgE-mediated stimulation have been illustrated. This dissertation further 
shows a redundant function for ITK/BTK in MC response to the bacterial endotoxin 
lipopolysaccharide (LPS), in that lack of ITK and BTK leads to hyper-production of 
MC-derived TNF-α, which exacerbates LPS-induced septic hypothermia.  
This work provides insights into the function of ITK in innate T cells, and the 
value of targeting ITK to enhance antigen-specific primary response by IMP CD8+ T 
cells, regulatory function of IMP CD4+ T cells, and expansion of anti-tumor HP CD8+ 
T cells, for therapeutic purposes. However, the MC response to LPS also raises 
concern on the potential use of ITK/BTK cross-reactive kinase inhibitors. 
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CHAPTER ONE 
Introduction 
  
  2 
Tec family non-receptor tyrosine kinases: structure and expression 
IL-2 inducible T-cell kinase (ITK), the main focus of this dissertation, is a 
member of the Tec family kinases (TFKs). TFKs, including ITK, Bruton’s tyrosine 
kinase (BTK), TEC, BMX and TXK is the second largest non-receptor protein-
tyrosine kinase family (second to Src family) (Takesono et al., 2002). These kinases 
are classified based on the unique Tec-Homology (TH) domain, which is composed of 
a zinc-binding Btk-homology (BH) motif and/or proline-rich regions (PRR) (Felices et 
al., 2007). Among all TFKs, ITK, BTK and TEC share the highest homology in 
structure consisting, from protein N terminal to C terminal, pleckstrin homology (PH), 
TH (BH + PRR), Src-homology (SH) 3, SH2, and kinase domains (Felices et al., 
2007). In BMX, PRR is absent from the TH domain; while in TXK, PH domain is 
replaced by a cysteine-string motif and BH motif is absent form the TH domain (Berg 
et al., 2005).  
TFKs are predominantly expressed in the hematopoietic cells, with distinct 
cell-specific patterns and differential levels in various cell types. ITK is the 
predominant among those expressed in T lymphocytes (ITK, TEC, and TXK), and is 
found in both differentiating and mature T cells at ~ 100 fold higher than the highly 
homologous TEC (Berg et al., 2005) and 3-10 fold higher than the less homologous 
TXK (Hu et al., 1995), at the mRNA level. ITK is critical in T cell development and 
initial activation, mainly because of its fundamental role downstream of T cell 
receptor (TcR) (Liao and Littman, 1995). In contrast, TEC is much less important in T 
cell differentiation and early activation through TcR signaling, but is involved in the 
mature T cell response to restimulation (Tomlinson et al., 2004). T cells developed in 
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the absence of TXK show no defects, but when ITK is deficient, additional loss of 
TXK can further exacerbate the T cell defects due to the loss of ITK function, 
suggesting some ITK-predominant and ITK/TXK redundant function during T cell 
differentiation (Schaeffer et al., 1999).  
BTK, the other TFK highly homologous to ITK, is ubiquitously expressed, in 
all myeloid cells such as mast cells and macrophages (see review (Brunner et al., 
2005)), and in most lymphoid cells, most highly expressed in differentiating and 
resting B cells (but not in T cells and mature effector plasma B cells) (Smith et al., 
1994). The interesting fact that BTK is less abundant in fully activated effector B cells 
suggests the major function of BTK in B cells is during development and initial 
activation, which is very similar to the role of ITK in T cells. Along with BTK, TEC is 
also expressed in B cells, and similar to the ITK/TXK redundancy in T cells, loss of 
TEC alone does not affect B cell differentiation, but when BTK is absent, additional 
loss of TEC results in more severe B cell deficiency (Ellmeier et al., 2000).  
Although ITK and BTK are highly homologous, they are selectively expressed 
in T and B cells respectively, and both are important for the cell differentiation, 
maturation and initial activation. Loss of ITK or BTK expression causes 
immunodeficiency in T or B cells, leading to severe immune disorders (details 
discussed below). In some cells, such as mast cells, ITK and BTK are both expressed, 
but are not required for the cell development, instead, they play some redundant as 
well as distinct functions in cell activation (Iyer et al., 2011). The main focus of this 
dissertation is ITK and ITK/BTK redundant functions, thus T cells with predominant 
ITK expression and mast cells with ITK/BTK co-expression are under investigation.  
  4 
ITK in T cell receptor (TcR) signaling 
The TcR is the common T cell surface receptor utilized by conventional T cells 
in recognizing peptide antigens presented on Major Histocompatibility complex 
(MHC) I or II by antigen presenting cells (APCs), over different T cell developmental 
stages, from antigen driven development in the thymus, to the response of naïve T 
cells to specific antigen in the periphery during an immune response to generate 
effector and memory T cells, and to the response of the latter cells during antigen re-
exposure (Anderson et al., 1996). Activation of TcR by peptide/MHC complexes 
triggers its downstream signaling cascade that can contribute to various outcomes for 
each stage of the T cell’s life (Anderson et al., 1996). ITK is abundantly expressed in 
T cells, and plays a critical role in TcR signaling for normal T cell development (Liao 
and Littman, 1995). 
As mentioned above, ITK is composed of multiple functional domains, 
including PH, TH (BH + PRR), SH3, SH2 and kinase domains, which are all involved 
in the ITK function downstream of TcR (see scheme of signaling pathways in Figure 
1-1 (adapted from review (Kannan et al., 2012)a), and details to be found in the 
following text). Upon TcR activation, Src family kinase Lck is activated, leading to 
activation of TcR co-receptor CD3 phosphorylation on its tyrosine-based activation 
motif, which recruits and activates ZAP-70, that further phosphorylates adaptor 
proteins LAT and SLP-76 (Bogin et al., 2007; Shan and Wange, 1999). Meanwhile, 
                                                
a Arun K. Kannan*, Weishan Huang*, Fei Huang*, and Avery August. (2012) Signal 
Transduction via the T cell Antigen Receptor in naïve and effector/memory T cells. 
The International Journal of Biochemistry & Cell Biology 44(12):2129-34. 
* Equal contributors. 
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PI3 kinase is activated by Lck, and catalyzes the generation of Phosphatidylinositol 
(3,4,5)-trisphosphate (PIP3) lipids, which interact with PH domain to recruit ITK onto 
plasma membrane (August et al., 1997). This PH domain-mediated translocation is 
critical for the function of ITK as membrane interaction is a requirement for its full 
activation by upstream receptors via Lck (August et al., 1997; Ching et al., 1999; 
Woods et al., 2001), and possibly through ITK-ITK intermolecular phosphorylation as 
ITKs form clusters in a PH domain-dependent manner in the vicinity of recruiting 
receptors (Qi et al., 2006). TH, SH3 and SH2 domains all mediate protein-protein 
interactions that regulate the signaling transduction proximal to ITK (August and 
Ragin, 2012). Zinc-binding motif in ITK TH domain is requisite for the transient 
interaction with Gα13 and their synergistic effect on the activation of the distal 
downstream serum response factor (SRF) (Huang et al., 2013b). SH2 and SH3 
domains are involved in ITK interaction with upstream and downstream signaling 
nodes and substrates, including activated adaptor proteins LAT and SLP-76 (Bunnell 
et al., 2000; Ching et al., 2000). The ITK/SLP-76 interaction is critical for the efficient 
activation of ITK as well as in TcR signaling. The SLP-76 tyrosine 145 (Y145) 
residue is involved in signaling downstream of ITK, although it is not required for the 
interaction; and T cells expressing the Y145F mutant of SLP-76 exhibit similar 
developmental and functional defects to those lacking ITK (Gordon et al., 2011; 
Jordan et al., 2008). This ITK/SLP-76 coupling is part of multi-protein complexes that 
are able to regulate the actin cytoskeleton and downstream signaling activation 
(Andreotti et al., 2010; August and Ragin, 2012; Berg et al., 2005; Kannan et al., 
2012).  
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Once activated, ITK performs cis auto-phosphorylation on its SH3 domain, 
which in turn regulates its binding to adaptor proteins and other substrates (Joseph et 
al., 2007a; Wilcox and Berg, 2003). The tightly regulated interaction between ITK and 
the adaptor proteins brings ITK in close proximity with its substrate PLC-γ, which is 
directly phosphorylated by ITK (Joseph et al., 2007b; Perez-Villar and Kanner, 1999). 
Phosphorylated PLCγ catalyzes the breakdown of phosphatidylinositol-4,5-
bisphosphate (PI4,5P) to second messengers- inositol-1,4,5-trisphosphate (IP3) and 
diacylglycerol (DAG). ITK also enhances this process by recruiting the enzyme 
PIP5K to the membrane, which is able to replenish PI4,5P at the site of action (Saito et 
al., 2003). IP3 binds to the IP3 receptor in the membrane of ER, resulting in the release 
of Ca2+ from the ER. This depletion of ER Ca2+ stores results in the opening of Ca2+ 
channels in the plasma membrane, triggered through the sensor STIM1 
communicating with CRAC channels in the plasma membrane, including the Orai1 
channels (reviewed in (Hogan et al., 2010)). ITK has critical functions in regulating 
the initiation and maintenance of calcium influx from the extracellular store into the T 
cells (Fowell et al., 1999; Liu et al., 1998; Schaeffer et al., 1999). The resulting Ca2+ 
influx leads to the activation and nuclear translocation of NFAT through calcineurin 
and calmodulin (Smith-Garvin et al., 2009). DAG on the other hand activates PKCθ as 
well as the RAS guanine nucleotide releasing protein, RASGRP. The CARMA 
proteins are also recruited to ADAP (which also interacts with SLP-76), and are 
phosphorylated by PKCθ, along with Akt/PKB, leading to activation of the NF-κB 
transcription factor via the PKCθ-dependent pathway (Blonska and Lin, 2011; 
Narayan et al., 2006; Wegener et al., 2006). RASGRP on the other hand, initiates the 
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MAPK pathway by activating Ras, leading to activation of Raf and ERK. Ras can also 
activates JNK and p38 MAPKs downstream of the TcR (Smith-Garvin et al., 2009).  
The ITK/SLP-76 complex generated during antigen induced TcR signaling 
form unique microclusters within the cell that is separate from the TcR clusters on the 
cytoplasmic membrane, and includes LAT, Grb-2, ZAP-70, PLC-γ and others 
(Seminario and Bunnell, 2008). These microclusters are important for activation of 
downstream pathways critical for activating the T cell (Seminario and Bunnell, 2008). 
The ITK/SLP-76 core can also traffick apart from the membrane to the cytoplasmic 
compartment, where it activates certain small G-proteins. The activation of other small 
G-proteins by TcR signals occur in part by the guanine nucleotide exchange factor 
Vav, which can activate CDC42 and Rac, both of which are upstream of MAPKs JNK 
and p38. CDC42 and Rac, along with the actin regulators Arp2/3 and WASP, are also 
important for regulating actin polymerization downstream of the TcR (for review see 
(Andreotti et al., 2010)). This TcR regulation of F-actin and retrograde actin flow also 
sustains the phosphorylation of PLC-γ and the release of intracellular Ca2+ store 
(Babich et al., 2012).  
Overall, ITK plays critical roles in regulating the signaling pathways 
downstream of TcR, as a signaling amplifier by initiating and sustaining the 
production of second messengers, as well as a unique signaling modulator for actin 
cytoskeleton. However, the absence of ITK does not ablate downstream signaling 
following TcR activation, but substantially reduces the consequential activities, 
leading to for example, impaired calcium influx (Lewis and Cahalan, 1995), MAPK 
activation (Miller and Berg, 2002; Schaeffer et al., 1999; Schaeffer et al., 2000), 
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NFAT regulated transcription (Crabtree and Olson, 2002), cytokine production 
(Gomez-Rodriguez et al., 2009; Liao and Littman, 1995; Liu et al., 1998) and actin 
rearrangement (Labno et al., 2003). Thus ITK deficiency does not abrogate TcR 
mediated T cell development and activation, but instead, alters T cell lineage 
differentiation in the steady state and T cell activation and function in pathogenic 
conditions (see details in later sections).  
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Figure 1-1. Signaling pathways mediated by ITK downstream of TcR. Dashed 
lines indicate indirect interactions or connections. Note the role of ITK as part of the 
signalosome regulating second messenger production and small G-protein activation, 
which contributes to transcriptional activation and rearrangement of actin 
cytoskeleton. Details are to be found in text.  
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ITK in T cell lineage development 
TcR signaling governs T cell lineage fate from the very early stages of T cell 
differentiation. Its engagement in tonic interaction with other cells provide T cell 
progenitors survival and developmental signals, and because of the substantial 
function of ITK downstream of TcR, ITK plays critical roles in development of 
conventional T cells as well as the non-conventional T cells (or innate T cells, such as 
the newly defined innate memory T cells). This section summarizes the conventional 
and innate T cell differentiation models and the role of ITK in these processes (Figure 
1-2, with details to be found in the following text).  
In the most accepted model for T cell differentiation, conventional T cells 
develop in the thymus, which is composed of cells of hematopoietic origin that can 
give rise to T cells, and thymic structure related stromal cells. In the thymus, the 
differentiating T cells derived from hematopoietic cells are named thymocytes. TcR 
signaling strength and duration helps thymocytes survive, differentiate and become 
mature T cells. These differentiating thymocytes are defined into 4 different classes in 
the conventional T cell differentiation model, based on their expression of CD4 and 
CD8 molecules. From early to late stages they are: CD4/CD8 double negative (DN), 
CD4/CD8 double positive (DP), and CD4/CD8 single positive (SP, CD4 SP and CD8 
SP share the same hierarchy in the lineage developmental tree) (Fowlkes et al., 1985). 
DN cells are the common T cell precursor for both conventional and non-conventional 
T cells, and may proceed toward αβ or γδ T cell fate, based on the early pre-TcR 
expression, in which αβ TcR is much more common than γδ TcR (Xiong and Raulet, 
2007).  
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DN cells that have received competent signals through the αβ pre-TcR expand 
and progress to the next differentiating stage, the CD4/CD8 DP stage (Ciofani and 
Raffa, 2009). ITK can promote, although to a small extend, this DNàDP transition, as 
Itk-/- DN cells exhibit impaired pre-TcR signaling and these mice have smaller thyme. 
Furthermore, Itk-/- hematopoietic cells exhibit a disadvantage when competing with 
WT cells in this process (Lucas et al., 2007). The DP αβ T cell precursor diverge onto 
several paths, based on the type of further stimulation through αβ TcR (Figure 1-2). 
In conventional T cell development, further progress of the DP T cell 
progenitors requires the interaction of the TcR and MHC expressed in the thymic 
stromal cells (TSC), via TcR and self-peptide/MHC complexes with help from CD4 or 
CD8 (Jameson et al., 1995). The DP cells, which receive moderate and adequate tonic 
stimulation through this interaction, will progress into CD4/CD8 SP cells, while those 
that receive insufficient signals undergo “death by neglect” (positive selection), those 
that have too high affinity with self-peptide/MHC are also eliminated through 
apoptosis (negative selection) (Bosselut, 2004; Singer and Bosselut, 2004). The 
lineage commitment towards CD4 or CD8 SP is determined by the pattern of TcR-
MHC interaction (MHCI for CD8 SP, and MHCII for CD4 SP) (Singer and Bosselut, 
2004). The proper DPàSP transition requires the expression of ITK, as in the absence 
of ITK, positive selection is defective to different degrees dependent on the strength of 
the selected TcR (Lucas et al., 2002), and negative selection is reduced or delayed 
(Liao and Littman, 1995; Lucas et al., 2002; Schaeffer et al., 2000).  
The overall DNàDPàSP differentiation path in the thymus gives rise to 
mature but naïve conventional CD4 or CD8 SP T cells that have low expression of 
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CD44 (CD44lo). These cells can migrate from the thymus to the periphery and require 
additional prolonged foreign antigenic stimulation to further differentiate in the 
periphery to become effector and/or memory T cells, forming one arm of adaptive 
immunity (Janeway CA, 2005).  
Unlike conventional T cells described above, which are selected on thymic 
stroma by peptide-MHC complexes and require further activation to become 
effector/memory cells, non-conventional innate T cells such as invariant natural killer 
T (iNKT) cells, innate memory T cells, and γδ T cells have distinct selection 
pathways, express markers typically found on memory T cells, and have the ability to 
rapidly respond with effector function upon stimulation (Anderson et al., 1994; Behar 
and Porcelli, 2007; Berg, 2007; Born et al., 2006; Cho et al., 2011; Hu and August, 
2008; Hu et al., 2007; Huang et al., 2013a; Oliveira et al., 2009; Urdahl et al., 2002).  
Some αβ TcR expressing DP T cell precursors express TcR that contains an 
invariant α chain, and can recognized glycolipids (such as the protypical α-galactosyl 
ceramide (α-GalCer)) presented on a non-classical MHCIb molecule, CD1d, 
expressed by hematopoietic cells (HC) (Bendelac et al., 2007). These cells pass 
through a few intermediate differentiation stages and end up in a mature state with 
high expression of memory T cell marker CD44 and natural killer (NK) cell marker 
NK1.1, thus are named invariant NKT cells (iNKT cells) (Bendelac et al., 2007). The 
mature CD44hiNK1.1+ NKT cells are very capable of secreting cytokines such as IL-4 
and IFN-γ when stimulated by α-GalCer through TcR activation (Godfrey et al., 
2010). ITK is abundantly expressed in NKT cells, and substantially influences their 
maturation, survival and activation. In the absence of ITK, the final maturation stage 
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of NKT cells (up-regulation of NK1.1) is severely impaired, accompanied by 
increased cell death and impaired cytokine production (Au-Yeung and Fowell, 2007; 
Felices and Berg, 2008; Gadue and Stein, 2002). TXK is also expressed in NKT cells, 
although at a much lower level, and when over-expressed to the level of ITK in Itk-/- 
mice, can rescue the NK1.1 expression and cytokine production but failed to rescue 
NKT cell survival. Thus ITK and TXK share redundant positive functions in NKT cell 
maturation and activation, however, ITK plays a unique role in promoting NKT cells 
survival in a Fas/p53-related manner (Qi et al., 2012).  
Although ITK is a substantial positive regulator for conventional T cell and the 
non-conventional NKT cell development, it has been found during the last decade to 
be, surprisingly, a negative regulator for other non-conventional innate T cell 
development, such as the innate memory T cells and a subset of NKT-like γδ T cells 
(see below). 
Innate memory T cells were brought to the frontier of immunology research 
through the T cell phenotypic characterization in Itk-/- mice, in which, CD8 SP 
thymocytes were firstly found significantly increased (Liao and Littman, 1995; Lucas 
et al., 2002; Schaeffer et al., 2000), and later shown to express memory T cell markers 
CD44, CD122, and transcription factor Eomesodermin (Eomes), with rapid effector 
cytokine production upon stimulation (Atherly et al., 2006; Broussard et al., 2006; 
Dubois et al., 2006; Hu et al., 2007; Huang et al., 2013a). Although these phenotypes 
are typical characteristic of memory T cells derived from conventional T cell 
activation in the periphery, Itk-/- CD8 SP thymocytes gain them in the thymus upon 
completion of development independent of peripheral stimulation, thus are termed 
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innate memory phenotype (IMP) T cells. The development of IMP T cells share the 
early part of the conventional T cell differentiation path, and diverge from the DP 
precursors (Figure 1-2). However atypically, IMP CD8+ T cell development is 
dependent on hematopoietic cell-MHCI (HC-MHCI) expression, but can be 
independent of the thymic MHCI and even the entire thymus, regardless the presence 
of ITK (Broussard et al., 2006; Huang et al., 2013a). Similar phenotypic alteration was 
also observed in the Itk-/- CD4 SP thymocytes, although to a lesser extent. In addition, 
some interesting characteristics such expression of PLZF (promyelocytic leukemia 
zinc finger), a transcription factor important for NKT function and IL-4 production 
was reported in these cells (Broussard et al., 2006; Hu and August, 2008; Raberger et 
al., 2008). And work described later in this dissertation found that IMP CD4+ T cell 
development is also dependent on HC-MHC expression, in this case, HC-MHCII, 
expressed on dendritic cells (chapter five).  
How ITK deficiency selectively enhances IMP T cell development is 
triggering more and more interest in the field, especially in the case of CD8+ T cells, 
because of the highly significant IMP CD8+ T cell accumulation in Itk-/- mice. Similar 
IMP T cell accumulative phenotypes have been observed in mice expressing SPL-76 
Y145F mutant (the mutant that disrupts ITK/SPL-76 coupling, thus impairs ITK 
downstream signaling, as described in earlier section), mice lacking transcription 
factors Krüppel-like factor 2 (KLF2), inhibitor of DNA binding 3 (ID3), or CREB 
binding protein (CBP), and mice with over-expression of T cell factor-1 (TCF-1) or β-
Catenin (Fukuyama et al., 2009; Jordan et al., 2008; Sharma et al., 2012; Verykokakis 
et al., 2010; Weinreich et al., 2009). A PLZF dependent IL-4 mediated pathway has 
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also been shown to control the generation IMP CD8+ T cells in the thymus in a T cell 
extrinsic manner (Gordon et al., 2011; Lai et al., 2011; Weinreich et al., 2010). 
Ablation of IL-4 receptor from Itk-/- abrogates the excessive IMP CD8+ T cell 
population, supporting the conclusion that IL-4 is responsible for IMP CD8+ 
accumulation in the absence of ITK (Weinreich et al., 2010). In the presence of ITK, 
NKT cells, which can execute PLZF-dependent IL-4 production, is responsible for 
memory-like CD8+ T cell development in BALB/c mice, thus was originally proposed 
to be the IL-4 source (Weinreich et al., 2010). However, in the absence of ITK, NKT 
cells are severely impaired in number as well as in IL-4 production (see above), thus it 
is highly possible that alternative mechanism(s) emanated by ITK deficiency is 
responsible for the IMP CD8+ T cells development in Itk-/- mice. Some possible 
candidates have been proposed, such as the CD4+ PLZF expressing innate T cells as 
described above, and a subset of NKT-like γδ T cells that are increased in Itk-/- mice 
(see below).  
γδ T cell precursors diverge, in the very early stage, from the conventional T 
cell differentiation path (Figure 1-2). Although the cell-cell interaction requirement 
for γδ T cell differentiation is unknown, it was reported that a stronger TcR strength 
will increase the chance of γδ T cell commitment, when DN T cell precursors are 
faced with the decision between αβ and γδ T cell fates (Haks et al., 2005; Hayes et al., 
2005), and so it was thought that ITK deficiency would reduce γδ T cell development, 
due to reduced TcR signaling activity in the absence of ITK. However, γδ T cells are 
found in dramatically increased number in the thymus and periphery in Itk-/- mice 
compared to WT (Felices et al., 2009; Qi et al., 2009). In Itk-/- mice, hyper-
  16 
immunoglobulin E (IgE) production (which was thought to be induced by increased 
IL-4 signals) can be reversed toward the WT level by removing γδ T cells (Felices et 
al., 2009; Qi et al., 2009), suggesting that γδ T cells participate to induce the IL-4-
driven phenotype(s) in the absence of ITK. In addition, a significant subset of the Itk-/- 
γδ T cells appears to be PLZF+ IL-4 producing NKT-like cells, thus it won’t be 
surprising if these NKT-like γδ T cells function to compensate the defective NKT cells 
and contribute to the IMP CD8+ T cell accumulation in Itk-/- mice. So together with the 
CD4+PLZF+IL-4 producing innate T cells, NKT-like γδ T cells was also proposed to 
be the alternative candidate for IL-4 source to induce IMP CD8+ T cells in Itk-/- mice. 
However, whether these speculations can stand remains to be investigated.  
Although it is proposed that increased IL-4 production by other cells is 
responsible for IMP CD8+ T cell development in the absence of ITK, in a T cell-
extrinsic manner, to date, there has been no direct evidence to show higher circulating 
levels of IL-4 or increased IL-4 signals influencing CD8+ T cell differentiation in Itk-/- 
mice. Hence, we cannot rule out a T cell-intrinsic ITK function in the IL-4 dependent 
IMP CD8+ T cell development. Very recently, a small subset of peripheral CD8+ T 
cells were found to carry “born memory” in mice, independently of antigenic 
stimulation, which is very similar to the innate CD8+ T cells. This newly found 
population have been termed “virtual memory (VM)” CD8+ cells, and were found with 
features of T cells that undergone homeostatic proliferation (Akue et al., 2012; 
Haluszczak et al., 2009; Lee et al., 2013). T cell maintenance/homeostasis in the 
periphery is mediated by the tonic interaction between TcR and self-MHC complex, 
and in lymphopenic conditions, in which T cell number is significantly lower than 
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“normal” amount, naïve T cells initiate homeostatic expansion to restore the number to 
the “normal” level. Naïve T cells that have undergone homeostatic expansion gain a 
memory-like phenotype independently of foreign antigens (Surh and Sprent, 2000). 
This process occurs during the neonatal lymphopenic period in both mice (Min et al., 
2003) and humans (Correa-Rocha et al., 2012), and can contribute to the induction of 
T cell homeostatic proliferation. Thus, it is reasonable to hypothesize a role of ITK in 
regulating CD8+ T cell number and memory acquisition through T cell homeostatic 
proliferation. A common and main obstacle in testing the function of ITK in the naïve 
CD8+ response to IL-4 and homeostatic environment, particularly proliferation and 
memory development, is the lack of naïve CD8+ T cells in Itk-/- mice, leading to the 
inability of using Itk-/- naïve CD8+ T cells to study the effect of loss of ITK function. 
Work to be presented later in the dissertation established and utilized a transgenic 
murine model that retains naïve CD8+ T cells in Itk-/- condition, thus allowing the 
investigation of T cell-intrinsic function of ITK in these cells.  
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Figure 1-2. ITK function in T cell lineage development. CD4-CD8- (DN) 
thymocytes differentiate into αβ or γδ T cell progenitors. ITK promotes the transition 
of DN cells into CD4+CD8+ (DP) αβ T cell precursors, which diverge onto different 
paths leading to thymic stromal cell (TSC)-MHC restricted conventional αβ T cells, 
hematopoietic cell (HC)-CD1d restricted αβ NKT cells, or HC-MHC restricted non-
conventional innate memory (IMP) αβ T cells. ITK positively regulate conventional T 
cell and NKT cell development, but suppresses IMP T cell development. γδ T cell 
development is negatively regulated by ITK as well. In the absence of ITK, IMP CD8+ 
T cells are significantly increased, accompanied by increased CD4+PLZF+ innate T 
cells and NKT-like γδ T cells that are capable of IL-4 production and are proposed as 
candidates for the source of IL-4 to induce IMP CD8+ T cells. More details are to be 
found through the text.  
 
 
 
 
  
DN 
DP 
DN 
DP 
DP 
DP 
Conventional !" T cells 
TSC 
HC 
HC 
? 
Y 
Y 
Y I 
Y I 
Y I 
!"TcR#
$%TcR#
Invariant NK T cells 
ITK 
MHC#
CD1d#
MHC#
Innate memory !" T cells 
CD4 
CD8 
CD44hi 
CD62Llo 
CD44hi 
CD122+ 
!" NKT 
SP 
CD4 
CD44lo 
CD62Lhi 
CD44lo 
CD122- 
$% T $% T cells 
ITK 
PLZF+ 
IL-4+? 
NKT-like 
IL-4+? 
ITK 
SP 
CD8 
  19 
ITK regulated T cell activation and function in disease 
Given the critical role that ITK plays in TcR signaling, and thus in T cell 
development, ITK was found to regulate multiple types of T cell-mediated 
pathogenesis in both human and mouse. It was decades after the discovery of the Itk 
gene (Siliciano et al., 1992) when the first clinical cases with ITK deficiency in 
humans were reported (Huck et al., 2009). Patients, who carry homozygous missense 
mutation in PH, SH3, and kinase domains, or homozygous nonsense mutation causing 
a pre-mature stop codon in ITK kinase domain with a resultant truncated ITK 
expression, were found with susceptibility to severe or fatal Epstein-Barr virus (EBV) 
-associated lymphoproliferative disorder (Huck et al., 2009; Linka et al., 2012; 
Stepensky et al., 2011). These mutants were all found to have a reduced half-life of 
ITK protein, associated with T cell deficiency, thus EBV infection, which is positively 
correlated to B cell lymphoma occurrence, leading to severe lymphoproliferative 
disorder in these patients (Linka et al., 2012). Although defective ITK expression 
results in significantly higher susceptibility to EBV-associated lymphoproliferative 
disorder, increased ITK expression in WT mature T cells was shown in patients with 
Th2-mediated atopic dermatitis (Matsumoto et al., 2002). Studies of single nucleotide 
polymorphism (SNP) showed that variants in the ITK gene promoter region could 
enhance binding of nuclear factors to contribute to a more active promoter function, 
and this variant is observed at a significantly higher frequency in asthmatic patients 
(Lee et al., 2011). Thus under genetically normal conditions, increased ITK expression 
is also a risk factor associated with certain human diseases. Similar to ITK deficiency, 
BTK deficiency leads to a primary immunodeficiency, however, in B cells, named X-
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linked agammaglobulinemia (XLA) in humans. XLA patients, almost exclusively 
males due to the X-linked heredity, are extremely susceptible to bacterial infection 
from early childhood, due to dramatic defect in B cell development and function that 
impairs serum immunoglobulin production (Tsukada et al., 1993; Vetrie et al., 1993).  
In mice, the resultant consequences of the absence of ITK are not overt in non-
pathogenic condition, as Itk-/- mice can live without obvious diseases until very old age 
(greater than one year). This is relatively mild, compared to the cases reported in 
humans. It is possibly due to the fact that only the cases where patients who already 
develop diseases and seek diagnosis were used to find out the consequence of ITK 
deficiency, in humans. More but not all humans with SNP associated with ITK over-
expression develop asthma, a disease induced by environmental cues (Lee et al., 
2011). It is possible that ITK only functions through T cell activation in pathogenic 
conditions to regulate disease development. Itk-/- mice have been tested with several 
disease-inducing experimental protocols, with main focus on the conventional T cell 
activation and function, including CD8+ T cell-mediated viral/bacterial clearance and 
CD4+ T cell-mediated inflammatory diseases.  
CD8+ T cells play critical roles in immune responses to bacterial and viral 
infections. Initial antigen or pathogen recognition initiates clonal expansion of naïve 
CD8+ T cells, which develop into effector T cells, which have cytotoxicity activity on 
infected cells, and can clear infectious agents through secreting cytokines such as IFN-
γ and TNF-α (Harty et al., 2000). In the absence of ITK, mice exhibited altered CD8+ 
T cell antiviral responses, with decreased CD8+ T cell cytotoxic function against 
Lymphocytic Choriomeningitis Virus, Vaccinia Virus, and Vesicular Stomatitis Virus, 
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with delayed viral clearance (Bachmann et al., 1999). It was originally thought that 
these data served as evidence to implicate a positive function of ITK in naïve CD8+ T 
cell effector function development skewed by viral infection. However, this work was 
done before the discovery of the IMP CD8+ T cell accumulation in Itk-/- mice. It is 
recently questioned that the impaired anti-viral CD8+ T cell function observed in Itk-/- 
mice is not solely due to the lack of ITK function downstream of TcR, but also 
included the impact of the CD8+ T cell phenotype in uninfected Itk-/- mice, which is 
highly distinct from that seen in WT. From the initial state of viral challenge, Itk-/- 
mice already has significantly higher proportion and number of memory-like cells, and 
whether this is the reason for the delayed anti-viral protection in Itk-/- is to date unclear.  
The function of ITK in conventional CD4+ T cell activation, sub-lineage 
differentiation and related disease development is better known, mainly because of the 
availability of naïve CD4+ T cells in Itk-/- mice. In WT mice, peripheral naïve CD4+ T 
cells represent up ~ 80% of total CD4+ T cells, and are reduced to less than 40% in the 
absence of ITK, in adult mice (Hu and August, 2008), however, this still allows 
isolation of naïve CD4+ T cells for specific investigation. Naïve CD4+ T cells can be 
activated by antigen in combination with different cytokines to differentiate into a 
variety of T helper subsets, defined by their ability to secrete different cytokines. Th1 
cells are those capable in secreting cytokines such as IFN-γ, and play important roles 
in immune response to intracellular bacterial/viral infection, and autoimmune diseases 
such as experimental autoimmune encephalomyelitis (EAE), multiple sclerosis (MS), 
diabetes, and lupus (Boehm et al., 1997; Cooper et al., 1993; Huang et al., 1993; 
Szabo et al., 2003). Th2 cells, by contrast, produce a representative cytokine IL-4, and 
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are involved in immune responses to worm infections, and are well known to promote 
inflammatory diseases such as allergic asthma (Busse and Lemanske, 2001; Finkelman 
et al., 1997; Lemanske and Busse, 2003; Maizels and Yazdanbakhsh, 2003). Whereas 
Th17 cells typically produce IL-17A, which is critical in recruiting neutrophils, and 
contributes to immune responses during infection of extracellular pathogens (including 
bacteria, mycobacteria and fungi), and the development of EAE and MS (Aranami and 
Yamamura, 2008; Curtis and Way, 2009; Oukka, 2007; Weaver et al., 2007).  
The absence of ITK leads to alterations in Th1, Th2 and Th17 cell 
differentiation (Au-Yeung et al., 2006; Gomez-Rodriguez et al., 2009; Kannan et al., 
2013b; Miller et al., 2004; Sahu et al., 2008). Itk-/- naïve CD4+ T cells have 
significantly higher accessibility in the IFN-γ gene promoter region, leading to 
preferential expression of IFN-γ (compared to IL-4), which further enhances other Th1 
related gene expression, and suppresses Th2 cell differentiation (Kannan et al., 
2013b). Mice lacking ITK fail to develop Th2-meidated allergic airway inflammation 
in experimental allergic asthma models, due to the impaired Th2 cell differentiation 
and Th2 cytokine production (Ferrara et al., 2006; Mueller and August, 2003). Some 
parasites such as Leishmania major, normally elicit Th2 response in WT mice, which 
is not sufficient to clear the parasitic agents, thus these parasites can cause severe 
sickness or death in WT mice. In contrast, in the absence of ITK, the same parasites 
can induce strong Th1 responses that are effective in clearing the pathogens, and help 
Itk-/- mice survive (Fowell et al., 1999; Sahu et al., 2008; Schaeffer et al., 2000; 
Schaeffer et al., 2001). However, Toxoplasma gondii, an intracellular parasitic 
protozoa that can induce strong Th1 response and IFN-γ production, resulted in more 
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severe pathogenesis and lethality in Itk-/- mice (Schaeffer et al., 1999), with unknown 
mechanism, suggested to be due to the defective memory response required to survive 
this infection (August and Ragin, 2012). Th17 cell differentiation and IL-17 
production by CD4+ T cells are significantly impaired in the absence of ITK (Gomez-
Rodriguez et al., 2009). Consistent to the cellular defect, Itk-/- mice are resistant to 
EAE, a Th17-mediated autoimmune disorder (meeting abstracts by (Douhan et al., 
2008) and (Kannan et al., 2013a)).  
More interestingly, in human CD4+ T cells, ITK enhances human 
immunodeficiency virus type 1 (HIV-1) infection. Productive HIV-1 infection requires 
CD4+ T cell activation, chemokine receptor expression, and actin reorganization, 
which are all regulated by ITK downstream of TcR signaling. And in vitro, loss of 
ITK expression, expression of ITK kinase-dead mutant, or application of ITK 
inhibitors can attenuate in part viral entry, replication and spread, in human CD4+ T 
cells (Readinger et al., 2008).  
The pivotal function of ITK in the development of Th2- and Th17-mediated 
inflammatory diseases has triggered significantly interest in using ITK as an anti-
inflammatory target. Although ITK is composed of multiple functional domains, its 
core function has been implicated to be the kinase activity, which is cooperatively 
regulated by other domain functions (see earlier section on ITK structure and function 
in signaling), thus inhibiting ITK kinase activity is currently the underlying strategy to 
target ITK therapeutically. A number of ITK inhibitor candidates have been found 
through high-throughput screen, and shown to bind to and block ITK activation with 
effect in reducing related T cell activation, production of pro-inflammatory cytokines 
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and development of inflammatory diseases (see reviews (Sahu and August, 2009; 
Vargas et al., 2013)).  
However, the interest in ITK as a therapeutic target was mainly induced by the 
role of ITK in conventional T cells. Conventional T cells require ITK to develop into 
pathogenic effectors in Th2 and Th17 inducing conditions, thus the lack of ITK can 
attenuate associated diseases. But in the absence of ITK function, IMP T cells 
selectively develop, and this is mainly due to lack of ITK kinase activity (Hu and 
August, 2008; Hu et al., 2007). It is possible that treating patients with ITK inhibitors 
can trigger accumulation of IMP T cells, and it is so far not clear what functions IMP 
T cells have in disease or immune responses. IMP CD8+ T cells have been shown in 
one study to be protective against Listeria monocytogenes (a bacterium) infection (Hu 
et al., 2007), without future details, while the function of IMP CD4+ T cells awaits 
investigation. Work presented later in this dissertation established murine models with 
predominantly naïve or IMP T cells, allowing the study of the function of IMP T cells 
in comparison to naïve T cells in vivo.  
More concern has been raised towards inhibitor specificity. Due to the high 
homology of Tec family kinases, especially among ITK, BTK and TEC, it has been a 
significant challenge to develop ITK inhibitors with desired potency and selectivity 
against other kinases (Sahu and August, 2009; Vargas et al., 2013). Cross-reactivity 
with BTK is one of the common problems. In allergic asthma, the disease for which 
scientists have the most interest in developing an ITK inhibitor, mast cells play critical 
roles in the pathogenesis. And because of the “quick responder” feature of mast cells, 
they may be one of those responding to ITK inhibition treatments. Thus it is important 
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to extend the study to understand the function of ITK and BTK in mast cells, to help 
evaluate whether ITK inhibition strategy can achieve satisfactory potency as well as 
specificity.  
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Mast cells and ITK/BTK  
Mast cells are derived from hematopoietic progenitors. After the migration of 
their precursors into vascular system or serosal cavity, they remain as tissue residents 
during the differentiation and maturation phases (see review (Kalesnikoff and Galli, 
2008)). Mast cells are essential effector cells in allergic responses and innate immunity 
(Galli et al., 2005a), and also regulate the differentiation of adaptive immunity in 
antigenic environments (Galli et al., 2005b).  
Mast cells carry numerous granules containing preformed factors that are 
released by exocytosis within seconds to minutes following stimulation. The process is 
termed “degranulation”, and results in the release of granule contents including 
histamine, serotonin, a variety of proteases, and a number of cytokines. Along with 
degranulation, activated mast cells also respond within minutes of stimulation with 
secretion of certain metabolic products that can enhance vascular permeability and 
smooth muscle contraction, and act on immune cells to trigger further immune 
responses. Thus, during innate immune responses, mast cells act rapidly upon 
stimulation, and serve as ‘‘sentinels’’ to alert the local surroundings of the potential 
detrimental challenges by invading agents (see reviews (Galli et al., 2005a; Galli et al., 
2005b)). Mast cell immunologic specificity is mediated by Fc epsilon receptor I 
(FcεRI), a high affinity receptor for IgE. When FcεRI expressed on mast cell is bound 
with IgE, mast cells can recognize the antigens that are specifically cognate to the 
bound IgE, and become activated in minutes (see review (Kalesnikoff and Galli, 
2008)). Antigen cross linking of IgE bound to the FcεRI on mast cells results in 
activation of downstream signaling events that lead to effector functions such as 
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degranulation and cytokine secretion. The inflammatory mediators and cytokines 
released from mast cells play a critical role in orchestrating the immune response 
against the antigen/allergen. As a result there is considerable interest in investigating 
critical modulators that regulate the processes of degranulation and cytokine secretion. 
Immediate signaling downstream of FcεRI/IgE/Antigen include activation of a variety 
of kinase, adaptor functions and Ca+ mobilization (see review (Felices et al., 2007)), 
among which Tec family kinases ITK and BTK were found to be involved.  
Mast cells express four out of five Tec family kinases namely, ITK, BTK, TEC 
and TXK (Qiu and Kung, 2000). Among these the roles for ITK, BTK and more 
recently TEC downstream of the FcεRI have been investigated (Kawakami et al., 
1994; Kawakami et al., 1995; Schmidt et al., 2009). ITK is activated in mast cells 
upon FcεRI-mediated signaling and Itk-/- mice have been reported to display decreased 
mast cell degranulation and histamine release in vivo (Forssell et al., 2005; Kawakami 
et al., 1995). However, analysis of ITK null mast cells revealed that the absence of 
ITK does not intrinsically affect mast cell degranulation either in vitro or in vivo (Iyer 
and August, 2008). Although ITK is critical for TcR-mediated induction of 
intracellular Ca2+ mobilization and Erk activation, ITK is not required for intracellular 
calcium signaling in response to FcεRI-mediated signaling in mast cells, and ITK-
deficient mast cells secrete elevated cytokines upon activation (Iyer and August, 
2008), strongly suggesting that ITK has cell type-specific functions. BTK shares very 
high structural homology with ITK (Felices et al., 2007), and is expressed in mast cells 
at similar level to ITK (meeting abstract by (Evans et al., 2009)). In mast cells, BTK is 
activated by the FcεRI, c-Kit and IL-3 receptors (Iwaki et al., 2005; Kawakami et al., 
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1997; Setoguchi et al., 1998). Mast cell development appears normal in the absence of 
BTK, both in vivo and in vitro. However, more bone marrow-derived mast cells 
(BMMCs) are produced from BTK deficient mice in response to IL-3 (Kawakami et 
al., 1997). Btk-/- BMMCs also exhibit mild to moderate impairment of early and late 
FcεRI-mediated responses such as degranulation, histamine release, and cytokine 
production (Hata et al., 1998; Iwaki et al., 2005). Of note, the defects in cytokine 
secretion observed in Btk-/- mast cells can be partially rescued by retroviral 
transduction of ITK, suggesting that ITK may have redundant or compensatory 
functions with BTK in regulating mast cell responses (Hata et al., 1998).  
Neither ITK nor BTK is required for the development of mast cells in vivo or 
in vitro. However, mice lacking both kinases exhibit lower histamine release in 
response to antigen induced systemic anaphylaxis. Furthermore, Itk-/-Btk-/- mice have 
significantly elevated serum IgE levels, which results in increased occupancy of FcεRI 
on mast cells by IgE. This may explain the decreased antigen specific degranulation in 
vivo. Analysis of Itk-/-Btk-/- BMMCs indicates that these cells have increased growth in 
response to IL-3, but also have a cell-intrinsic defect in degranulation and intracellular 
Ca2+ mobilization in response to antigenic stimulation. In this response, both ITK and 
BTK contribute to the mast cell function, with some common and distinct features. For 
examples, BTK contributes positively to the secretion of IL-2, IL-3, IL-4, TNF-α and 
GM-CSF; while ITK contributes positively to secretion of IL-3 and GM-CSF, 
negatively to IL-2 and GM-CSF, and does not make significant contributions to the 
secretion of IL-4 and TNF-α. (Iyer and August, 2008; Iyer et al., 2011; Kawakami et 
al., 1994; Kawakami et al., 1995; Schmidt et al., 2009) 
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In addition to the well-known FcεRI/IgE mediated immunity to multi-cellular 
parasites and in the pathogenesis of allergy and asthma, the importance of mast cells in 
pathogen-associated molecular patters (PAMP)-mediated innate immune defense 
against bacteria and viruses is attracting more and more appreciation. Mast cells 
express Toll-like receptors (TLRs) and respond to TLR ligands by secreting cytokines, 
chemokines, and lipid mediators (Sandig and Bulfone-Paus, 2012). Gram-negative 
bacterial endotoxin lipopolysaccharide (LPS) is a TLR4 specific ligand (Iwasaki and 
Medzhitov, 2004). In mast cells, LPS was shown to bind to TLR4 (McCurdy et al., 
2001) to activate MAPKs (Masuda et al., 2002) and NF-κB (Nigo et al., 2006), and 
induced PI3K/Akt activation that regulates NK-κB activation (Song et al., 2012). 
Different from the FcεRI/IgE-mediated response, LPS induced mast cell response does 
not execute mast cell degranulation or intracellular Ca2+ mobilization (Supajatura et 
al., 2002). BTK has been shown to bind TLR4 and be involved in NF-κB activation 
(Jefferies et al., 2003). In human monocytic cell line (Gray et al., 2006) and primary 
hematopoietic cells (Marron et al., 2012), BTK phosphorylates TLR4 downstream 
MyD88-adaptor like protein (MAL), leading to MAL degradation, forming a negative 
feedback to TLR4 signaling. However, the role of BTK in LPS-induced mast cell 
response is not very clear. Some reports suggest that BTK is a positive mediator in 
TLR4 signaling (Doyle et al., 2005; Gray et al., 2006; Jefferies et al., 2003; Mansell et 
al., 2006; Semaan et al., 2011), others suggest that BTK is dispensable (a negative 
regulator) in mast cell response to LPS, as LPS induced TNF-α and IL-6 was actually 
increased in 129/Sv (mouse strain) BMMCs lacking BTK, suggesting that the role of 
BTK in TLR4 signaling might be cell type specific or strain dependent (Zorn et al., 
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2009). Whereas the role of ITK in mast cell response to LPS is not yet investigated. 
Given the rapid and potent response to allergen and endotoxin, mast cells are 
critical promoting players in the development of allergy (Galli and Tsai, 2012) and 
sepsis (Ramos et al., 2010), which can lead to life-long sickness and sudden death 
respectively. Understanding the biological and biomedical function of ITK (and BTK) 
in mast cell response to related pathogenic conditions, will contribute to our 
knowledge of whether pharmacological inhibition of ITK is a promising strategy for 
disease therapy.  
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Overview of research goals and dissertation outline 
Immunity protects hosts against environmental invasions (such as parasitic 
infection) and endogenous attack (such as tumorigenesis), but also can harm the hosts 
through auto- and over- immune responses mainly by causing inflammation. Immunity 
is composed of innate and adaptive immunity. Innate immunity is the first line of 
defense for the immune system to face incoming invasion, and initiate adaptive 
immunity. Tec family kinase ITK is well characterized for its function in regulating T 
cell acquired immunity, and has been proposed as a therapeutic target in several 
immune diseases. Much less is known about its role(s) in innate immune functions. 
This dissertation focuses on the function of ITK in innate immunity, in particular, in 
innate T cells and mast cells, aiming to extend our understanding of the value of 
targeting ITK in therapies.  
Loss of ITK results in increased innate memory-like T cells, thus the first aim 
of this dissertation is understand the development and function of these memory-like T 
cells and the role of ITK in these processes. This is attempted to help us determine 
whether innate T cell, which are selectively developed in the absence of ITK, can 
influence the effect of targeting ITK. Due to the high homology ITK and BTK, it is 
difficult to target ITK specifically, thus this dissertation also investigated the 
redundant function of ITK and BTK in mast cells, which express both kinases. Work 
done on the compensatory function of ITK and BTK in mast cells will help us 
determine the possible side effects when ITK inhibitors are off-target.  
Chapter one reviews the Tec family kinases with focus on ITK, on its protein 
structure, function in signaling, function in cell activation, and role(s) in related 
disease development. Chapter two introduces an innate memory phonotype (IMP) 
CD8+ T cell population, which is significantly expanded in the absence of ITK, and 
reports the developmental and functional characteristics of such cells. This population 
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carries memory-like features independently of antigenic stimulation, and is distinct 
from cells resulted from homeostatic proliferation. This work established murine 
models with predominant naïve or IMP CD8+ T cells, and suggests the involvement of 
IMP CD8+ T cells in innate immune response. This work further extended the concept 
of innate immunity, and shed light on a novel function of IMP CD8+ T cells in 
bridging the innate and adaptive immunity. Chapter three focuses on the function of 
ITK in regulating the development of IMP CD8+ T cells. In the current model, IL-4 
derived from NKT-like γδ T cells is thought to be responsible for the accumulation of 
IMP CD8+ T cells in Itk-/- mice in a T cell-extrinsic manner, however, my work finds 
that γδ T cells are dispensable in this process, and that ITK functions directly 
downstream of IL-4 to regulate the development of innate CD8+ T cells. To my 
knowledge, this work, for the first time, shows a T cell-autonomous function of ITK in 
regulating innate T cell development, which challenges the current model. Chapter 
four describes a regulatory function for ITK in population dynamics and effector 
memory generation of CD8+ T cells undergoing lymphopenia-induced proliferation, 
and that ITK suppresses the anti-tumor immunity of such cells in a cell-autonomous 
manner. Chapter five establishes murine models carrying predominant naïve or innate 
memory CD4+ T cells, and demonstrates that innate memory CD4+ T cells are 
protective against autoimmune graft-versus-host disease post bone marrow 
transplantation. Chapter six describes the cooperative regulatory function for ITK and 
BTK in mast cell response to endotoxic stimulation. In the absence of ITK and BTK, 
mast cells exhibit hyperactive TNF-α production induced by bacterial endotoxin, and 
exacerbate the hypothermic septic response. This work implicates the complex 
function of Tec kinases in immune diseases and provides warning on using them as 
therapeutic targets. Due to the case specific function of ITK and BTK, drug 
applications should be selected based on the differential roles of these kinases. 
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Chapter seven summarizes the function of ITK in innate T cells and mast cells, and 
discusses the value and concerns of targeting ITK in inflammatory diseases.  
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Abstract 
Innate memory phenotype (IMP) CD8+ T cells are non-conventional αβ T cells 
exhibiting features of innate immune cells, and are significantly increased in the 
absence of ITK. Their developmental path and function are not clear. Here we show 
hematopoietic MHCI dependent generation of antigen specific IMP CD8+ T cells 
using bone marrow chimeras. WT bone marrow gives rise to IMP CD8+ T cells in 
MHCI-/- recipients, resembling those in Itk-/- mice, but distinct from those derived via 
homeostatic proliferation (HP), and independent of recipient thymus. By contrast, 
MHCI-/- bone marrow does not lead to IMP CD8+ T cells in WT recipients. OTI IMP 
CD8+ T cells generated via this method exhibited enhanced early response to antigen 
without prior primary stimulation. Our findings suggest a method to generate antigen 
specific “naïve” CD8+ IMP T cells, demonstrate that they are not HP cells and can 
promptly respond in an antigen specific fashion. 
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Introduction 
Conventional T cells arise as naïve T cells through thymic selection, and 
require further exposure to antigens to expand and acquire effector/memory function 
(Berg, 2007). While conventional T cells are selected on thymic stroma by peptide-
MHC complexes, non-conventional innate T cells have distinct selection pathways, 
spontaneously express markers typically found on memory T cells, and have the 
ability to rapidly respond upon stimulation (Anderson et al., 1994; Behar and Porcelli, 
2007; Berg, 2007; Born et al., 2006; Cho et al., 2011; Oliveira et al., 2009; Urdahl et 
al., 2002). Non-conventional CD8+ T cells are distinguished by their memory-like 
attributes of the effector program such as secretion of IFN-γ and expression of CD44 
and CD122 (IL-2Rβ) (Intlekofer et al., 2005; Pearce et al., 2003), and are thus termed 
“Innate Memory” or “Innate Memory Phenotype (IMP)” CD8+ T cells (Berg, 2007; 
Broussard et al., 2006; Horai et al., 2007; Hu et al., 2007; Lai et al., 2011; Weinreich 
et al., 2010). IMP CD8+ T cells may be selected independent of thymic MHCIa, with a 
dominant role played by hematopoietic MHCI (Broussard et al., 2006; Horai et al., 
2007). However, it was also suggested recently that innate memory-like CD8+ 
thymocytes are mainly selected by nonhematopoietic MHCIa (Rafei et al., 2011), 
strongly alluding to alternative pathways for IMP CD8+ T cell development.  
IMP CD8+ exist in specific-pathogen-free as well as in germ-free mice (Huang 
et al., 2005), independent of immunization and infection, and are significantly 
increased in the absence of Tec kinase ITK, and the transcriptional regulators CBP, 
KLF2 and Id3, or mice carrying the ITK binding mutant of Slp-76 (Berg, 2007; 
Broussard et al., 2006; Fukuyama et al., 2009; Horai et al., 2007; Hu et al., 2007; 
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Jordan et al., 2008; Verykokakis et al., 2010; Weinreich et al., 2009). IL-4 has been 
shown to be involved in the generation of these cells in cell extrinsic manner in the 
absence of ITK (Weinreich et al., 2010). Although it is known that IMP CD8+ are 
distinct from antigen-induced memory CD8+ T cells, they share markers of T cells that 
have undergone homeostatic expansion (Haluszczak et al., 2009), and so it is not clear 
whether IMP CD8+ T cells arise through homeostatic proliferation. Functionally, IMP 
CD8+ T cells can facilitate the clearance of Listeria monocytogenes infection (Hu et 
al., 2007), however, it has been difficult to directly examine whether IMP CD8+ T 
cells can respond to antigen during an immune response due to the difficulty 
discriminating IMP CD8+ T cells from conventional memory CD8+ T cells. 
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Materials and Methods 
 
Mice.  
All mice were on a C57BL/6 background. WT, MHCI-/- (B2m-/-: B6.129P2-
B2mtm1Unc/J), and nude (B6.Cg-Foxn1nu/J) mice were from the Jackson Laboratory 
(Bar Harbor, ME). MHCI-/-OTI mice were derived by crossing OTI transgenic mice 
and MHCI-/- mice. All experiments were approved by the Office of Research 
Protection’s IACUC at Pennsylvania State and Cornell Universities.  
 
Generation of bone marrow chimeras.  
Bone marrow from donor mice was injected i.v. into lethally irradiated recipients (6-9 
weeks old). In some cases recipients or donors were congenic for CD45 as indicated in 
the figures. T cell depleted bone marrow was obtained by negative selection using 
biotinylated-anti-CD3ε antibody (eBioscience, San Diego, CA) and magnetic column 
separation (Miltenyi Biotec, Cambridge, MA). Mice were kept in specific pathogen 
free environment, and fed acid water containing antibiotics (1 mg/ml Gentamycin 
Sulfate) for 8-9 weeks post BMT prior to analysis. 
 
Cell sorting, microarray and quantitative real-time PCR.  
Cell sorting was performed on a FACSAria Cell Sorter (BD Biosciences, San Jose, 
CA). IMP CD8+ T cells (TCRβ+CD8α+CD44hi) were sorted from splenocytes of 
WTàMHCI-/- chimeras 8 weeks post transplantation and 8-week old Itk-/- mice. HP 
cells were generated by i.v. injecting naïve CD8+ T cells (TCRβ+CD8α+CD44lo) into 
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Rag1-/- recipients (0.5×106/mouse), followed by sorting of TCRβ+CD8α+CD44hi cells 
8 weeks post transfer. mRNA from sorted cells was extracted, amplified and used for 
microarray (GeneChip Mouse Genome 430 2.0 Array, Affymetrix, Santa Clara, CA) at 
the Cornell University Life Sciences Core Laboratories Center. Microarray data were 
analyzed using GeneSpring GX software (Agilent Technologies, Clara, CA). RMA-
normalized probe values were used to generate correlation coefficient matrix, further 
converted to gene expression values with Quantile normalization, followed by analysis 
of gene differential expression. Data have been deposited into the NCBI GEO 
repository (accession # GSE41482). Quantitative real-time PCR was carried out using 
Taqman probe sets (Applied Biosystems, Foster City, CA). 
 
In vitro stimulation.  
Splenocytes were stimulated with PMA/Ionomycin (Sigma-Aldrich, St. Louis, MO), 
100 µg/ml Ovalbumin (Sigma) or 1 µg/ml OVA257-264 (SIINFEKL, Peptides 
International, Louisville, KY) as indicated. 10 µg/ml Brefeldin A (Sigma) was added 
on day 1, 3 and 6 for the last 6 - 7 hours, followed by staining and flow cytometric 
analysis. 
 
Antibodies.  
All antibodies used are listed in “fluorochrome-target” format as follows: eFluor 450-
CD122, PE-MHCI, Alexa Fluor 700-CD45.2, PerCP-Cy5.5-TNF-α, PE-Cy7-IFN-γ 
(eBioscience); V500-CD44, FITC-CD45.1, FITC-TCRVβ5, PE-TCRVβ5, PE-
TCRVα2, PE-CD44, PE-Cy5-CD44, Allophycocyanin-Cy7-TCRβ (BD Biosciences); 
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PE-Texas Red-CD8α (Invitrogen, Carlsbad, CA). 
 
Data analysis.  
Two-tailed Student’s t test was performed using GraphPad Prism v5.00 (GraphPad, 
San Diego, CA), with p < 0.05 considered statistically significant.  
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Results 
 
Development of IMP CD8+ T cells via hematopoietic MHCI selection independent of 
the thymus  
IMP CD8+ T cells have been reported to be able to develop in the thymus 
independent of MHCI molecules on thymic stroma (Broussard et al., 2006). We took 
advantage of this to generate mice carrying predominantly IMP or naïve CD8+ T cells 
through BMTs utilizing WT and MHCI-/- (B2m-/-) mice. The spleens of WTàMHCI-/- 
mice had predominantly CD44hiCD122+ IMP CD8+ T cells that rapidly produced IFN-
γ upon P/I stimulation, as has been observed (Berg, 2007; Broussard et al., 2006; 
Horai et al., 2007; Hu et al., 2007; Lai et al., 2011; Weinreich et al., 2010). By 
contrast, WT recipients of MHCI-/-àWT contained predominantly naïve CD8+ T cells 
(Figure 2-1 A). As expected, hematopoietic MHCI expression is necessary and 
sufficient for development of IMP CD8+ T cells.  
Further examination revealed that the thymus is dispensable for IMP CD8+ T 
cell development, since transplant of WT bone marrow into athymic Nude mice 
resulted in the development of similar cells to that seen in the WTàMHCI-/- 
transplants (Figure 2-1 B&C). Of note, while endogenous CD8+ T cells in nude mice 
are CD44hi, they do not express CD122 and fail to rapidly produce IFN-γ in response 
to P/I (Figure 2-1 B).  
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Figure 2-1. Development of IMP CD8+ T cells via hematopoietic MHCI selection 
independent of the thymus. (A) Representative flow cytometric analysis of IMP 
CD8+ T cells (upper panel, CD44hiCD122+) and P/I induced IFN-γ production (lower 
panel). Donor TCRβ+CD8α+ cells from WTàWT (MHCI+CD45.2+), MHCI-/-àWT 
(MHCI-CD45.2+) and WTàMHCI-/- (MHCI+CD45.2-) chimeras are shown. (B&C) 
The thymus is not required for development of IMP CD8+ T cells. (B) Bone marrow 
chimeras were generated as indicated and donor TCRβ+CD8α+ cells analyzed by flow 
cytometry for CD44 and CD122, and IFN-γ producing capacity induced by P/I, 
compared to those from WT and Nude mice. (C) Percentages of IMP, naïve and P/I 
induced CD44hi IFN-γ producing CD8+ T cells, along with numbers of total, IMP and 
naïve CD8+ T cells, in “WTàWT” and “WTàNude” chimeras. n = 4 in each group. 
*p < 0.05 by Student’s t test. 
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IMP CD8+ T cells are distinct from homeostatic expanded CD8+ T cells 
 When transferred into lymphopenic environments, naïve CD8+ T cells undergo 
significant proliferation in an attempt to restore “normal” levels of T cells. Along with 
this proliferation, naïve CD44loCD8+ T cells acquire a phenotype resembling memory-
like CD8+ T cells, a process termed “homeostatic expansion” (Cho et al., 2000; Sprent 
et al., 2008). Naïve CD8+ T cells also proliferate and differentiate upon antigen 
recognition and activation, converting into long-lived antigen specific memory CD8+ 
T cells that reside in part in bone marrow (Becker et al., 2005). It is therefore possible 
that the cells we observed are due to homeostatic expansion of a small number of 
naïve T cells and/or proliferation of memory T cells in the transferred donor bone 
marrow. However, we found that depletion of T cells prior to BMT did not affect the 
development of IMP CD8+ T cells (Figure 2-2). This suggests that IMP CD8+ T cells 
observed in WTàMHCI-/- chimeric model are the result of hematopoietic MHCI 
selection and development rather than homeostatic expansion of T cells from donor 
bone marrow.  
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Figure 2-2. IMP CD8+ T cells in WTàMHCI-/- chimeras develop despite 
depletion of T cells from donor bone marrow. WT bone marrow was either left 
intact or depleted of T-cells, and used as donors to generate “WTàWT” and 
“WTàMHCI-/-” chimeras. Donor TCRβ+CD8α+ cells were analyzed. (A) Flow 
cytometric analysis for CD44 and CD122, and percentage of CD44hi IFN-γ producing 
CD8+ T cells in response to P/I. (B) Percentages and numbers of IMP and naïve CD8+ 
T cells, and percentage of P/I induced CD44hi IFN-γ+ CD8+ T cells. n = 3 in each 
group. *p < 0.05, ns = not significant, by Student’s t test. 
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To confirm that the IMP CD8+ T cells in the WTàMHCI-/- chimeras are not 
the result of homeostatic expansion, we analyzed whole genome gene expression 
profiles of sorted IMP CD8+ T cells from WTàMHCI-/- chimeras (WM), Itk-/- mice, 
and CD8+ T cells derived from homeostatic expansion of naïve CD8+ T cells in Rag1-/- 
recipients (Figure 2-3 A). Correlation coefficient matrix shows that gene expression 
between WM IMP CD8+ T cells and Itk-/- IMP CD8+ T cells are highly correlated 
(Correlation coefficient > 0.98), while both are less correlated with HP CD8+ T cells 
(Correlation coefficient: 0.66 ~ 0.87) (Figure 2-3 B). Among 27800 genes, compared 
to WM CD8+ T cells, there are ~ 4000 up regulated and > 4000 down regulated by 
more than 2 fold in HP CD8+ T cells (P < 0.05, P values were generated by asymptotic 
computation with Benjamini-Hochberg false discovery rate correction), while there 
are only 21 of these in Itk-/- CD8+ T cells (Figure 2-3 C). We examined a few 
meaningful genes that were changed between these cells by q-RT-PCR and consistent 
with the differential expression profile identified by microarray (Figure 2-3 D), we 
found up-regulation of TNFR (Tnfarsf1a) and NFκB2 (Nfkb2), and down-regulation of 
Eomesodermin (Eomes) and Bim (Bcl2l11) (Figure 2-3 E), in HP CD8+ T cells but 
not Itk-/- CD8+ T cells compared to WM IMP CD8+ T cells. This whole genome 
expression analysis strongly suggests that IMP CD8+ cells generated in WTàMHCI-/- 
chimeras highly resemble IMP CD8+ T cells in Itk-/- mice, and are distinct from those 
derived from homeostatic expansion.  
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Figure 2-3. Hematopoietic MHCI dependent CD8+ T cells resemble innate 
memory CD8+ T cells in Itk-/- mice, but are distinct from HP cells. Comparison of 
HP, Itk-/- and WM (WTàMHCI-/-) CD8+ T cells. (A) HP, Itk-/- and WM CD8+ T cells 
share expression of CD44 and CD122. (B) Itk-/- and WM CD8+ T cells show 
extremely high correlation in whole genome gene expression, which is distinct from 
HP CD8+ T cells. Samples were clustered based on the hierarchy of correlation. (C) 
HP but not Itk-/- CD8+ T cells, exhibit significantly higher number of differentially 
expressed genes compared to WM CD8+ T cells. Genes with significant change (fold 
change > 2, corrected P < 0.05) are shown in red. Numbers in red indicate numbers of 
gene that significantly up- or down- regulated. (D) Relative Tnfrsf1a, Nfkb2, Eomes 
and Bcl2l11 expressional level in HP and Itk-/- CD8+ T cells compared to WM IMP 
CD8+ T cells as determined by microarray analysis. Quantile normalized gene 
expressional values were normalized to mean values of WM IMP CD8+ T cells. n = 3 
in each group. (E) Relative mRNA expression for Tnfrsf1a, Nfkb2, Eomes and Bcl2l11 
expressional level in HP and Itk-/- CD8+ T cells compared to WM IMP CD8+ T cells, 
determined by qRT-PCR. Gene expressional level was first normalized to GAPDH 
value of each sample, than normalized to the average value of WM IMP CD8+ T cells. 
n = 3 in each group. *p < 0.05, ns = no significance by Student’s t test. 
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Antigen-naïve OVA specific IMP CD8+ T cells promptly respond to antigen in the 
absence of primary antigen exposure 
The BMT approach suggests a method to generate antigen-naïve, antigen 
specific IMP CD8+ T cells. To study the primary response of antigen specific IMP 
CD8+ T cells, we utilized OTI mice (expressing OVA specific T cell receptor on CD8+ 
T cells) as bone marrow donors, to generate antigen-naïve OVA specific IMP CD8+ T 
cells in MHCI-/- recipients. Reciprocally, OTI transgenic mice that lack MHCI-/- 
(MHCI-/-OTI) were used as donors to generate OVA specific naïve CD8+ T cells in 
WT recipients, with OTIàWT chimeras as controls. Similar to the results of BMTs in 
non-transgenic backgrounds, OTIàMHCI-/- chimeras had predominantly TCR 
transgene positive OVA specific CD44hiCD122+ IMP CD8+ T cells that rapidly 
produced IFN-γ. Analogously, MHCI-/-OTIàWT chimeras had predominantly TCR 
transgene positive OVA specific CD44loCD122- naïve CD8+ T cells (Figure 2-4 
A&B). Using this model, we examined whether antigen-naïve, antigen specific IMP 
CD8+ T cells can respond to antigen in the absence of prior antigenic exposure. OTI 
transgenic IMP and naïve CD8+ T cells were directly stimulated in vitro with antigen 
presenting cell/OVA or OVA257-264 epitope of OVA recognized by the OTI TCR, 
without prior primary antigen exposure in vivo. We found that OVA/OVA257-264 
specific IFN-γ and TNF-α production by CD44hi CD8+ T cells peaked on the third day 
post stimulation in OTI IMP CD8+ T cells (OTIàMHCI-/-) (Figure 2-4 C), suggesting 
that these cells were highly functional IFN-γ/TNF-α double producers (Figure 2-4 C), 
and indicating that antigen naïve OVA specific IMP CD8+ T cells can rapidly respond 
in a highly functional manner to specific antigen in the absence of primary antigenic 
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exposure. By contrast, naïve OTI cells (MHCI-/-OTIàWT) did not show significant 
cytokine response > 6 days of stimulation as would be expected in vivo.  
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Figure 2-4. Hematopoietic MHCI dependent OTI IMP CD8+ T cells exhibit 
prompt and potent antigen specific response in vitro without primary antigen 
exposure. BMTs were done as indicated and donor TCR transgene positive CD8α+ 
cells from OTIàWT (CD45.2+MHCI+), MHCI-/-OTIàWT (CD45.2+MHCI-) and 
OTIàMHCI-/- (CD45.2+MHCI+) chimeras analyzed. (A) Flow cytometric analysis of 
CD8+ T cells for CD44 and CD122 and P/I induced IFN-γ production in chimeric 
spleens. (B) Percentages and numbers of CD44hiCD122+ IMP CD8+ T cells, 
CD44loCD122- naïve CD8+ T cells, and proportion of CD44hi IFN-γ producing cells in 
response to P/I. *p < 0.05, ns = not significant, by Student’s t test. Data represent 
results from three independent experiments. (C) Percentages of CD44hi IFN-γ+, CD44hi 
TNF-α+ and IFN-γ+/TNF-α+ double positive donor CD8+ T cells in response to OVA 
and OVA257-264 peptide along the time course. All values were corrected for the 
response of non-stimulated controls. *p < 0.05, compared to “OTIàWT” chimeras, §p 
< 0.05, compared to “MHCI-/-OTIàWT” chimeras, by two-way ANOVA. Data 
represent results from two independent experiments. 
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Discussions 
The function of IMP CD8+ T cells, and the mechanism behind their 
development, has elicited significant interest. Recently, Rafei et. al. showed that 
antigen-naïve OTI transgenic CD44hiCD8+ thymocytes selected on thymic MHCIa and 
that have never left thymus, can promptly respond to OVA-peptide with cytokine 
secretion (Rafei et al., 2011). In addition, Haluszczak et. al. showed that a proportion 
of functional antigen-specific peripheral CD8+ T cells in germ-free mice have a 
memory-like phenotype, although one cannot rule out that these cells are antigen-
experienced (Haluszczak et al., 2009). Our findings that endogenous CD8+ T cells in 
nude mice have a partial innate memory phenotype suggests that perhaps other signals 
may be required for the complete development and/or maturation of these cells, which 
may be indirectly dependent on the thymic structure or the Foxn1 gene. This could 
involve a precursor that traffics through the thymus prior to our BMT. In the absence 
of ITK or the transcription factor KLF2, the increase in innate memory-like CD8+ T 
cells have been suggested to be due to the influence of IL-4 produced by NKT-like 
cells in these mice (Weinreich et al., 2010). What role IL-4 signaling plays in the 
development of these hematopoietic MHCI-dependent IMP CD8+ T cells remains to 
be determined. Our preliminary analysis indicates that IMP CD8+ T cells differentially 
express the TNFR (lower than HP cells) and Bim and the transcription factor 
Eomesodermin (higher than HP cells), the latter previously observed in IMP CD8+ T 
cells (Lee et al., 2011). Future experiments will distinguish the role of such factors in 
the development of these cells. 
Using bone marrow chimeras and transgenic approaches, we show for the first 
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time that we can develop significant numbers of antigen-naïve, antigen specific IMP 
CD8+ T cells that are similar to those that develop in the absence of ITK, but different 
from those that develop due to homeostatic expansion, although they have similar 
phenotypes. Our work provides a model, and opens the door for more detailed analysis 
of the development and more importantly, function of such cells.  
In the immune system, innate immune cells initiate a relatively antigen non-
specific response to primary infection, allowing cells of the adaptive immune system 
to develop more specific and exquisite antigen responses, along with the generation of 
immune memory (Iwasaki and Medzhitov, 2010; Zinkernagel, 2002). In particular, 
antigen specific memory T cell responses are thought to be generated only after 
antigenic exposure (Janeway CA, 2005). However, our work suggests that antigen 
naïve innate memory CD8+ T cells can generate potent memory-like antigen specific 
responses. We suggest that such IMP CD8+ T cells evolved to rapidly respond early in 
infections in an antigen specific fashion, assisting the innate immune response and 
allowing priming of the antigen specific adaptive immune response. These cells may 
occupy an essential niche in the early immune response to primary infection. 
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CHAPTER THREE 
 
ITK tunes IL-4 induced development of innate memory CD8+ T cells in a γδ  T 
cell independent mannercd  
                                                
c Weishan Huang, Arun Kumar Kannan, Qian Qi, Jianfang Hu, and Avery August. 
ITK tunes IL-4 induced development of innate memory CD8+ T cells in a γδ T cell 
independent manner. Submitted. 
 
d Weishan Huang, and Avery August. Editorial: Jack of all trades? The versatility of 
IL-4 in CD8+ T cell polarity. Journal of Leukocyte Biology. Invited review, in press.  
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Abstract 
The development of different types of memory CD8+ T cells has been 
intensely studied. True memory CD8+ T cells develop in response to antigenic 
exposure, and can provide life-long protection against reinfection. More recently other 
types of memory CD8+ T cells have been described. In mice lacking ITK, memory-
like CD8+ T cells spontaneously arise, referred to as innate memory phenotype (IMP, 
CD44hi/CD122+) cells, suggested to develop under the influence of IL-4 secreted by 
NKT-like γδ T cells found in Itk-/- mice. However, we report here that while IMP 
CD8+ T cell development in Itk-/- mice is dependent on IL-4/STAT6 signaling, it is not 
dependent on γδ T cells, including NKT-like γδ T cells. Moreover, our experiments 
suggest a model of IMP CD8+ T cell development where ITK tunes the CD8+ T cell 
response to exogenous IL-4, leading to the innate memory phenotype. This work 
challenges the current model of IMP CD8+ T cell development, illustrating a γδ T cell-
independent, cell-intrinsic role for ITK in memory CD8+ T cell development through 
synergy between IL-4 and the TcR. These findings furthermore suggest that some 
naïve CD8+ T cells may be pre-programmed by weak homeostatic T cell receptor 
signals, to become memory phenotype cells with the ability to rapidly elaborate 
effector function. The role of ITK in this process suggests a mechanism by which IMP 
CD8+ T cells can be rapidly generated in response to infection. 
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Introduction 
The development of different types of memory CD8+ T cells has been 
intensely studied. True memory CD8+ T cells develop in response to antigenic 
exposure, and can provide life-long protection against reinfection (Harty and 
Badovinac, 2008; Lau et al., 1994). More recently other types of memory CD8+ T 
cells have been described, including those generated during homeostatic proliferation 
in lymphopenic environments (or HP cells), virtual memory (or VM cells) or innate 
memory phenotype (IMP cells) (Akue et al., 2012; Broussard et al., 2006; Cheung et 
al., 2009; Haluszczak et al., 2009; Huang et al., 2013). The routes by which these cells 
develop seem to vary, and with the exception of true memory cells, their provenance is 
to date unclear. IMP CD8+ T cells (characterized by the phenotype CD44hi/CD122+) 
express the transcription factor Eomesodermin (Eomes), carry preformed mRNA for 
and rapidly produce IFN-γ upon stimulation (Broussard et al., 2006; Hu et al., 2007; 
Huang et al., 2013).  
The Tec family non-receptor tyrosine kinase ITK plays an important role in T 
cell activation and differentiation, and its absence leads to defects in positive selection 
in the thymus, as well as alterations in Th2 and Th17 cytokine secretion, with reduced 
Th2/Th17 responses to infection or diseases such as allergic asthma (Au-Yeung et al., 
2006; Ferrara et al., 2006; Gomez-Rodriguez et al., 2009; Lucas et al., 2002; Miller et 
al., 2004; Mueller and August, 2003; Schaeffer et al., 2001). In addition, iNKT cells in 
Itk-/- mice exhibit defective maturation and reduced ability to produce effector 
cytokines, including IL-4 (Au-Yeung and Fowell, 2007; Felices and Berg, 2008; Qi et 
al., 2012; Qi et al., 2011). However, while the absence of ITK results in reduced Th2 
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responses, they paradoxically carry elevated serum IgE, suggestive of an ongoing Th2 
response (Miller et al., 2004; Schaeffer et al., 2001). While, Itk-/- mice also have 
elevated numbers of NKT-like γδ T cells that express the transcription factor PLZF 
and secrete IL-4 (Felices et al., 2009; Qi et al., 2009; Yin et al., 2013). We and others 
have shown that the elevated serum IgE, observed in Itk-/- mice is dependent in part on 
NKT-like γδ T cells that secrete IL-4 in these mice (Felices et al., 2009; Qi et al., 
2009).  
Mice lacking ITK also develop a population of IMP CD8+ T cells, shown to be 
dependent on IL-4 and PLZF (Lai et al., 2011; Weinreich et al., 2010), and it has been 
proposed that IMP CD8+ T cell development in the absence of ITK is due to the 
PLZF-dependent NKT-like γδ cells producing IL-4, which acts on by-stander cells in a 
cell-extrinsic manner (Lai et al., 2011). Indeed, IL-4 can directly act on naïve CD8+ T 
cells to induce IFN-γ and Eomes expression (Oliver et al., 2012), providing support for 
this model. We have tested this model and find that while IMP CD8+ T cell 
development in Itk-/- mice is dependent on IL-4/STAT6 signaling, it is surprisingly not 
dependent on γδ T cells, including NKT-like γδ T cells. Furthermore, results from WT 
and Itk-/- mixed bone marrow chimeric models and partial ITK re-expression in Itk-/- 
background model suggest a cell-autonomous role for ITK in this process. We also 
show that that ITK negatively tunes the differentiation of CD44hiCD122+ CD8+ T cells 
from naïve precursors. This work challenges the current model of IMP CD8+ T cell 
development, illustrating a γδ T cell-independent cell-intrinsic role of ITK in memory 
CD8+ T cell development through synergy between IL-4 and the TcR. Furthermore, 
the role of ITK in this process suggests a mechanism by which IMP CD8+ T cells can 
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be rapidly generated in response to infection.   
  75 
Materials and Methods 
 
Mice.  
All mice were on a C57BL/6 background. WT, Tcrd-/- (B6.129P2-Tcrdtm1Mom/J), 
Thy1a (B6.PL-Thy1a/CyJ) and CD45.1 (B6.SJL-Ptprca Pepcb/BoyJ) mice were from 
the Jackson Laboratory (Bar Harbor, ME). Itk/Tcrd DKO mice were generated by 
crossing Itk-/- and Tcrd-/- mice. Thy1a Itk-/- mice were generated by crossing Thy1a and 
Itk-/- mice. Il4ra-/- mice were a kind gift from Dr. Frank Brombacher (University of 
Cape Town, South Africa), via Dr. Fred Finkelman (University of Cincinnati) (Herbert 
et al., 2008). Itk-/-Il4ra-/- mice were generated by crossing Itk-/- and Il4ra-/- mice. Stat6-
/- (generated by Grusby’s group (Kaplan et al., 1996)) and Il13-/- (from Dr. Alfred 
Bothwell at Yale University) mice were kindly provided by Dr. Margaret S. Bynoe 
(Cornell University). Itk-/-Stat6-/- and Itk-/-Il13-/- mice were generated by crossing Itk-/- 
with Stat6-/- or Il13-/- mice. ITKtgItk-/- (Tg(hCD2-Itk)Itk-/-) mice were as previously 
described (Hu and August, 2008). OTI Rag-/- (B6.129S7-Rag1tm1Mom 
Tg(TcraTcrb)1100Mjb N9+N1) mice were purchased from Taconic (Hudson, NY). 
Itk-/- OTI Rag-/- mice were generated by crossing Itk-/- and OTI Rag-/- mice. All 
experiments were approved by the Office of Research Protection’s Institutional 
Animal Care and Use Committee at Cornell University.  
 
Antibodies and reagents.  
All fluorescent antibodies are listed in “fluorochrome-target” format as follows: 
eFluor 450-CD122, FITC-TCRγδ, PerCP-eFluor 710-Eomes, PE-Cy7-IFN-γ 
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(eBioscience, San Diego, CA); V500-CD44, FITC-TCRβV5, FITC-Thy1a, PE-
TCRαV2, PE-T-bet, Alexa Fluor 647-IL-4, Alexa Fluor 647-T-bet, Allophycocyanin-
CD45.2, Alexa Fluor 700-CD4, Alexa Fluor 700-Ki67, PE-Cy7-CD62L, 
Allophycocyanin-Cy7-TCRβ, Allophycocyanin-Cy7-TCRαV2, Allophycocyanin-
Cy7-Thy1a (BD Biosciences, San Jose, CA); PE-Texas Red-CD8α (Invitrogen, 
Carlsbad, CA); Allophycocyanin-NK1.1 (BioLegend, San Diego, CA). Fc blocking 
antibody was from eBioscience. Biotin-conjugated anti- Gr-1, DX5, TER119, CD122 
and CD11b were from BD Biosciences, and anti- B220, F4/80, CD25, CD4 and CD8α 
were from eBioscience. Purified anti-CD3ε and CD28 antibodies used in stimulation 
were from BD Biosciences. PE-PBS57 loaded CD1d tetramer was from the National 
Institute of Allergy and Infectious Diseases Tetramer Facility. Anti-IL-4 monoclonal 
antibody (clone 11B11) was from ATCC (Manassas, VA). Recombinant murine IL-4 
and IL-13 were from PeproTech (Rocky Hill, NJ) and IL-5 was a kind gift from Dr. 
Judith Appleton (Cornell University). 
 
T cells stimulation for flow cytometry.  
Live cells were blocked and stained immediately after collection. For IMP CD8+ T 
cell response, thymocytes and splenocytes were stimulated with PMA/Ionomycin (P/I: 
100 ng/ml/0.5µM) and Brefeldin A (10µg/ml) (Sigma-Aldrich, St. Louis, MO) for 6 
hours, followed by fixation/permeabilization and staining with indicating antibodies 
using FoxP3 staining buffer Kit (eBioscience). For iNKT cell response, 2 µg/mouse α-
GalCer (KRN 7000, Cayman Chemical, Ann Arbor, MI) was injected i.p. to mice 2 
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hours prior to collection of splenocytes, followed by 4-hour incubation with Brefeldin 
A and staining with surface markers, fixation with 4% paraformaldehyde (Electron 
Microscopy Sciences, Hatfield, PA), permeabilization and staining of cytokine 
antibodies using PBS containing 0.4% saponin (Sigma). All flow cytometry data were 
acquired on LSRII (BD Biosciences), and analyzed in FlowJo (Tree Star, Ashland, 
OR). 
 
Mixed bone marrow chimerism.  
Bone marrow chimeras were generated as previously described (Huang et al., 2013), 
with bone marrow composed of 1:1-mixed WT and Itk-/- cells.  
 
Cell purification and real time q-PCR.  
CD8+ and CD4+ T cells were purified by magnetic negative selection. Cells were 
stained with biotin-conjugated antibodies against Gr-1, DX5, TER119, CD11b, B220, 
F4/80, CD25, CD122 and CD4, followed by anti-biotin MicroBeads (Miltenyi Biotec, 
MA). Naïve CD8+ T cells from OTI Rag1-/- or Itk-/- OTI Rag1-/- with purity higher than 
92% (CD8α+TCRβV5+CD44loCD122-) were used. Purified cells were used to extract 
RNA for real time q-PCR as previously described (Qi et al., 2012), or used for in vitro 
stimulation. 
 
IL-4 stimulation in vitro and in vivo.  
Naïve CD8+ T cells cells were treated in vitro with IL-4 (PeproTech, Rocky Hill, NJ; 
40 ng/ml) and/or anti-CD3ε/28 antibodies (1 µg/ml of each, unless otherwise 
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specified) for 5 days for flow cytometry analysis. Cells with IL-4 in culture had more 
than 90% viability by the time of analysis, based on trypan blue (Sigma) staining. For 
in vivo stimulation, 0.4 µg of IL-4 was incubated in room temperature with 4 µg of IL-
4 antibody (11B11) for 5 minutes to form stable IL-4/antibody complex, then given to 
mice via retro-orbital injection every 24 hours. 24 hours post the 6th dose, mice were 
euthanized for analysis.  
 
Statistical analysis.  
Un-paired two-tailed Student’s t test was performed using GraphPad Prism v5.00 
(GraphPad, San Diego, CA), with p < 0.05 considered statistically significant. 
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Results 
 
γδ  T cells are dispensable for development of IMP CD8+ T cells in Itk-/- mice 
Itk-/- mice have elevated development of IMP CD8+ T cells, which is thought to 
be dependent on IL-4 (Weinreich et al., 2010). iNKT cells have been proposed to be 
the source of IL-4, however, iNKT cells in Itk-/- mice have impaired ability to produce 
IL-4 production ((Qi et al., 2012), and see Figure 3-2). By contrast, these mice have 
increased NKT-like γδ T cells that are able to produce IL-4 (Felices et al., 2009; Qi et 
al., 2009; Yin et al., 2013). Given these findings, we explored whether γδ T cells serve 
as producers of IL-4 in the place of the defective iNKT cells for induction of IMP 
CD8+ T cell development in the absence of ITK. We generated Itk-/- mice that lack the 
ability to make γδ T cells by removing the Tcrd gene. We then analyzed the thymi 
(Figure 3-1 A) and spleens (Figure 3-1 B) of WT, Tcrd-/-, Itk-/- and Itk-/-Tcrd-/- mice 
for CD8+ T cells that carry the markers of IMP T cells, CD44 and CD122, their ability 
to rapidly produce IFN-γ, and their expression of transcription factors T-bet and 
Eomes. To our surprise, we found that the absence of γδ T cells on the Itk-/- 
background does not affect the development of IMP CD8+ T cells (Figure 3-1 A&B, 
upper panels), their capacity to rapidly produce IFN-γ (Figure 3-1 A&B, middle 
panels), or their expression of Eomes (Figure 3-1 A&B, lower panels). This suggests 
that although γδ T cells with enhanced potential for IL-4 production are increased in 
Itk-/- mice, they are dispensable for the excessive development of IMP CD8+ T cells in 
these mice. This is different from their requisite role in the hyper-IgE syndrome in Itk-
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/- mice (Felices et al., 2009; Qi et al., 2009). 
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Figure 3-1. γδ  T cells are dispensable for development of IMP CD8+ T cells in Itk-
/- mice. Expression of memory markers CD44 and CD122 (top panel), P/I induced 
IFN-γ (middle panel) and transcription factors Eomes/T-bet (bottom panel) in (A) 
CD8 single positive thymocytes and (B) CD8+ splenocytes from WT, Tcrd-/-, Itk-/- and 
Itk-/-Tcrd-/- mice. *p < 0.05, “ns” = no significance, by Student’s t test. n ≥ 6 from 3 
independent experiments. 
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Persistent deficiency in iNKT development and function Itk-/- mice lacking γδ  T 
cells 
In Itk-/- mice, there is enhanced development of a subpopulation of γδ T cells 
that have features of NKT cells, albeit with features of incomplete differentiation (Yin 
et al., 2013). It has been suggested that the absence of ITK favors the development of 
γδ NKT cells over iNKT cells, due to potential competition between the two 
populations, although recent studies have suggested that such competition may be 
between the most mature subsets of each cell type (Felices and Berg, 2008; Yin et al., 
2013). However, this evidence is indirect, and since we did not observe any effect of 
the absence of γδ T cells on the development of IMP CD8+ T cells in Itk-/- mice, we 
wondered whether the blockade of γδ NKT cell development in Itk-/-Tcrd-/- mice 
would result in an enhancement of iNKT cell development, potentially rescuing their 
ability to produce IL-4. This could also have the effect of influencing development of 
IMP CD8+ T cells in these mice. We therefore analyzed development and function of 
iNKT cells in the Itk-/-Tcrd-/- mice. As previously reported, in the absence of ITK, 
there is reduced maturation and numbers of the CD1d tetramer positive iNKT cell 
population, and these cells are defective in secreting IL-4 and IFN-γ upon stimulation 
with the iNKT cell ligand α-GalCer (Felices and Berg, 2008; Qi et al., 2012; Yin et 
al., 2013). Similar to what was observed for Itk-/- iNKT cells, there was reduced 
percentage, number (Figure 3-2 A&B, upper panels), maturation (Figure 3-2 A&B, 
lower panels) and α-GalCer induced IL-4 and IFN-γ production (Figure 3-2 C&D) by 
iNKT cells in Itk-/-Tcrd-/- mice. Thus the Itk-/-Tcrd-/- mice present an interesting 
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condition for enhanced IMP CD8+ T cell development in which ITK and γδ T cells are 
absent, and iNKT cells are impaired in ability to produce IL-4. Thus possible 
explanations for the continued presence of IMP CD8+ T cells in Itk-/-Tcrd-/- mice 
include alternative source(s) of IL-4 and/or a cell-autonomous role of ITK.  
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Figure 3-2. Impaired development of iNKT cells and cytokine production in Itk-/- 
mice lacking γδ  T cells. Proportion of iNKT cells and expression of maturation 
markers by iNKT cells in the (A) thymus and (B) spleens of WT, Tcrd-/-, Itk-/- and Itk-/-
Tcrd-/- mice. n ≥ 6 from 3 independent experiments. (C) α-GalCer induced IL-4 and 
IFN-γ production by iNKT cells in the spleens of WT, Tcrd-/-, Itk-/- and Itk-/-Tcrd-/- 
mice. *p < 0.05, “ns” = no significance, by Student’s t test. n ≥ 5 from 3 independent 
experiments. 
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ITK negatively tunes IMP CD8+ T cell development in an IL-4/STAT6 dependent 
cell-intrinsic manner 
Confirming the role for IL-4 in this process, removal of either the IL-4Rα or 
STAT6 resulted in complete loss of IMP CD8+ T cells in the absence of ITK in the 
thymus and spleen (Figure 3-3 A&B). Furthermore, although the IL-4 related 
cytokine IL-13 shares the IL-4Rα to transduce its signals and can also activate 
STAT6, the loss of IL-13 along with ITK does not affect the development of IMP 
CD8+ T cells, indicating that the requirement is uniquely associated with IL-4/STAT6 
signaling axis. Indeed, in vitro stimulation revealed that naïve CD8+ T cells uniquely 
respond to IL-4, but not the other two canonical Th2 cytokines, IL-5 and IL-13, with 
increased proliferation, capacity for IFN-γ expression and expression of STAT6 
(Supplemental Figure 3-1). However, IMP CD8+ T cells require the presence of other 
T cells (or B cells) as a source for IL-4 as illustrated in the following experiment. We 
generated mice lacking ITK along with all T (and B cells), except for antigen specific 
T cell receptor transgenic cells (Ovalbumin specific OTI T cells, OTI/Rag1-/-/Itk-/-), 
and determined the phenotype of the resulting CD8+ T cells. We found that the 
resulting Itk-/- CD8+ T cells did not have the IMP phenotype (Figure 3-4 A), 
suggesting that the absence of ITK requires the corporation of IL-4 produced by other 
T (or B cells) to drive the development of IMP CD8+ T cells.  
We have so far failed to identify alternative sources of IL-4 in Itk-/-Tcrd-/- mice, 
and so we focused on the possibility that ITK plays cell-intrinsic function in the 
development of IMP CD8+ T cells. Our previous work identified ITK as a cell-
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intrinsic suppressor of NKT-like γδ T cells using “WT + Itk-/-” 1:1-mixed bone 
marrow chimeras (Qi et al., 2009). Using these chimeric models, we further found that 
despite a lower ratio of total CD8+ T cells derived from Itk-/- donor, a high percentage 
of the CD8+ T cells of Itk-/- origin developed the memory phenotype, while the WT 
CD8+ T cells did not develop the same phenotype, despite being in the same 
environment during development (Figure 3-3 C, lower panel). Furthermore, mice 
expressing ITK on the Itk-/- background to ~35% of WT levels (ITKtgItk-/- mice) 
develop intermediate levels of IMP CD8+ T cells, suggesting an inverse correlation 
between ITK expression levels and development of IMP CD8+ T cells (Figure 3-3 D). 
These data suggest a cell-intrinsic regulatory role of ITK in IMP CD8+ T cell 
differentiation, dependent on IL-4 signaling.  
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Figure 3-3. IL-4/STAT6 signaling axis is required and ITK plays a cell-
autonomous role in development of IMP T cells. Percentage, number of 
CD44+CD122hi IMP CD8+ T cells, percentage of Eomes+ cells and percentage of P/I 
induced IFN-γ producing cells of (A) CD8 single positive thymocytes and (B) CD8+ T 
splenocytes from WT, Itk-/-, Il13-/-, Itk-/-Il13-/-, Il4ra-/-, Itk-/-Il4ra-/-, Stat6-/-, and Itk-/-
Stat6-/- mice. n ≥ 3, combined from 3 independent experiments. (C) WT (Thy1a-
CD45.1+) and Itk-/- (Thy1a+CD45.1-) bone marrow cells were mixed in 1:1 ratio and 
used as donors. Donor originated splenocytes of chimeric mice were analyzed. Ratio 
of γδ T cells of WT and Itk-/- origin were used to confirm functional reconstitution and 
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donor CD8+ T cells analyzed for percentages and number of IMP T cells. n = 3 shown, 
data represent results of 2 independent experiments. (D) Percentage and number of 
IMP CD8+ T cells in WT (100% ITK expression), ITKtgItk-/- (~35% ITK expression) 
and Itk-/- (0% ITK expression) splenocytes. n = 3. Data represent result of more than 3 
independent experiments. *p < 0.05, “ns” = no significance, by Student’s t test.  
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 We next investigated the potential role of ITK downstream of IL-4 and the 
TcR, using naïve CD8+ T cells isolated from WT or Itk-/- mice in OTI Rag-/- 
background, which avoids complicating factors when using the CD8+ T cells from the 
Itk-/- mice (Figure 3-4 A). When cultured in vitro in the presence of IL-4 for 5 days, 
Itk-/- naïve CD8+ T cells required the presence of TcR signals to expand to the WT 
levels, however, a higher proportion of these cells took on an IMP-like state 
(CD44hiCD122+), and these CD44hiCD122+ CD8+ T cells are induced to a 
significantly higher level when both IL-4 and TcR signals are present (Figure 3-4 B). 
These data suggest that in vitro, ITK inversely tunes the response to naïve CD8+ T 
cells to IL-4 to develop into IMP-like cells. 
We also tested whether this was the case in vivo, administering IL-4 (in the 
form of the stabilized IL-4/α-IL-4 complex) (Finkelman et al., 1993), to further 
determine the function of ITK in regulating naïve CD8+ T cell responses to IL-4. We 
found that 6 days post in vivo IL-4/α-IL-4 administration, both WT and Itk-/- CD8 
single positive thymocytes and CD8+ T cells in the spleens exhibited an IMP-like 
state, with elevated percentage and number of CD44hiCD122+ cells compared to 
controls. In addition, the percentage and number of these cells were significantly 
higher in the absence of ITK (Figure 3-4 C). More interestingly, although naïve Itk-/- 
CD8+ T cells had far higher levels of Eomes mRNA compared to WT, it is not 
translated into Eomes protein until IL-4 is provided, suggesting that the naïve Itk-/- 
CD8+ T cells exist in a primed state for IL-4 signals (Figure 3-4 D). 
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Figure 3-4. ITK negatively tunes IL-4/TcR synergy in IMP CD8+ T cell 
development. All cells used in the experiments shown in this figure were on the OTI 
Rag1-/- background. (A) IMP marker expression by CD8 single positive thymocytes 
and CD8+ T splenocytes in WT and Itk-/- mice. Data represent results from more than 
10 mice each. (B) Purified WT and Itk-/- naïve CD8+ T cells were stimulated as 
indicated for 5 days, and total CD8+ T cell number, percentage and number of 
CD44hiCD122+ CD8+ T cells analyzed. n = 3 in each. Data represent result of 2 
independent experiments. (C) WT and Itk-/- mice that received 6 doses of IL-4/α-IL-4 
Ab complexes were analyzed for CD44hiCD122+ proportion of CD8 single positive 
thymocytes and CD8+ splenocytes. n ≥ 3. (D) Eomes mRNA expression of purified 
WT and Itk-/- naïve CD8+ T cells with WT level set as 1 and mean fluorescent intensity 
(MFI) for Eomes protein expression in CD8+ T cells from splenocytes of mice in (C). 
n ≥ 3. *p < 0.05, by Student’s t test. 
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Discussions 
Taken together, our data suggest that in naive CD8+ T cells, ITK acts as a cell-
intrinsic tuner for IL-4 signals. Downstream of the TcR ITK acts to negatively tune the 
IL-4 signals since in its absence, naïve CD8+ T cells exhibit better differentiative 
responses. It is possible that, as has been recently reported for IL-7, TcR signals tune 
cytokine signals that cells receive, in the example of IL-7 by regulating expression 
receptor expression (Kimura et al., 2013). In the case of IL-4, reduced TcR signals in 
the absence of ITK allows enhanced responses to IL-4 signals. Furthermore, this may 
be combined with the ability of ITK signals to suppress the expression of Eomes, 
which may be involved in the development of the IMP state. In the absence of ITK, 
Eomes mRNA is highly upregulated in naïve CD8+ T cells, but IL-4 is required to 
drive the translation of this message. 
While the development of IMP CD8+ T cells in Itk-/- mice is dependent on the 
IL-4/STAT6 signaling axis, this work challenges the prevailing notion that 
development of these cells is due primarily to IL-4 production by NKT-like γδ T cells 
(Hu et al., 2007; Yin et al., 2013). Indeed our experiments suggest that these cells 
develop in response to a combination of exogenous IL-4 signals, but with intrinsic 
tuning by ITK. Weinreich et al. (Weinreich et al., 2010) previously suggested that an 
in vivo environment created by the absence of ITK can influence WT CD8+ T cells to 
develop an IMP-like state in the presence of Itk-/- cells (using a “WT minority + Itk-/- 
majority” bone marrow chimerism strategy), and indeed, WT CD8+ T cells can be 
skewed towards the IMP-state in the presence of IL-4. However, we have found that 
when the ratio of WT:Itk-/- bone marrow is 1:1, the WT cells are not influenced, while 
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the Itk-/- cells retain the ability to develop into IMP cells, suggesting that there may be 
a threshold for the effects of IL-4 to induce IMP CD8+ T cell differentiation, and that 
the absence of ITK tunes that threshold such that it is lower in its absence. If 
analogous to TcR tuning of IL-7 signals, the proposal that ITK tunes IL-4 signals 
would suggest an IL-4 receptor-mediated mechanism. However IL-4Rα expression is 
similarly maintained between WT and Itk-/- and γC was slightly lower in Itk-/- naïve 
CD8+ T cells (Supplemental Figure 3-2), and so it is possible that ITK regulates the 
intracellular signaling sensitivity to IL-4. Indeed, a role for TcR signals in modifying 
IL-4 signaling has been previously suggested. In CD4+ T cells, TcR signals can 
positively modify the IL-4Rα signaling complexes, via the ERK/MAPK and 
Calcium/Calcineurin pathways (Yamashita et al., 2000; Yamashita et al., 1999). By 
contrast, it has also been suggested that TcR signals transiently desensitize IL-4R 
signaling via these two pathways (Zhu et al., 2000). Moreover, the presence of IL-4 
during the development of CD8+ T cells results in reduced TcR-induced calcium 
responses (Lewis et al., 1991). It should be noted that ITK positively regulates TcR 
induced activation of both the ERK/MAPK and calcium pathways (Andreotti et al., 
2010), suggesting that perhaps ITK tunes IL-4 signaling in CD8+ T cells via these 
pathways.  
The cell-autonomous role of ITK in suppressing IMP CD8+ T cell 
differentiation was further supported by the fact that in Itk-/-Tcrd-/- mice where γδ T 
cells are absent and iNKT cells are defective in IL-4 production, CD8+ T cells largely 
have the memory phenotype in the absence of ITK. The synergy of IL-4 and TcR 
signaling pathways in CD44hiCD122+ phenotype differentiation provides a potential 
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explanation for the excess of IMP CD8+ T cell in the absence of ITK. Indeed, the fact 
that Eomes mRNA is significantly increased in Itk-/- naïve CD8+ T cells provides 
strong evidence for an intrinsic role for ITK. Furthermore this elevated Eomes mRNA 
is not translated unless IL-4 is provided, indicating a requisite role of IL-4 in IMP 
CD8+ T cell generation, and suggests that ITK suppresses Eomes expression and in its 
absence, mRNA is transcribed, priming for expression upon a signal for translation, 
and conversion to the memory phenotype. We suggest that under WT conditions, 
CD8+ T cells that have received weak signals (such as those mimicked by the absence 
of ITK) may transcribe Eomes mRNA, and be primed to generate memory phenotype 
cells under inductive conditions such as IL-4. These findings furthermore suggest that 
some naïve CD8+ T cells may be pre-programmed by virtue of weak signals they 
received either during development or during homeostatic expansion upon leaving the 
thymus, to become memory phenotype cells with ability to rapidly respond with 
effector function.  
We have previously reported that IMP CD8+ T cells can rapidly respond to 
primary antigens by producing IFN-γ and TNF-α (Huang et al., 2013), which can be 
critical in developing rapid response or vaccination strategies for emerging pathogens. 
ITK serves as a CD8+ T cell-autonomous tuner for IMP differentiation, and targeting 
ITK may enhance selection or expansion of IMP CD8+ T cells. This would be of 
tremendous benefit in dealing with emerging infectious diseases. 
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Supplemental Figure 3-1. Naïve CD8+ T cells respond uniquely to IL-4 of the 
classical Th2 cytokines. Purified WT naïve CD8+ T cells were stimulated with IL-4 
(40ng/ml, PeproTech), IL-5 (50ng/ml, gift from Dr. Judith Appleton at Cornell 
University) or IL-13 (100ng/ml, PeproTech) for 5 days, then cells analyzed for (A) 
Ki67, or (B) expression of IFN-γ following stimulation with P/I. (C) Number of cells 
recovered. (D) Expression of STAT6 following stimulation with the indicated 
cytokines. n ≥ 3 shown, data represents results of more 3 independent experiments. 
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Supplemental Figure 3-2. Relative expression of IL-4Rα and γC expression on 
naïve CD8+ T cells in WT and Itk-/- OTI-Rag-/- mice. CD8+ T cells from the thymus 
and spleen of WT and Itk-/- OTI-Rag-/- mice were stained with IL-4Rα and γC 
antibodies. WT mean fluorescence intensity (MFI) average was set as 1. n = 5, 
combined from 2 independent experiments. p values were generated by Student’s t 
test, NS: not significant. 
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CHAPTER FOUR 
 
ITK suppresses CD8+ T cell homeostatic proliferation and anti-tumor immunitye 
  
                                                
e Weishan Huang, Junjie Luo, Lu Huang, Fei Huang, and Avery August. ITK suppresses 
CD8+ T cell homeostatic proliferation and anti-tumor immunity. Manuscript in 
preparation. 
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Abstract 
Loss of ITK perturbs CD8+ T cell homeostasis and leads to spontaneous 
acquisition of innate memory/effector phenotype. Using naïve CD8+ T cells obtained 
from OTI Rag-/- background, here we show that ITK regulates lymphopenia-induced 
CD8+ T cell expansion in a T cell-autonomous manner. Itk-/- naïve CD8+ T cells 
exhibit massive immediate expansion, accompanied with potent death programing and 
collapse right after. We show that this is independent of APC-MHCI, but dependent 
on the CD8+ T cell-T cell interaction. The lack of ITK resulted in an enhanced effector 
program and anti-tumor immunity in homeostatically expanded CD8+ T cells. These 
data suggest that ITK intrinsically regulates CD8+ T cell homeostasis and ITK 
deficient homeostatically expanded T cells can generate potent anti-tumor immunity.  
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Introduction 
CD8+ memory T cells, typically characterized by high expression of CD44 and 
CD122, are involved in a broad spectrum of immune activities, such as parasitic 
infection (Cerwenka et al., 1999), immune disorders (Gluck et al., 2007) and 
tumorigenesis (Dobrzanski et al., 2004). Antigenic stimulation normally induces true 
memory CD8+ T cells that can provide life-long protection against reinfection (Ahmed 
and Gray, 1996; Harty and Badovinac, 2008; Lau et al., 1994). In unimmunized 
condition, some other memory-like CD8+ T cell types have been described, including 
those derived through homeostatic proliferation in lymphopenic environments (HP 
CD8+ T cells), virtual memory cells found in normal homeostatic environment (VM 
CD8+ T cells) and innate memory phenotype cells that can be selected through 
hematopoietic MHCI (IMP CD8+ T cells) (Akue et al., 2012; Broussard et al., 2006; 
Cheung et al., 2009; Haluszczak et al., 2009; Hu et al., 2007; Huang et al., 2013). 
Among these exogenous antigen-independent CD8+ T cells, VM cells carry markers 
and features of HP cells (Haluszczak et al., 2009), while IMP CD8+ T cells are distinct 
from HP cells (Huang et al., 2013).  
HP CD8+ T cells are typically derived from naïve T cells proliferation in 
response to lymphopenia condition, dependent on cytokines (IL-7 and/or IL-15) and 
self-antigen-MHCI tonic interaction(Cho et al., 2000; Ernst et al., 1999; Goldrath and 
Bevan, 1999a; Kieper and Jameson, 1999; Le Campion et al., 2002). During 
lymphopenia-induced proliferation, CD8+ T cells undergo clonal expansion 
(Haluszczak et al., 2009) and functional maturation and progressively acquire a 
memory-like phenotype, but carry several distinctions compared to antigen-induced 
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memory. HP CD8+ T cells do not up-regulate antigen-induced early activation markers 
CD25 and CD69, do not shed CD62L like in true memory cells, and express higher 
CD44 and CD122 (Cho et al., 2000; Goldrath et al., 2000; Murali-Krishna et al., 
1999). However, like antigen-induced true memory cells, HP CD8+ require the 
presence of CD4+ T cells during proliferation to acquire protective memory (Hamilton 
et al., 2006). These protective HP CD8+ T cells have been shown to provide 
considerable protection against infection (Hamilton et al., 2006) and tumor growth 
(Dummer et al., 2002; Hu et al., 2002; Wrzesinski and Restifo, 2005), executed by 
IFN-γ mediated cytotoxicity. It is recently reported that, following initiation of 
homeostatic proliferation in a lymphopenic environment, IL-7 is essential in inducing 
mTOR activity which further induces T-bet expression in early proliferation, and this 
T-bet expression is essential for the protective HP CD8+ T cell memory formation in 
later stage; in the later stage, IL-15 gets involved, which turns down mTOR activity 
and so T-bet expression, and turns on the reciprocal Eomes expression for HP-induced 
memory differentiation (Li et al., 2011). 
Tec family kinase, IL-2 inducible T-cell kinase (ITK) is an essential signaling 
mediator downstream of T cell receptor and plays critical roles in T cell differentiation 
and activation (see review (Andreotti et al., 2010)). In the absence of ITK (and/or 
TXK), CD8+ T cells spontaneously develop a memory-like phenotype independently 
of prior antigenic stimulation (Berg, 2007; Broussard et al., 2006; Hu et al., 2007). 
Similar phenotype have been observed in mice expressing a mutant of SLP-76 which 
is defective in interacting with ITK, and in those lacking transcription factors Krüppel-
like factor 2, inhibitor of DNA binding 3 protein, CREB binding protein, and over-
  105 
expressing of T cell factor-1 and β-Catenin (Fukuyama et al., 2009; Jordan et al., 
2008; Sharma et al., 2012; Verykokakis et al., 2010; Weinreich et al., 2009). IMP 
CD8+ T cells express high level of Eomes, and can rapidly produce IFN-γ upon non-
antigenic and antigenic stimulation (Broussard et al., 2006; Hu et al., 2007; Huang et 
al., 2013). The acquired innate memory phenotype in CD8+ T cells in Itk-/- mice is 
dependent on IL-4 (Weinreich et al., 2010), and is genomically distinct from HP CD8+ 
T cell memory (Huang et al., 2013). Nevertheless, the lack of ITK perturbs CD8+ 
memory homeostasis, and ITK regulates the reciprocal expression of T-bet and 
Eomes, to regulate the IFN-γ promoter accessibility (Kannan et al., 2013). Whether 
ITK plays any functions in HP CD8+ T cell proliferation, memory differentiation 
mediated by T-bet/Eomes, protective ability formation mediated by IFN-γ remains to 
be investigated.  
Because of the pivotal role of ITK in T cell activation and function-mediated 
development of allergic diseases, targeting ITK kinase activity has been proposed for 
therapeutic purpose (see review (Sahu and August, 2009)). Here we show that, ITK 
suppresses CD8+ T cell proliferation in a lymphopenic environment and associated 
anti-tumor immunity in a CD8+ T cell manner, thus targeting ITK may have additional 
clinical benefit in cancer therapy.   
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Materials and Methods 
 
Mice.  
All mice were on a C57BL/6 background. OTI Rag-/- (B6.129S7-Rag1tm1Mom 
Tg(TcraTcrb)1100Mjb N9+N1) mice were purchased from Taconic Labs (Hudson, 
NY). Itk-/- OTI Rag-/- mice were generated by crossing Itk-/- and OTI Rag-/- mice. 
CD45.1+ OTI Rag-/- mice were generated by crossing CD45.1+ (B6.SJL-Ptprca 
Pep3b/BoyJ, The Jackson Laboratory, Bar Harbor, ME) and OTI Rag-/- mice. B2m-/- 
Rag-/- mice were generated by crossing B2m-/- (B6.129P2-B2mtm1Unc, Jackson) and 
Rag-/- mice. The Rag-/- mice were kind gifts from Drs. Judith Appleton, Eric Denkers 
and Margaret Bynoe (Cornell University). All experiments were approved by the 
Office of Research Protection’s Institutional Animal Care and Use Committee at 
Cornell University. 
 
Antibodies.  
All fluorochrome-conjugated antibodies used are listed in “fluorochrome-target” 
format as follows: eFluor 450-CD122 (IL-2Rβ/IL-15Rα), PE-T-bet, PerCP-Cy5.5-
CD127 (IL-7Rα), PerCP-eFluor 710-Eomes, PE-Cy7-IFN-γ, and PE-Cy7-NKG2D 
were purchased from eBioscience (San Diego, CA); V500-CD44, FITC-CD45.1, 
FITC-CD45.2, FITC-Fas, FITC-TCRVβ5, PE-Annexin V, PE-IL-4Rα, PE-TCRVα2, 
PE-TNF-α, PE-CF594-CD8α, Cy5-Annexin V, Alexa Fluor 647-T-bet, Alexa Fluor 
700-CD45.1, Alexa Fluor 700-CD45.2, Alexa Fluor 700-CD62L, Alexa Fluor 700-
Ki67 and Allophycocyanin-Cy7-TCRVα2 were purchased from BD Biosciences (San 
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Diego, CA); PE-Texas Red-CD8α were purchased from Invitrogen (Carlsbad, CA); 
FITC-Bcl-2, FITC-KLRG1, Allophycocyanin-CD132 (γC) and PE-Cy7-CD62L were 
from Biolegend (San Diego, CA). Biotin-conjugated anti- Gr-1, DX5, TER119, 
CD122 and CD11b were from BD Biosciences, anti- B220, F4/80, CD11c, c-kit, 
CD25 and CD4 and CD8α were from eBioscience, and anti- CD44 was from 
Biolegend.  
 
Cell purification and adoptive transfer.  
CD8+ naïve T cells were purified from age matching OTI Rag-/- (referred to as WT) 
and Itk-/- OTI Rag-/- (referred to as Itk-/-) littermates through magnetic negative 
selection. Splenocytes were stained by biotin-conjugated antibodies against Gr-1, 
DX5, TER119, CD11b, B220, F4/80, CD25, CD44, CD122 and CD4, followed by 
anti-biotin MicroBeads (Miltenyi Biotec, Cambridge, MA). Cells passed though MS 
column (Miltenyi) with purity (CD8α+TCRVβ5+CD44loCD122-) higher than 95% 
were used for adoptive transfer into Rag-/- recipients, through retro-orbital injection 
(120,000 cell/mouse unless specified otherwise). Recipients were sacrificed for 
analysis at indicated time points.  
 
in vitro stimulation.  
For analysis of IFN-γ and TNF-α secretion by expanded cells, splenocytes were 
collected, plated at 2×106 cells/ml, and either left unstimulated, or stimulated with 100 
ng/ml PMA/0.5 µM Ionomycin (Sigma) (referred to as P/I), 0.1µg/ml OVA257-264 
peptide (Peptides International, Louisville, KY), in the presence of 10 µg/ml Brefeldin 
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A (Sigma) for 6-7 hours, followed by staining and flow cytometric analysis. 
 
Rapamycin treatment.  
Rapamycin (Rapa) was purchase from LC Laboratories (Woburn, MA). Rag-/- hosts 
were weighted and 10 mg/kg (rapa/body weight) was delivered through intraperitoneal 
injection daily for 10 days consecutively following adoptive transfer of purified OTI-
Rag-/- naïve CD8+ T cells. 
 
Tumor inoculation and HP CD8+ T cell treatment. 
EG7-OVA thymoma cells (American Type Culture Collection, Manassas, VA) were 
injected subcutaneously to the backside of CD45.1 mice. 2 days post tumor 
inoculation, rescuing cells (0.12×106 WT or Itk-/- 65 day HP expanded CD8+ T cells) 
were adoptive transferred by retro-orbital injection. Tumor diameters (major and 
minor) were measured with calipers at indicated the time points, and used in an ellipse 
area formula: Volume = 0.524 × (major diameter/2) × (minor diameter/2)2. At 
endpoint of the experiment, tumors were excised and weighed. Tumors, draining 
lymph nodes (axillary and brachial lymph nodes on the side of the tumor), and spleens 
were collected to determine donor HP CD8+ T cell counts. Cells from draining lymph 
nodes were stimulated with P/I or OVA257-264 peptide to determine cytokine 
production.  
 
Flow cytometric staining.  
Cells were resuspended and blocked with anti mouse CD16/CD32 antibody (Fc block, 
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eBioscience) in 2% fetal bovine serum containing PBS (flow buffer), followed by 
surface staining by the indicated antibodies. After surface staining: cells subjected to 
cytokine and nuclear staining were fixed and permeablized with the FoxP3 staining 
buffer set (eBioscience), followed by incubation with antibodies; cells subjected to 
apoptotic assay were stained for Annexin V and PI/RNase as previously described (Qi 
et al., 2012). Stained cells were analyzed on LSRII system (BD Biosciences). Data 
were analyzed using FlowJo software (Tree Star Inc., OR). 
 
Statistical analysis.  
Statistical graphs present data “mean ± s.e.m.”. Unpaired two-tailed student’s t test 
(referred to as t test) and two-way ANalysis Of VAriance between groups (referred to 
as ANOVA) were performed using GraphPad Prism version 5.00 for Macintosh 
(GraphPad, San Diego, CA). A difference with p ≤ 0.05 is considered significant.  
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Results 
 
ITK regulates lymphopenia-induced proliferation 
Under normal condition, naïve CD8+ T cells rarely divide, however, when T 
cell numbers are reduced to low levels, naïve CD8+ T cells will expand to repopulate 
the host, generating a memory phenotype. This lymphopenia-induced homeostatic 
proliferation could be achieved by transferring naïve CD8+ T cells into lymphopenic 
hosts such as Rag-/- mice (Cho et al., 2000; Goldrath and Bevan, 1999a; Goldrath and 
Bevan, 1999b; Marrack et al., 2000; Surh and Sprent, 2008). CD8+ T cells in Itk-/- 
mice carry a spontaneous innate memory phenotype(Broussard et al., 2006; Hu et al., 
2007) (Figure 4-1 a, “Non-Tg”), which is distinct from the memory-like phenotype 
formed post homeostatic proliferation in lymphopenic environment (Huang et al., 
2013). CD8+ T cell memory acquisition in Itk-/- mice has been shown to be induced by 
an IL-4 secreting lymphocytes (Weinreich et al., 2010). In order to investigate the role 
of ITK in naïve CD8+ T cells expansion in a lymphopenic environment, we generated 
Itk-/- mice carrying an OTI transgene (transgenic T cell receptor on only CD8+ T cells, 
specific for chicken ovalbumin 257-264 presented by MHCI H-2kb (Hogquist et al., 
1994)), in Rag-/- background where no other lymphocytes (Mombaerts et al., 1992) 
other than OTI-CD8+ T cells can develop. CD8+ T cells in Itk-/- OTI-Rag-/- mice are 
thus predominantly naïve unlike what is observed in the Itk-/- mice (Figure 4-1 a). We 
used these OTI-Rag-/- models to purify WT and Itk-/- CD8+ T cells and transferred 
them into lymphopenic Rag-/- recipients to examine homeostatic expansion of these 
cells. We found that Itk-/- naïve CD8+ T cells underwent rapid and massive expansion, 
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resulting a > 10 fold population in 10 days, compared to WT cells (Figure 4-1 b). This 
was followed by an early population collapse. The Itk-/- HP population decline was 
comparable to the level of WT T cells, 40 days post transfer, while the WT HP 
population keep on rising to the peak level around 60 days post transfer (Figure 4-1 
b). Thus ITK regulates the dynamics of CD8+ T cell homeostatic proliferation in a 
lymphopenic environment, as ITK deficiency results in loss of control in early 
expansion and alter sustenance of this population. 
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Figure 4-1. ITK deficiency in naïve CD8+ T cells results to massive early 
expansion followed by collapse during homeostatic expansion. (a) Representative 
plots of CD44 and CD122 expression of CD8+ T cells from non-transgenic (Non-Tg) 
or OTI-Rag-/- transgenic WT and Itk-/- mice. (b) Model and dynamics of WT (red 
circle as in a) vs. Itk-/- (blue circle as in a) naïve CD8+ T cell expansion in 
lymphopenic environment: numbers of Vα2+CD8α+ expanded from 0.12×106 naïve 
CD8+ T cells along the time course. n = 3 -14, from more than 2 independent 
experiments for each time point. p values was generated by ANOVA. 
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ITK regulates CD8+ T cell proliferation and apoptosis during expansion induced by 
lymphopenia 
The relative pace of cell proliferation and death determines the rate of CD8+ T 
cell repopulation. To provide more insight into the altered dynamics of the CD8+ T 
cell lymphopenic expansion by the lack of ITK, we examined the proliferative 
capacity and apoptotic tendency of the HP CD8+ T cells. The CD8+ T cell in total 
splenocytes taken directly from WT or Itk-/- OTI Rag-/- mice were used to examine the 
phenotype at initial time point (day 0). Purified WT and Itk-/- OTI Rag-/- CD8+ T cells 
transferred into Rag-/- mice and expanded in spleen of the recipients were analyzed at 
early (day 10) and late (day 75) phases of the lymphopenic expansion. Based on 
analysis of markers of proliferation (Ki67+) and programed cell death (Annexin V+), 
we found that Itk-/- CD8+ T cells exhibited significantly higher signs of proliferation in 
the early phase, and retained a higher proliferative ability into the later phase of the 
lymphopenic expansion compared to WT CD8+ T cells (Figure 4-2 a, left). On the 
other hand, Itk-/- CD8+ T cells exhibited significantly higher apoptotic program much 
earlier than the WT cells (Figure 4-2 a, right). Expression of the pro-apoptotic Fas and 
anti-apoptotic Bcl-2 genes has been shown to regulate CD8+ T cell apoptosis through 
distinct mechanisms in regulating T cell homeostasis (Fortner et al., 2010; Strasser et 
al., 1995). We thus examined the expression of these and found that Itk-/- CD8+ T cells 
significantly up-regulated Fas and down-regulated Bcl-2 in the process of 
lymphopenia-induced proliferation (Figure 4-2 b, top row), suggesting a more potent 
and rapid-acting cell programed cell death and reduced survival ability, compared to 
WT cells. Lymphopenia-induced T cell expansion has been reported to be extrinsically 
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regulated by the common γ chain (γC) cytokines such as IL-2, IL-7 and IL-15, and 
recently reports suggest that IL-4 may also play a role in regulating CD8+ T cell 
expansion (Oliver et al., 2012). We found, very interestingly, that the robustly 
expanding Itk-/- CD8+ T cell expressed lower levels of IL-2Rβ/IL-15Rα (shared 
subunit by IL-2 and IL-15 receptor complexes), IL-4Rα,  IL-7Rα and  γC compared to 
the WT cells during lymphopenia-induced proliferation (Figure 4-2 b, bottom row). 
The reduced expression of cytokine receptors in Itk-/- cells may be the result of 
downregulation of these cytokines following the immediate hyper-proliferation in 
lymphopenic environment, and may further contribute to the observed failure in 
sustaining cell survival at the later stages of HP. It is therefore likely that ITK 
functions as “cruise control” through some environment-sensing, growth/death-
regulating machinery. 
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Figure 4-2. ITK regulates CD8+ T cell proliferation and death in lymphopenic 
environment. Analysis of Vα2+CD8α+ T cells as indicated. (a) Representative plots 
and percentages of proliferative (Ki67+) and apoptotic (Annexin V+) CD8+ T cells at 
initial (day 0), early (day 10) and late (day 75) phase of lymphopenia-induced 
expansion. n ≥ 6, from more than 2 independent experiments for each time point. (b) 
Dynamics of expression (Mean Fluorescent Intensity, MFI, mean ± s.e.m.) of Fas, 
Bcl-2, IL-2Rβ/IL-15Rα, IL-4Rα, IL-7Rα, γC expression CD8+ T cell during 
lymphopenia-induced expansion. n ≥ 3, from more than 2 independent experiments for 
each time point. p values were generated by ANOVA. 
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ITK deficiency enhances CD8+ T cell effector function during lymphopenia-induced 
proliferation 
CD8+ T cells undergoing lymphopenia-induced proliferation progressively 
acquire a memory phenotype, however, antigen-inducible early activation and effector 
markers are not typically expressed (Cho et al., 2000). For example, they display high 
levels of CD44 and CD122, but do not shed CD62L (Goldrath et al., 2000; Murali-
Krishna et al., 1999). However, we found that in the absence of ITK, such cells 
acquire a strong effector memory phenotype characterized by CD44hiCD62Llo 
(Wherry et al., 2003), from very early during HP, which persisted (Figure 4-3 a), 
suggesting that the lack of ITK signals resulted in a bias or enhancement in effector 
memory CD8+ T cells. This effector memory phenotype is accompanied by expression 
of NKG2D, which can regulate TcR-independent, cytotoxic killing of other cells, 
including CD8+ T cells (Chu et al., 2013). T-bet, a potent transcriptional factor that 
regulates driving IFN-γ producing antigen-induced CD8+ effector T cells and their 
function, including cytotoxicity (Sullivan et al., 2003), was transiently up-regulated in 
Itk-/- CD8+ T cells undergoing lymphopenia-induced proliferation at the very early 
stage (Figure 4-3 b). In CD8+ T cell differentiation, T-bet expression is induced by 
mTOR activation and is essential for effector formation; while Eomes expression as a 
result of low mTOR activity contributes to memory differentiation (see review (Chi, 
2012)). In non-transgenic Itk-/- mice, CD8+ T cells exhibit a predominant memory 
phenotype, with significantly up-regulated Eomes expression (Atherly et al., 2006). In 
contrast, we did not observe an increase but rather a slight decrease in Eomes 
expression in Itk-/- HP CD8+ T cells, compared to WT counterpart (Figure 4-3 b). 
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When stimulated by PMA/Ionomycin, a similar proportion of WT and Itk-/- HP CD8+ 
T cells secreted IFN-γ and TNF-α, but Itk-/- HP CD8+ T cells secreted more cytokine 
per cells as shown by higher mean fluorescent intensity (Figure 4-3 b). 
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Figure 4-3. ITK deficiency promotes CD8+ T cell effector memory development 
in lymphopenia-induced proliferation. (a) Representative plots and summary of 
CD44hiCD62Llo effector memory phenotype CD8+ T cells derived from CD8+ T cells 
from the lymphopenic environment. n ≥ 3, from at least 2 independent experiments for 
each time point. p value was generated by ANOVA. (b) Representative (of n ≥ 10) 
plots of NKG2D, T-bet and Eomes expression and P/I induced IFN-γ and TNF-α in 
CD8+ T cells in early (day 10) and late (day 60) phase of lymphopenic proliferation. 
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The hyperactive lymphopenia-induced proliferation in the absence of ITK requires 
mTOR activation 
During CD8+ T cell activation and differentiation, CD62L shedding, increased 
T-bet expression, and reduced expression of Eomes, KLF2, FoxO3 and Bim 
expression are hallmarks of mTOR activity (see review (Chi, 2012)). We observed 
these changes in the Itk-/- HP CD8+ T cells, (including reduction in Eomes, KLF2, 
FoxO3 and Bim expression at the mRNA level (Supplemental Figure 4-1)), 
suggesting the possibility that mTOR is hyperactive in the absence of ITK during this 
process. To further examine this hypothesis, we blocked mTOR activation using 
Rapamycin during the early phase of CD8+ T cell lymphopenic expansion (i.p. 
injection, 10 consecutive days). We found that, blocking mTOR activation 
significantly shrunk the increased CD8+ T cell population in the absence of ITK: Itk-/- 
CD8+ naïve T cells only gave rise to a very limited numbers of cells, comparable to 
those of WT origin (Figure 4-4 a). More importantly, blocking mTOR activation 
prevented the enhanced CD62L shedding in Itk-/- HP CD8+ T cells undergoing 
lymphopenic expansion (Figure 4-4 b). The lack of mTOR activity also alters the 
expression of IL-2 and IL-15 shared receptor and reduced the expression of 
proliferative marker Ki67 to levels similar to WT cells (compared to PBS treated 
group) (Figure 4-4 c, top row). In support of a role for mTOR in this process, we also 
observed reduced expression of T-bet in Rapamycin treated recipients of Itk-/- CD8+ T 
cells, while Eomes remained at a lower level compared to WT (Figure 4-4 c, middle 
row). These data suggest that mTOR activity is required, in the absence of ITK, for the 
hyperactive proliferation and effector phenotype generation in CD8+ T cells 
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undergoing lymphopenia-induced proliferation. However, the impaired survival ability 
indicated by increased expression of Fas and decreased expression of Bcl-2 in the 
absence of ITK is an mTOR independent phenotype (Figure 4-4 c, bottom row).  
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Figure 4-4. ITK regulates CD8+ T cell proliferation and effector memory 
development but not programmed cell death through mTOR. Rag-/- recipients of 
naïve WT or Itk-/- OTI-Rag-/- CD8+ T cells were treated for 10 days with PBS or 
Rapamycin (Rapa). (a) Representative plots and number (sum of spleen and lymph 
node) of WT and Itk-/- CD8+ T cells expanded 10 days post transfer. (b) 
Representative plots and percentage of CD44hiCD62Llo effector memory phenotype 
CD8+ T cells. (c) Representative plots of IL-2Rβ/IL-15Rα, Ki67, IL-4Rα, Fas, Bcl-2, 
T-bet and Eomes in expanded CD8+ T cells. n ≥ 5, from 4 independent experiments. 
*p < 0.05; ns = “not significant”, by t test. 
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CD8+ T cell-intrinsic regulation by ITK in lymphopenia-induced proliferation and 
memory differentiation 
Although WT and Itk-/- naïve CD8+ T cells were transferred and initiated 
lymphopenia-induced proliferation in exactly the same environmental setting, Itk-/- 
cells turned on an immediate massive expansion resulting in a significantly larger 
population compared to WT cells. The large Itk-/- HP CD8+ T cell population at the 
early phase of lymphopenia-induced proliferation may have significant influence on 
the conditions in vivo, for example, in cytokine abundance and cell-cell 
proximity/interaction, which may further lead to the altered later phenotype observed 
in Itk-/- proliferation, death and memory differentiation compared to WT cells. To test 
this possibility, we utilized naive T cells from congenic CD45.1+ WT and CD45.2+ Itk-
/- mice on the OTI-Rag-/- background as donors, and performed an equally mixed 
donor transfer (Figure 4-5 a). This co-transfer model allows WT and Itk-/- CD8+ T 
cells to proliferate in exactly the same in vivo environment along the time course. We 
found that, Itk-/- CD8+ T cells still exhibited the hyperactive expansion, forming a 
significantly higher fraction (Figure 4-5 b&c), and number (Figure 4-5 d) among total 
CD8+ T cells expanded in lymphopenic recipients, independently of the presence of 
co-expanding WT cells. Compared to WT cells, the down-regulation of IL-2/IL-5, IL-
4 and IL-7 receptor expression, enhanced proliferative property (Ki67), up-regulated 
Fas and down-regulated Bcl-2 expression was T cell intrinsic in Itk-/- HP cells, as the 
co-presence of WT cells in the same lymphopenic recipients did not change these 
previously observed differences. Differences in effector memory markers such as 
reduced CD62L, increased CD44, KLRG1, and NKG2D also persisted in this co-
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expansion model. In addition, transient up-regulation of T-bet transient was also 
maintained with no change in Eomes (Figure 4-5 f). These data suggest that the T cell 
sensitivity to growth driving signals and cytokines, along with survival potential is T 
cell-intrinsically regulated by ITK.  
However interestingly, we noted that the presence of WT cells prevented the 
collapse of the Itk-/- population as previously observed upon single transfer (shown in 
Figure 4-1). Furthermore we observed that there was a similar potential of apoptotic 
program in WT and Itk-/- cells, suggesting that the previously enhanced apoptotic 
potential observed upon single transfer (shown in Figure 4-2) is a cell-extrinsic effect, 
likely due to reduced availability of vital resources per cell under those conditions. 
Note that, when co-expanded with Itk-/- cells, WT HP CD8+ T cells exhibit higher 
apoptotic potential starting at the early stage (day 10 in Figure 4-5 e, ~ 30%) 
compared to when expanding alone (day 10 in Figure 4-2 a, ~ 10%). It is possible 
that, in the co-transfer model, WT and Itk-/- T cells compete for the growth factors and 
cytokines, and Itk-/- T cells can better compete, driving more proliferation and survival 
of these cells, despite the increases in pro-apoptotic Fas and decreased anti-apoptotic 
Bcl-2 expression.  
Evaluation of cytokine producing capability of WT and Itk-/- T cells expanded 
for 10 and 60 days by stimulation with PMA/Ionomycin (P/I) revealed that they had 
similar percentage of cells secreting IFN-γ and TNF-α (Figure 4-5 g). ITK is 
downstream of TcR and is critical for cytokine production to antigenic stimulation 
(see review (Andreotti et al., 2010)). Although Itk-/- cells responded to OVA peptide 
stimulation with lower percentage of cells secreting these cytokines, this percentage 
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rose over the time during the expansion (day 60 vs. day 10, is 1.2 fold in WT, but 3 
fold in Itk-/-), suggesting that Itk-/- HP T cells adjusted their sensitivity to TcR signaling 
during homeostatic proliferation, leading to subsequent increases in cytokine 
production upon antigenic stimulation. 
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Figure 4-5. ITK intrinsically regulates CD8+ T cell proliferation, death and 
effector memory development in lymphopenia-induced homeostatic proliferation. 
(a) Purified congenic naïve WT (CD45.1+) and Itk-/- (CD45.1-) CD8+ T cells were 
mixed 1:1, and a total of 120,000 T cells were transferred to Rag-/- lymphopenic 
recipients. (b) Representative plots and (c) summary of fractions of WT and Itk-/- 
Vα2+CD8α+ T cells expanded in lymphopenic environment for 10 and 60 days. p 
values were generated by t test, comparing WT and Itk-/- at each time point. (d) 
Number of expanded WT and Itk-/- CD8+ T cells. p value was generated by ANOVA. 
(e) Percentage of Annexin V+ WT and Itk-/- Vα2+CD8α+ T cells expanded in 
lymphopenic environment for 10 and 60 days. ns = “not significant”, by t test. (f) 
Representative plots for expression of indicated markers by WT and Itk-/- CD8+ T cells 
expanded for 10 and 60 days. (g) IFN-γ and TNF-α expression induced by P/I and 
OVA257-264 peptide. n ≥ 6, from more at least 3 independent experiments for each time 
point. ns = “not significant”. 
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MHCI expression in recipients is not required to trigger hyperactive proliferation 
and effector memory program by donor Itk-/- HP CD8+ T cells 
Lymphopenia-induced CD8+ T cell proliferation has been defined to be the cell 
cycling in response to space, although independent of cognate antigenic simulation, it 
has been suggested that tonic interaction with self-antigen-MHC is critical (Ernst et 
al., 1999; Goldrath and Bevan, 1999a). However, CD8+ T cell memory maintenance 
seems to be independent of host MHC- T cell TcR interaction, as memory CD8+ T 
cells can maintain active division in MHCI deficient recipients (Murali-Krishna et al., 
1999). Thus, we wondered whether the lymphopenic recipient required MHCI 
expression to trigger the hyper-proliferation of Itk-/- CD8+ T cells. To investigate this, 
we generated lymphopenic Rag-/- mice with additional loss of a key component of 
MHCI, β2m resulting in lack of MHCI, (B2m-/-Rag-/-), and used them as lymphopenic 
recipients. Co-transfer of equal numbers of WT and Itk-/- naïve CD8+ T cells into B2m-
/-Rag-/- recipients gave rise to predominantly Itk-/- HP CD8+ T cells (Figure 4-6 a&b), 
leading to significantly larger Itk-/- HP population (Figure 4-6 c). These data suggest 
that tonic interaction between recipient-MHCI and HP CD8+ T cell receptor is not 
required for Itk-/- HP CD8+ T cell hyper-proliferation. Furthermore, the expression of 
cytokine receptors and effector memory markers resembled that of the case when 
recipient MHCI was available (Figure 4-6 e), suggesting that recipient MHCI is not 
required for the T cell intrinsic function regulated by ITK during CD8+ T cell 
homeostatic proliferation in lymphopenic condition. Quite interestingly, Itk-/- HP cells 
expanded in the absence of lymphopenic recipient expression of MHCI exhibited had 
equal ability to produce IFN-γ and TNF-α, and adjusted their sensitivity to cognate 
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antigen/TcR stimulation at a much early stage. This was evidenced by the fact that on 
day 10, Itk-/- HP cells could readily respond to OVA peptide stimulation with more 
40% cells secreting high level of IFN-γ and TNF-α (Figure 4-6 f). This number in the 
case when recipient MHCI was available was around 15% on day 10, and required 
much longer times (60 days) to rise to around 40%. These data suggest that the 
absence of host MHCI enhances the tuning of TcR for increased sensitivity in the 
absence of ITK. 
Also notable was that the lack of recipient MHCI allowed a much larger fold 
expansion (over initial number) by Itk-/- CD8+ T cells during HP (33-fold expansion by 
day 10 in the absence of MHCI (Figure 4-6 c), compared to 3-fold expansion in the 
presence of MHCI (Figure 4-5 d)). This 10-fold higher expansion suggests a 
regulatory function for recipient MHCI in controlling the homeostasis of Itk-/- HP 
CD8+ T cells. Also interestingly, when the Itk-/- CD8+ T cells were the predominant 
population in lymphopenic conditions, the population collapse in later phase of HP 
was similar to the case when Itk-/- cells was expanding in single transfers (Figure 4-1 
b, Itk-/- dynamics). On day 60 under MHCI deficient conditions where the Itk-/- CD8+ T 
cells underwent expansion, WT cells exhibited significantly higher apoptotic potential 
(55.6% vs. 23.6% Annexin V+) (Figure 4-6 d), accompanied by significantly higher 
expression of Fas (MFI ratio = 1:1.65) and lower expression of Bcl-2 (MFI ratio = 
1:0.65), suggesting that WT cells competed poorly for survival signals in the presence 
of the overwhelming response of the Itk-/- HP CD8+ T cells. 
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Figure 4-6. The CD8+ T cell-intrinsic function of ITK in lymphopenia-induced 
proliferation is independent of recipient MHCI expression. (a) 1:1 mixture (total 
120,000) of WT and Itk-/- naïve OTI-Rag-/- CD8+ T cells were transferred into B2m-/-
Rag-/- recipients: representative plots and (b) summary of fractions of WT and Itk-/- 
Vα2+CD8α+ T cells expanded in lymphopenic environment for 10 and 60 days. p 
values were generated by t test, comparing WT and Itk-/- at each time point. (c) 
Number of expanded WT and Itk-/- CD8+ T cells. p value was generated by ANOVA. 
(d) Percentage of Annexin V+ WT and Itk-/- Vα2+CD8α+ T cells expanded in 
lymphopenic environment for 60 days. ns = “not significant”, by t test. (e) 
Representative plots for expression of indicated markers by WT and Itk-/- CD8+ T cells 
expanded for 60 days. (f) IFN-γ and TNF-α expression induced by P/I and OVA257-264 
peptide in cells expanded for 10 days. n ≥ 5, from at least 2 independent experiments 
for each time point. 
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T cell-T cell interactions promote Itk-/- HP CD8+ T cell hyper-proliferation 
As CD8+ T cell also express MHCI and T cell-T cell (T-T) interactions can 
drive the proliferation and effector development of CD8+ T cells (Gerard et al., 2013), 
we examined the role of T cell-T cell interaction in lymphopenia-induced CD8+ T cell 
proliferation. Since transfer of 120,000 T cells could potentially allow T-T interaction, 
we reduced the number of transferred cells to reduce the incidence of T-T interaction 
after transfer. WT and Itk-/- naïve CD8+ were equally mixed at a very low density 
(2000 cells in total), and transfer into B2m-/-Rag-/- recipients and monitored for 
expansion. Ten days post transfer we found that WT cells hardly proliferated, while 
Itk-/- cells did, thus Itk-/- formed the predominant HP population (Figure 4-7 a&b) 
when the T-T proximity was reduced, suggesting that the hyperactive proliferation in 
the absence of ITK is T cell intrinsic, with these cells more sensitive compared to WT 
cells.  
It was however interesting that in the relatively smaller compartment, the 
lymph node, some WT cells were seen, suggesting that this environment may be able 
to generate the proximity required for responses by WT cells. Indeed, when we 
compared the fold expansion over initial numbers of transferred CD8+ T cells, we 
found that when the T cell-T cell proximity was reduced, the significantly higher fold 
expansion of Itk-/- cells in B2m-/-Rag-/- recipients was reduced to a similar level of that 
seen in Rag-/- recipients, (Figure 4-7 c). This data suggest that while recipient-MHCI 
acts to suppress homeostatic expansion of Itk-/- cells, MHCI is required for this 
expansion, and T cell-T cell interaction is sufficient to allow this hyper-expansion.  
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Figure 4-7. T cell-T cell interaction promotes hyperactive proliferation of Itk-/- 
CD8+ T cells. (a) 1:1 mixture (total 120,000 or 2000) WT and Itk-/- naïve OTI-Rag-/- 
CD8+ T cells were transferred into B2m-/-Rag-/- recipients: representative plots and 
summary of fractions of WT and Itk-/- Vα2+CD8α+ T cells expanded in lymphopenic 
environment for 10. (b) Number of WT and Itk-/- CD8+ T cells expanded from 120,000 
(left y axis) or 2000 (right y axis) initial cells. (c) Fold expansion of WT and Itk-/- 
CD8+ T cells in the same environment: 120,000 initial cells in Rag-/- recipients, 
120,000 initial cells in B2m-/-Rag-/- recipients, and 2000 initial cells in B2m-/-Rag-/- 
recipients. p values were generated by t test; ns = “not significant”. n ≥ 2, combined 
from 2 independent experiments. 
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ITK suppresses anti-tumor immunity in lymphopenia-induced proliferated CD8+ T 
cells 
Early transient expression of T-bet regulated by mTOR activation is required 
for the effector memory T cells that give rise to anti-tumor memory CD8+ T cells. This 
transition is control by down-regulating mTOR activity and thus T-bet expression (Li 
et al., 2011). We have observed, in Itk-/- CD8+ T cells, a transient hyper-expression of 
T-bet in early HP that was significantly reduced at later stages (Figure 4-3 b), 
suggesting that Itk-/- HP CD8+ T cells might exhibit an anti-tumor effector immunity. 
WT HP CD8+ cells can develop a protective cytotoxic memory function with the help 
of CD4+ T cells during HP process (Hamilton et al., 2006). In our model, naïve CD8+ 
T cells expanding in lymphopenic recipients would fail to generate protective HP 
CD8+ T cells due to the absence of CD4+ T cells. However, the fact that we observed a 
strong effector phenotype in Itk-/- HP CD8+ T cells, which was not seen in WT cells, 
suggested the possibility that the absence of ITK in during HP of CD8+ T cells may 
result in enhanced anti-tumor effector in the expanded cells. To test this hypothesis, 
we inoculated WT mice with EG7-OVA 0.5 million lymphoma cells, and 2 days post 
tumor inoculation, we transferred WT or Itk-/- HP CD8+ T cells that had been 
separately expanded for 70 days in Rag-/- recipients. Consistent to previous reports 
(Hamilton et al., 2006), WT HP CD8+ T cells expanded in the absence of CD4+ T cells 
did not exhibit any anti-tumor immunity. By contrast, Itk-/- HP CD8+ T cells 
suppressed tumor size by more than 50% (Figure 4-8 a&b). We did not observe 
significant hyper-proliferation of Itk-/- HP CD8+ T cells in tumor recipients, however, 
there was a trend towards increased numbers of these cells at the tumor site, 
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suggesting increased accumulation of these cells in the site of the tumor (Figure 4-8 
c).  
We have described the increased sensitivity of Itk-/- HP CD8+ T cells 
responding to antigenic stimulation over the time of expansion (Figure 4-5). Thus we 
examined whether these cells could secrete cytotoxic cytokines IFN-γ and TNF-α in 
response to antigen specific stimulation given the presence of this tumor antigen 
environment. We found that Itk-/- HP CD8+ T cells from draining lymph nodes readily 
responded to P/I stimulation with increased IFN-γ and TNF-α production (Figure 4-8 
d, P/I). More importantly, these cells responded to tumor antigen OVA257-264 with 
increased IFN-γ and TNF-α (Figure 4-8 d). The anti-tumor immunity in HP CD8+ T 
cell in the absence of ITK gain, in the absence of CD4+ T cell help suggests that ITK 
is a CD8+ T cell-intrinsic suppressor for the development of effector function during 
homeostatic proliferation.  
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Figure 4-8. ITK suppresses CD8+ T cell homeostatic proliferation induced anti- 
tumor immunity. CD45.1+CD45.2- WT mice were inoculated (s.c.) with EG7-OVA 
thymoma cells, and received CD45.1-CD45.2+ WT or Itk-/- HP CD8+ T cells 2 days 
later. (a) Tumor size of tumor recipients that received no (control), WT HP or Itk-/- HP 
CD8+ T cells along the time course post tumor inoculation. p values were generated by 
ANOVA. (b) Tumor weight on day 15. (c) Numbers of CD45.2+ CD8+ T cells in 
tumor site, draining lymph nodes, and spleen on day 15. (d) P/I and OVA257-264 
induced IFN-γ and TNF-α production by CD45.2+ CD8+ T cells in draining lymph 
nodes of tumor recipients on day 15. p values in (b-d) were generated by t test. n ≥ 7, 
ns = “not significant”.  
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Discussions 
We have shown in our previous work that in the absence of ITK, although 
CD8+ T cells spontaneously acquire a memory-like phenotype, they are distinct from 
memory-like cells derived from lymphopenia-induced homeostatic proliferation 
(Huang et al., 2013). It was suggested that the memory-like CD8+ T cells generated in 
Itk-/- mice were dependent on a T cell-extrinsic IL-4 mediated effect (Weinreich et al., 
2010). Here we show a CD8+ T cell-intrinsic regulatory function of ITK in 
lymphopenia-induced proliferation and anti-tumor immunity development.  
In lymphopenia, due to, for example, chemotherapy or irradiation or viral 
infection, naïve CD8+ T cells initiate homeostatic proliferation in response to 
cytokines and self-antigen-MHC tonic interaction (Cho et al., 2000; Ernst et al., 1999; 
Goldrath and Bevan, 1999a). As a result, naïve CD8+ T cells derive the phenotypic 
characteristics of antigen-induced memory, such as high expression of CD44 and 
CD122, rapid production of IFN-γ and cytotoxicity in response to antigenic 
stimulation; but vary in expression of early T cell activation (eg. CD25 and CD69) and 
effector markers (eg. CD62L) (Goldrath et al., 2004; Marleau and Sarvetnick, 2005; 
Stockinger et al., 2004). The absence of ITK in naïve CD8+ T cells results in a 
progressively rapid expansion triggered by lymphopenic environment. Unlike WT HP 
CD8+ T cells that retain CD62L expression, and lack the expression of effector 
memory markers in early stage of lymphopenia-induced proliferation (Cho et al., 
2000), Itk-/- HP CD8+ T cells significantly down-regulate CD62L, giving rise to a 
majority of CD44hiCD62Llo effector memory-like population, together with up-
regulation of effector markers NKG2D and KLGR1. This is accompanied by an 
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mTOR activity dependent up-regulated expression of T-bet, a critical transcriptional 
factor in activating CD8+ T cell effector memory differentiation (Li et al., 2011). 
Inhibiting mTOR suppresses the hyper-proliferation, up-regulated of T-bet expression 
and massive shedding of CD62L in Itk-/- homeostatically expanded CD8+ T cells, 
suggesting that ITK is a regulatory factor in lymphopenia induced CD8+ T cell 
proliferation and effector memory differentiation, and it functions through regulating 
the activity of mTOR. The hyper-proliferative activity and effector memory formation 
induced by the lack of ITK in this process is CD8+ T cell intrinsic, as the co-presence 
of WT CD8+ T cells in lymphopenic recipients fails to rescue these Itk-/- HP CD8+ T 
cell phenotype.  
We have observed a consistent down-regulation of IL-2/IL-15, IL-4 and IL-7 
receptors from early phase of lymphopenia-induced CD8+ T cell proliferation in the 
absence of ITK. These cytokines have potent effect on CD8+ T cell proliferation 
and/or homeostasis (Cho et al., 2007; Oliver et al., 2012; Sprent and Surh, 2011). The 
down-regulation of these cytokine receptors on Itk-/- HP CD8+ T cells compared to 
WT cells, may be the result of early responsiveness, which functions as a regulatory 
machinery to compensate the hyper-active early response. The early competitiveness 
of these cytokine receptors in the absence of ITK may be, in part, the reason of the 
early massive expansion.  
In comparison to the naïve CD8+ T cell homestasis in static state, HP 
homeostasis share the same requirement of self-antige/MHC tonic stimulation 
(Marrack et al., 2000), but differ in that HP memory sustention is independent of co-
stimulatory signaling (Prlic et al., 2001). It has been proposed that the recipient MHCI 
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expression (or antigen presenting cell (APC) -expressed MHCI) is a prerequisition for 
self-antigen presentation to trigger the lymphopenia-induced proliferation (Cho et al., 
2000; Seddon and Zamoyska, 2002), however, we found that in the absence of ITK, 
recipient MHCI actually provides a regulatory system to try to compromise the hyper-
active prliferation of Itk-/- HP CD8+ T cells. As Itk-/- naïve CD8+ T cells expanded 10-
fold more in the absence of recipient MHCI. Then who provides the proliferation-
promoting “tonic interaction”? CD8+ T cells express MHCI, and in antigen-induced 
memory differentiation, CD8+ T cell-T cell synaptic interation plays a major role in 
the development of protective memory, beyond the role of APC (Gerard et al., 2013). 
T-T synapse can be disrupted by blocking the interaction mediator (integrin LFA-1 
component CD11a), or by extensive dilution on T cell density to prevent the 
accessible proximity among T cells (Gerard et al., 2013). In the absenc of APC-MHCI, 
when T-T interaction was interupted in Itk-/- CD8+ T cells, we observed a significantly 
reduced fold expansion, suggesting that T-T interation gives the major contribution to 
the hyper-proliferation seen in Itk-/- HP CD8+ T cells. However, in the absence APC-
MHCI with reduced T-T interaction, Itk-/- cells can still proliferate significantly more 
than the WT cells, which may be contributed by the cytokine effects.  
One profound function of HP CD8+ T cells is anti-tumor activity, which 
benefits tumor therapy following immunocompromiation due to chemo- or radio-
therapy (Dummer et al., 2002; Hu et al., 2002; Wrzesinski and Restifo, 2005). The 
inherent difficulty in using this strategy in cancer therapy is autoimmunity caused by 
the proliferating T cells, especially when the TGF-β signaling intensity is reduced 
(Dudley et al., 2002; Zhang and Bevan, 2012). The occcurance of this autoimmune 
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complication is dependent on the co-presence of CD4+ and CD8+ T cells (Zhang and 
Bevan, 2012). Naïve CD4+ T cells alone cause severe autoimmune inflammatory 
bowel disease in lymphopenia host mediated by CD4+ effector cells (Morrissey et al., 
1993), although this effect can be suppressed by addition of memory CD4+ T cell 
(Mottet et al., 2003). Due to the fundamental role of CD4+ T cell help in inducing 
protective immunity in CD8+ cells during lymphopenia-induced proliferation 
(Hamilton et al., 2006), anti-tumor WT CD8+ T cell clonal expansion may have to 
include CD4+ T cell in the initial infusion. This creates a dilemma of having both 
CD8+ T cell anti-tumor immunity, and CD4+ T cell autoimmunity in lymphopenic 
recipients. 
We report here that, in the absence of ITK, CD8+ T cell clonal expansion in 
lymphopenia gives rise to significant anti-tumor protection. Although ITK is 
downtrean of TcR, Itk-/- CD8+ T cells seemed to adujust their sensitivity in sensing 
associared clonal antigen, with increasing ability in IFN-γ and TNF-α cytokine 
production. This CD8+ T cell-intrinsic training is executable in the absence of ITK. To 
date, no evidence has shown autoimmunity mediated by CD8+ T cells expanded in 
lymphopenia, and the rapidly expanded Itk-/- HP CD8+ T cells described in our model 
didn’t induced mouse wasting or other overt problems, suggesting that these cells 
target and perform cytotoxicity in an antigen specific manner. Our discovery suggests 
a potential way of targeting ITK to selectively skew anti-tumor immunity in HP CD8+ 
T cells in the absence of CD4+ T cell help. This menthod can be significantly 
benefitial when tumor antigen can be identified.  
  
  139 
Acknowledgements 
I thank Lu Huang in help with Rag-/- mouse care in Baker Institute and tumor 
isolation, Dr. Fei Huang for generating Itk-/- OTI-Rag-/- mouse, and Dr. Avery August 
for overall supervision and thoughtful discussion, Lavanya G. Sayam, Misty S. 
Pocwierz, Tina Chew, Yoko Yoda, Dr. Rod Getchell and Dr. Walter Iddings for 
technical support, and Amie L. Wood for animal care. I also thank Drs. Judith 
Appleton, Margaret Bynoe, and Eric Denkers for Rag-/- mice, Dr. Bynoe also for her 
helpful discussion on T cell survival signaling. This work was supported by grants 
from the National Institutes of Health (AI051626 and AI065566 to A.A.).  
 
 
  
  140 
References 
Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: 
understanding their relation. Science 272:54-60. 
Akue, A.D., J.Y. Lee, and S.C. Jameson. 2012. Derivation and maintenance of virtual 
memory CD8 T cells. J. Immunol. 188:2516-2523. 
Andreotti, A.H., P.L. Schwartzberg, R.E. Joseph, and L.J. Berg. 2010. T-cell signaling 
regulated by the Tec family kinase, Itk. Cold Spring Harb. Perspect Biol. 
2:a002287. 
Atherly, L.O., J.A. Lucas, M. Felices, C.C. Yin, S.L. Reiner, and L.J. Berg. 2006. The 
Tec family tyrosine kinases Itk and Rlk regulate the development of 
conventional CD8+ T cells. Immunity 25:79-91. 
Berg, L.J. 2007. Signalling through TEC kinases regulates conventional versus innate 
CD8(+) T-cell development. Nat. Rev. Immunol. 7:479-485. 
Broussard, C., C. Fleischacker, R. Horai, M. Chetana, A.M. Venegas, L.L. Sharp, 
S.M. Hedrick, B.J. Fowlkes, and P.L. Schwartzberg. 2006. Altered 
development of CD8+ T cell lineages in mice deficient for the Tec kinases Itk 
and Rlk. Immunity 25:93-104. 
Cerwenka, A., T.M. Morgan, A.G. Harmsen, and R.W. Dutton. 1999. Migration 
kinetics and final destination of type 1 and type 2 CD8 effector cells predict 
protection against pulmonary virus infection. J. Exp. Med. 189:423-434. 
Cheung, K.P., E. Yang, and A.W. Goldrath. 2009. Memory-like CD8+ T cells 
generated during homeostatic proliferation defer to antigen-experienced 
memory cells. J. Immunol. 183:3364-3372. 
Chi, H. 2012. Regulation and function of mTOR signalling in T cell fate decisions. 
Nat. Rev. Immunol. 12:325-338. 
Cho, B.K., V.P. Rao, Q. Ge, H.N. Eisen, and J. Chen. 2000. Homeostasis-stimulated 
proliferation drives naive T cells to differentiate directly into memory T cells. 
J. Exp. Med. 192:549-556. 
Cho, J.H., O. Boyman, H.O. Kim, B. Hahm, M.P. Rubinstein, C. Ramsey, D.M. Kim, 
C.D. Surh, and J. Sprent. 2007. An intense form of homeostatic proliferation of 
naive CD8+ cells driven by IL-2. J. Exp. Med. 204:1787-1801. 
Chu, T., A.J. Tyznik, S. Roepke, A.M. Berkley, A. Woodward-Davis, L. Pattacini, 
M.J. Bevan, D. Zehn, and M. Prlic. 2013. Bystander-activated memory CD8 T 
cells control early pathogen load in an innate-like, NKG2D-dependent manner. 
Cell Rep. 3:701-708. 
  141 
Dobrzanski, M.J., J.B. Reome, J.A. Hollenbaugh, and R.W. Dutton. 2004. Tc1 and 
Tc2 effector cell therapy elicit long-term tumor immunity by contrasting 
mechanisms that result in complementary endogenous type 1 antitumor 
responses. J. Immunol. 172:1380-1390. 
Dudley, M.E., J.R. Wunderlich, P.F. Robbins, J.C. Yang, P. Hwu, D.J. 
Schwartzentruber, S.L. Topalian, R. Sherry, N.P. Restifo, A.M. Hubicki, M.R. 
Robinson, M. Raffeld, P. Duray, C.A. Seipp, L. Rogers-Freezer, K.E. Morton, 
S.A. Mavroukakis, D.E. White, and S.A. Rosenberg. 2002. Cancer regression 
and autoimmunity in patients after clonal repopulation with antitumor 
lymphocytes. Science 298:850-854. 
Dummer, W., A.G. Niethammer, R. Baccala, B.R. Lawson, N. Wagner, R.A. Reisfeld, 
and A.N. Theofilopoulos. 2002. T cell homeostatic proliferation elicits 
effective antitumor autoimmunity. J. Clin. Invest. 110:185-192. 
Ernst, B., D.S. Lee, J.M. Chang, J. Sprent, and C.D. Surh. 1999. The peptide ligands 
mediating positive selection in the thymus control T cell survival and 
homeostatic proliferation in the periphery. Immunity 11:173-181. 
Fortner, K.A., P. Bouillet, A. Strasser, and R.C. Budd. 2010. Apoptosis regulators Fas 
and Bim synergistically control T-lymphocyte homeostatic proliferation. Eur. 
J. Immunol. 40:3043-3053. 
Fukuyama, T., L.H. Kasper, F. Boussouar, T. Jeevan, J. van Deursen, and P.K. 
Brindle. 2009. Histone acetyltransferase CBP is vital to demarcate 
conventional and innate CD8+ T-cell development. Mol. Cell. Biol. 29:3894-
3904. 
Gerard, A., O. Khan, P. Beemiller, E. Oswald, J. Hu, M. Matloubian, and M.F. 
Krummel. 2013. Secondary T cell-T cell synaptic interactions drive the 
differentiation of protective CD8+ T cells. Nat. Immunol. 14:356-363. 
Gluck, J., B. Rogala, E. Rogala, and E. Oles. 2007. Allergen immunotherapy in 
intermittent allergic rhinitis reduces the intracellular expression of IL-4 by 
CD8+ T cells. Vaccine 26:77-81. 
Goldrath, A.W., and M.J. Bevan. 1999a. Low-affinity ligands for the TCR drive 
proliferation of mature CD8+ T cells in lymphopenic hosts. Immunity 11:183-
190. 
Goldrath, A.W., and M.J. Bevan. 1999b. Selecting and maintaining a diverse T-cell 
repertoire. Nature 402:255-262. 
Goldrath, A.W., L.Y. Bogatzki, and M.J. Bevan. 2000. Naive T cells transiently 
acquire a memory-like phenotype during homeostasis-driven proliferation. J. 
Exp. Med. 192:557-564. 
  142 
Goldrath, A.W., C.J. Luckey, R. Park, C. Benoist, and D. Mathis. 2004. The molecular 
program induced in T cells undergoing homeostatic proliferation. Proc. Natl. 
Acad. Sci. USA 101:16885-16890. 
Haluszczak, C., A.D. Akue, S.E. Hamilton, L.D. Johnson, L. Pujanauski, L. 
Teodorovic, S.C. Jameson, and R.M. Kedl. 2009. The antigen-specific CD8+ T 
cell repertoire in unimmunized mice includes memory phenotype cells bearing 
markers of homeostatic expansion. J. Exp. Med. 206:435-448. 
Hamilton, S.E., M.C. Wolkers, S.P. Schoenberger, and S.C. Jameson. 2006. The 
generation of protective memory-like CD8+ T cells during homeostatic 
proliferation requires CD4+ T cells. Nat. Immunol. 7:475-481. 
Harty, J.T., and V.P. Badovinac. 2008. Shaping and reshaping CD8+ T-cell memory. 
Nat. Rev. Immunol. 8:107-119. 
Hogquist, K.A., S.C. Jameson, W.R. Heath, J.L. Howard, M.J. Bevan, and F.R. 
Carbone. 1994. T cell receptor antagonist peptides induce positive selection. 
Cell 76:17-27. 
Hu, H.M., C.H. Poehlein, W.J. Urba, and B.A. Fox. 2002. Development of antitumor 
immune responses in reconstituted lymphopenic hosts. Cancer Res. 62:3914-
3919. 
Hu, J., N. Sahu, E. Walsh, and A. August. 2007. Memory phenotype CD8+ T cells 
with innate function selectively develop in the absence of active Itk. Eur. J. 
Immunol. 37:2892-2899. 
Huang, W., J. Hu, and A. August. 2013. Cutting edge: innate memory CD8+ T cells 
are distinct from homeostatic expanded CD8+ T cells and rapidly respond to 
primary antigenic stimuli. J. Immunol. 190:2490-2494. 
Jordan, M.S., J.E. Smith, J.C. Burns, J.E. Austin, K.E. Nichols, A.C. Aschenbrenner, 
and G.A. Koretzky. 2008. Complementation in trans of altered thymocyte 
development in mice expressing mutant forms of the adaptor molecule SLP76. 
Immunity 28:359-369. 
Kannan, A.K., N. Sahu, S. Mohanan, S. Mohinta, and A. August. 2013. IL-2-inducible 
T-cell kinase modulates T2-mediated allergic airway inflammation by 
suppressing IFN-gamma in naive CD4 T cells. J. Allergy Clin. Immunol.  
Kieper, W.C., and S.C. Jameson. 1999. Homeostatic expansion and phenotypic 
conversion of naive T cells in response to self peptide/MHC ligands. Proc. 
Natl. Acad. Sci. USA 96:13306-13311. 
Lau, L.L., B.D. Jamieson, T. Somasundaram, and R. Ahmed. 1994. Cytotoxic T-cell 
memory without antigen. Nature 369:648-652. 
  143 
Le Campion, A., C. Bourgeois, F. Lambolez, B. Martin, S. Leaument, N. Dautigny, C. 
Tanchot, C. Penit, and B. Lucas. 2002. Naive T cells proliferate strongly in 
neonatal mice in response to self-peptide/self-MHC complexes. Proc. Natl. 
Acad. Sci. USA 99:4538-4543. 
Li, Q., R.R. Rao, K. Araki, K. Pollizzi, K. Odunsi, J.D. Powell, and P.A. Shrikant. 
2011. A central role for mTOR kinase in homeostatic proliferation induced 
CD8+ T cell memory and tumor immunity. Immunity 34:541-553. 
Marleau, A.M., and N. Sarvetnick. 2005. T cell homeostasis in tolerance and 
immunity. J. Leukoc. Biol. 78:575-584. 
Marrack, P., J. Bender, D. Hildeman, M. Jordan, T. Mitchell, M. Murakami, A. 
Sakamoto, B.C. Schaefer, B. Swanson, and J. Kappler. 2000. Homeostasis of 
alpha beta TCR+ T cells. Nat. Immunol. 1:107-111. 
Mombaerts, P., J. Iacomini, R.S. Johnson, K. Herrup, S. Tonegawa, and V.E. 
Papaioannou. 1992. RAG-1-deficient mice have no mature B and T 
lymphocytes. Cell 68:869-877. 
Morrissey, P.J., K. Charrier, S. Braddy, D. Liggitt, and J.D. Watson. 1993. CD4+ T 
cells that express high levels of CD45RB induce wasting disease when 
transferred into congenic severe combined immunodeficient mice. Disease 
development is prevented by cotransfer of purified CD4+ T cells. J. Exp. Med. 
178:237-244. 
Mottet, C., H.H. Uhlig, and F. Powrie. 2003. Cutting edge: cure of colitis by 
CD4+CD25+ regulatory T cells. J. Immunol. 170:3939-3943. 
Murali-Krishna, K., L.L. Lau, S. Sambhara, F. Lemonnier, J. Altman, and R. Ahmed. 
1999. Persistence of memory CD8 T cells in MHC class I-deficient mice. 
Science 286:1377-1381. 
Oliver, J.A., V.R. Stolberg, S.W. Chensue, and P.D. King. 2012. IL-4 acts as a potent 
stimulator of IFN-gamma expression in CD8+ T cells through STAT6-
dependent and independent induction of Eomesodermin and T-bet. Cytokine 
57:191-199. 
Prlic, M., B.R. Blazar, A. Khoruts, T. Zell, and S.C. Jameson. 2001. Homeostatic 
expansion occurs independently of costimulatory signals. J. Immunol. 
167:5664-5668. 
Qi, Q., W. Huang, Y. Bai, G. Balmus, R.S. Weiss, and A. August. 2012. A unique role 
for ITK in survival of invariant NKT cells associated with the p53-dependent 
pathway in mice. J. Immunol. 188:3611-3619. 
Sahu, N., and A. August. 2009. ITK inhibitors in inflammation and immune-mediated 
  144 
disorders. Curr. Top. Med. Chem. 9:690-703. 
Seddon, B., and R. Zamoyska. 2002. TCR and IL-7 receptor signals can operate 
independently or synergize to promote lymphopenia-induced expansion of 
naive T cells. J. Immunol. 169:3752-3759. 
Sharma, A., Q. Chen, T. Nguyen, Q. Yu, and J.M. Sen. 2012. T cell factor-1 and beta-
catenin control the development of memory-like CD8 thymocytes. J. Immunol. 
188:3859-3868. 
Sprent, J., and C.D. Surh. 2011. Normal T cell homeostasis: the conversion of naive 
cells into memory-phenotype cells. Nat. Immunol. 12:478-484. 
Stockinger, B., G. Kassiotis, and C. Bourgeois. 2004. Homeostasis and T cell 
regulation. Curr. Opin. Immunol. 16:775-779. 
Strasser, A., A.W. Harris, D.C. Huang, P.H. Krammer, and S. Cory. 1995. Bcl-2 and 
Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 
14:6136-6147. 
Sullivan, B.M., A. Juedes, S.J. Szabo, M. von Herrath, and L.H. Glimcher. 2003. 
Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. 
Acad. Sci. USA 100:15818-15823. 
Surh, C.D., and J. Sprent. 2008. Homeostasis of naive and memory T cells. Immunity 
29:848-862. 
Verykokakis, M., M.D. Boos, A. Bendelac, and B.L. Kee. 2010. SAP protein-
dependent natural killer T-like cells regulate the development of CD8(+) T 
cells with innate lymphocyte characteristics. Immunity 33:203-215. 
Weinreich, M.A., O.A. Odumade, S.C. Jameson, and K.A. Hogquist. 2010. T cells 
expressing the transcription factor PLZF regulate the development of memory-
like CD8+ T cells. Nat. Immunol. 11:709-716. 
Weinreich, M.A., K. Takada, C. Skon, S.L. Reiner, S.C. Jameson, and K.A. Hogquist. 
2009. KLF2 transcription-factor deficiency in T cells results in unrestrained 
cytokine production and upregulation of bystander chemokine receptors. 
Immunity 31:122-130. 
Wherry, E.J., V. Teichgraber, T.C. Becker, D. Masopust, S.M. Kaech, R. Antia, U.H. 
von Andrian, and R. Ahmed. 2003. Lineage relationship and protective 
immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225-234. 
Wrzesinski, C., and N.P. Restifo. 2005. Less is more: lymphodepletion followed by 
hematopoietic stem cell transplant augments adoptive T-cell-based anti-tumor 
immunotherapy. Curr. Opin. Immunol. 17:195-201. 
  145 
Zhang, N., and M.J. Bevan. 2012. TGF-beta signaling to T cells inhibits autoimmunity 
during lymphopenia-driven proliferation. Nat. Immunol. 13:667-673. 
 
  
  146 
 
 
Supplemental Figure 4-1. Altered expression of transcriptional factor in Itk-/- 
naïve CD8+ T cells. Purified WT and Itk-/- OTI-Rag-/- naïve CD8+ T cells were 
analyzed for gene expression by quantitative real-time PCR. Values were normalized 
to internal GAPDH values first, and then normalized to WT average. n = 3, *p < 0.05 
by Student’s t test.  
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Innate Memory CD4+ T cells suppress autoimmune graft-versus-host disease in 
micef 
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August. Innate Memory CD4+ T cells suppress autoimmune graft-versus-host disease 
in mice. Submitted. 
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Abstract 
 Chronic graft-versus-host disease (cGVHD) is the major complication post 
bone marrow transplant (BMT). Major histocompatibility complex class II (MHCII) 
influenced CD4+ T cell differentiation and function play critical roles in cGVHD, and 
the lack of hematopoietic MHCII causes cGVHD in syngeneic recipients. Using 
murine models of BMT, we find that MHCII-/-àWT BMTs exhibited defective 
development of hematopoietic MHCII-dependent innate memory phenotype (IMP, 
CD44hi/CD62Llo) CD4+ T cells, and developed cGVHD. Transferring IMP CD4+ T 
cells, but not conventional T regulatory cells (Treg), abrogates pathogenesis, while 
dendritic cells (DC) expressing MHCII rescues IMP CD4+ T cell development and 
prevents pathogenesis. Furthermore the absence of Tec kinase IL-2-inducible T-cell 
kinase (Itk) in MHCII-/- donors leads to preferential development of IMP CD4+ T cells 
and partially prevents pathogenesis. We conclude that IMP CD4+ T cells, regulated by 
Itk and DC-MHCII, can be suppressive during cGVHD. This work provides a 
mechanism for the development of, and an approach to suppress, cGVHD.  
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Introduction 
Bone marrow transplant (BMT) is a widely used therapeutic approach however 
graft-versus-host disease (GVHD) affects post-transplant recovery (Li and Sykes, 
2012). GVHD can be categorized as acute GVHD (aGVHD) or chronic (cGVHD). 
aGVHD is typically mediated by direct cytotoxic effect of donor-derived T cells 
towards the host, where both CD4+ and CD8+ T cells are involved (Schroeder and 
DiPersio, 2011). In contrast, only CD4+ T cells are necessary and cytotoxic CD8+ T 
cells are dispensable for the development of cGVHD (Rolink and Gleichmann, 1983; 
Rolink et al., 1983; Zhang et al., 2006). Syngeneic transplantation in mice has 
revealed that MHCII-CD4 interactions play critical roles in the establishment of 
successful graft acceptance(Marguerat et al., 1999; Teshima et al., 2003). 
Transplantation of bone marrow lacking expression of MHCII into lethally irradiated 
syngeneic WT recipients (MHCII-/-àWT) evolves into systemic cGVHD, with lethal 
colitis, suggesting an impaired hematopoietic-MHCII mediated peripheral regulatory 
mechanism (Marguerat et al., 1999), which is to date unclear.  
 We and others have previously described a subset of CD4+ T cells that have a 
memory-like phenotype, which we refer to as innate memory phenotype (IMP, 
CD44hiCD62Llo) CD4+ T cells (Hu and August, 2008; Qiao et al., 2012). Memory-like 
cells have been better described in the CD8+ T cell compartment, with elevations 
observed in a variety of genetically manipulated mice such as those lacking Itk, CBP, 
Id3 or KLF2 (Berg, 2007; Broussard et al., 2006; Fukuyama et al., 2009; Horai et al., 
2007; Hu et al., 2007; Verykokakis et al., 2010; Weinreich et al., 2010) or expressing a 
Slp-76 mutant that is defective in Itk binding (Jordan et al., 2008), and those over-
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expressing TCF-1, β-catenin (Sharma et al., 2012) or PLZF (Kovalovsky et al., 2010). 
Itk-/- mice exhibit an increased percentage of IMP CD4+ T cells that rapidly produce 
IFN-γ upon stimulation (Hu and August, 2008). Here we have generated mice with 
predominantly naïve or IMP CD4+ T cells, and show that such IMP CD4+ T cells are 
transcriptomically similar to those that develop in WT mice. We further show that the 
lack of IMP CD4+ T cells in the MHCII-/-àWT BMT chimeras is associated with 
significant weight loss, active inflammatory intraepithelial lymphocytes (IEL) in the 
intestine, and a systemic collapse of regulatory CD4+ T cell function. IMP CD4+ T 
cells produced IL-10, and unlike conventional T regulatory cells, could prevent weight 
loss, gut inflammation and activation of inflammatory CD8αβ IEL in MHCII-/-àWT 
chimeras. Furthermore MHCII expression on dendritic cells (DCs) completely rescues 
the development of IMP CD4+ T cells, which suppressed the pathogenesis of cGVHD 
in such chimeras. Finally, we show that Itk plays a role in the development of these 
IMP cells.  
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Materials and Methods 
 
Mice.  
All mice were on a C57BL/6 background. MHCII-/- (B6.129S2-H2dlAb1-Ea/J), Thy1.1 
(B6.PL-Thy1a/CyJ) and CD45.1 (B6.SJL-Ptprca Pepcb/BoyJ) mice were from The 
Jackson Laboratory (Bar Harbor, ME). CD11c promoter driven MHCII re-expressing 
Tg(CD11c-MHCII)/MHCII-/- (referred to as MHCIIDC) mice were previously 
described (Lemos et al., 2003). Itk-/-MHCII-/- mice were generated by crossing Itk-/- 
and MHCII-/- mice. All experiments were approved by the Office of Research 
Protection’s Institutional Animal Care and Use Committee at The Pennsylvania State 
University and Cornell University. 
 
Bone marrow chimeras and body weight.  
Bone marrow chimeras were generated as previously described (Hu and August, 
2008), and weighed at indicated time points post transplantation the same time each 
day.  
 
Antibodies and flow cytometric staining.  
All fluorochrome-conjugated antibodies used are listed in “fluorochrome-target” 
format as follows: PE-FoxP3, Allophycocyanin-CD4, PerCP-Cy5.5-TNF-α, PE-Cy7-
Thy1.1, PE-Cy7-CD62L and PE-Cy7-IFN-γ were from eBioscience (San Diego, CA); 
FITC-CD45.1, V500-CD44, FITC-TCRβ, PE-CD8β, PE-CD25, Alexa Fluor 700-
CD45.2, Alexa Fluor 700-CD62L, Alexa Fluor 700-IL-10, PE-Cy5-CD44, PerCP-
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Cy5.5-CD8α, PE-Cy7-CD4 and Allophycocyanin-Cy7-TCRβ were from BD 
Biosciences (San Diego, CA); PE-Texas Red-CD4 and PE-Texas Red-CD8α were 
from Invitrogen (Carlsbad, CA). Cells were stained for flow cytometric analysis as 
previously described(Huang et al., 2013), followed by analysis on a FC500 (Beckman 
Coulter, Brea, CA) or LSRII system (BD Biosciences). Data were analyzed using 
FlowJo software (Tree Star Inc., OR). 
 
Cell sorting and adoptive transfer.  
WT naïve (CD44loCD62Lhi) and WT IMP (CD44hiCD62Llo) TCRβ+CD4+ T cells from 
WT mice, chimeric naïve (CD45.2+ MHCII-/-àCD45.1+ WT: 
CD45.2+CD44loCD62Lhi) and chimeric IMP (CD45.1+ WTàCD45.2+ MHCII-/-: 
CD45.2-CD44hiCD62Llo) TCRβ+CD4+ T cells of donor source from bone marrow 
chimeras were sorted on a Cytopeia Influx Cell Sorter (Cytopeia, Seattle, WA), and 
cells with purity higher than 95% were used for all experiments. For regulatory cell 
transfer experiments, conventional regulatory T cells (TCRβ+CD4+CD25hi) and IMP 
CD4+ T cells (TCRβ+CD4+CD44hiCD62Llo) were sorted from WT mice (Thy1.1+) on 
a FACSAria Cell Sorter (BD Biosciences). 0.2-0.3×106 cells per injection was used if 
not specified. Intraepithelial lymphocytes (IEL) were isolated as described (Denning et 
al., 2007). 
 
Microarray analysis.  
Total RNA was isolated from sorted WT naïve, WT IMP, chimeric naïve and chimeric 
IMP CD4+ T cells using a RNeasy Plus Mini Kit (Qiagen, Valencia, CA), amplified 
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using MessageAmp™ Premier RNA Amplification Kit (Life Technologies, Grand 
Island, NY), followed by examination on Affymetrix Mouse 430.2 array (Affymetrix, 
Santa Clara, CA). Microarray data were processed, analyzed and rendered using 
Genespring Version 12 (Agilent, Santa Clara, CA) as previously described (Huang et 
al., 2013). All values were further normalized to the average of WT naïve CD4+ T 
cells. Data have been deposited into the National Center for Biotechnology 
Information’s Gene Expression Omnibus repository 
(http://www.ncbi.nlm.nih.gov/gds) under accession number GSE46892.  
 
T cell stimulation and cytokine assay.  
Splenocytes were left unstimulated, or stimulated as previously described (Hu and 
August, 2008; Hu et al., 2007) prior to staining and flow cytometric analysis. To 
examine T cell-derived cytokine production, total splenocytes were stimulated with 1 
µg/ml anti-CD3ε and anti-CD28 antibodies (eBioscience) for 3 days. Supernatants 
were examined for cytokines on a Milliplex multiplex system (EMD Millipore, 
Billerica, MA); cells were re-stimulated with PMA/Ionomycin/Brefeldin A as 
previously described for flow cytometric analysis (Hu and August, 2008).  
 
Statistical analysis.  
Unpaired two-tailed student’s t test and two-way ANOVA were performed using 
GraphPad Prism (GraphPad, San Diego, CA). Group average was plotted with error 
bar indicating s.e.m.. Differences with probability P < 0.05 were considered 
statistically significant.  
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Results  
 
IMP CD4+ T cells develop dependent on hematopoietic MHCII expression and 
independent of thymic positive selection  
Naïve or conventional CD4+ T cells are characterized as CD44lo/CD62Lhi 
(Surh and Sprent, 2008), and require the expression of MHCII on thymic epithelium 
for development (Laufer et al., 1996; Markowitz et al., 1993). The memory αβ T cell 
population (CD44hi and/or CD62Llo) is heterogeneous and is composed of both 
genuine antigen-specific memory T cells, as well as memory phenotype cells that arise 
independently of antigen stimulation (MacLeod et al., 2009; Surh and Sprent, 2008). 
Hematopoietic MHCI is required for the development of innate memory CD8+ T cells 
(Horai et al., 2007; Huang et al., 2013). To investigate this in the CD4+ T cell 
compartment, we generated bone marrow chimeras to allow T cell development in the 
absence of either hematopoietic or thymic epithelial MHCII. Compared to the WT 
bone marrow control, transfer of MHCII-/- bone marrow into WT mice (MHCII-/-
àWT chimeras) gave rise to predominantly naïve CD4+ T cells, with defects in the 
development of functional IMP CD4+ T cells (CD44hiCD62Llo IFN-γ producers). By 
contrast, transfer of WT bone marrow into MHCII-/- deficient mice (WT à MHCII-/- 
chimeras) gave rise to predominantly IMP CD4+ T cells (Figure 5-1 a&b). The lack of 
hematopoietic MHCII in the MHCII-/-àWT chimeras led to defects in the 
development of IMP CD4+ T cells, while the absence of thymic MHCII in the WT à 
MHCII-/- chimeras significantly diminished naïve CD4+ T cell development and 
allowed for IMP CD4+ development, suggesting that IMP CD4+ can bypass thymic 
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selection. To confirm this, we utilized athymic Nude mice in similar experiments. In 
Nude mice, only a few dysfunctional memory-like CD4+ T cells (with memory 
markers but not IFN-γ producing ability) were seen (Supplemental Figure 5-1 a&b). 
However, Nude recipients of WT bone marrow (WTàNude chimeras) gave rise to 
functional IMP CD4+ T cells, suggesting that these cells can develop in the absence of 
a thymus (Supplemental Figure 5-1 c&d).  
To compare naïve and IMP CD4+ T cells derived via this process to those from 
WT mice, we sorted MHCII-/-àWT (MW) naïve and WTàMHCII-/- (WM) IMP 
CD4+ T cells and compared their gene expression profiles to non-manipulated WT 
counterparts. We found few genes differentially expressed in cells from the chimeric 
mice compared to WT cells (Figure 5-1 c). Hierarchical clustering of genes with > 2 
fold change between at least two groups, also classified chimeric naïve and IMP CD4+ 
T cells as similar to their non-grafted naïve and IMP CD4+ T cells counterparts 
respectively (Figure 5-1 d). Thus the bone marrow chimeras can be considered as 
models to generate separate populations of naïve and IMP CD4+ T cells.  
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Figure 5-1. Generation of chimeric mice with predominant naïve or IMP CD4+ T 
cells. Bone marrow chimeras were generated and analyzed as indicated. (a) Flow 
cytometric analysis of expression of CD44, CD62L and IFN-γ by donor CD4+ T cells. 
Data represent results from more than 5 independent experiments. (b) Percentages 
(upper) and numbers (lower) of naïve (left) and IMP (right) CD4+ T cells in indicated 
chimeras. Data were combined from more than 3 independent experiments. P values 
were generated by Student’s t test. (c) Volcano plot of genes differentially expressed 
in CD4+ T cells from MW naïve, WM IMP and WT IMP CD4+ T cells. Genes with > 
2 fold change, P < 0.05, compared to WT naïve CD4+ T cells were included. (d) 
Hierarchical clustering of genes expressed by naïve and IMP CD4+ T cells from 
chimeric (MHCII-/-àWT: MW; WTàMHCII-/-: WM) and WT mice. Quantile 
normalized gene expression (to average level of WT naïve cells) were filtered for > 2 
fold change between at least 2 groups.  
 
 
a
CD44 
C
D
62
L 
WT!WT MHCII-/-!WT WT!MHCII-/- 
0102 103 104 105
85.7
5.49
0102 103 104 105
0
102
103
104
105
9.75
83.8
0102 103 104 105
1.79
95.4 naïve 
IMP 
c
0
20
40
60
80
100
120 P < 0.0001
P < 0.0001
%
 n
aï
ve
 C
D4
0
20
40
60
80
100
P < 0.0001
P < 0.0001
%
  I
M
P 
CD
4
WT
!
WT
MH
CII
-/- !
WT
WT
!
MH
CII
-/-
0
5
10
15
20
P < 0.0001
P < 0.0001
P < 0.0001
X 
10
6 
na
ïv
e 
CD
4
WT
!
WT
MH
CII
-/- !
WT
WT
!
MH
CII
-/-
0.0
0.5
1.0
1.5
2.0
2.5
3.0
P < 0.0001
P = 0.0036
P < 0.0001
X 
10
6  
IM
P 
CD
4
0102 103 104 105
0
102
103
104
105 0.323 4.61
16.878.3
0102 103 104 105
0 15.3
51.233.7
0102 103 104 105
0.21 0.965
13.984.9IF
N
-!
"
b
W
T 
na
ïv
e 
1 
W
T 
na
ïv
e 
2 
W
T 
na
ïv
e 
3 
M
W
 n
aï
ve
 1
 
M
W
 n
aï
ve
 2
 
M
W
 n
aï
ve
 3
 
W
T 
IM
P 
1 
W
T 
IM
P 
2 
W
M
 IM
P 
1 
W
M
 IM
P 
2 
W
M
 IM
P 
3 
low high 
d
Log2 (Fold change) 
-L
og
10
 (P
 v
al
ue
) 
MW naïve vs 
 WT naïve  
WM IMP vs 
 WT IMP  
  157 
Autoreactive pro-inflammatory IELs develop in the absence of hematopoietic 
MHCII  
It has been reported that transfer of MHCII-/- bone marrow into syngeneic WT 
recipients results in fulminating autoimmune graft-versus-host disease, with 
deteriorating intestinal inflammation and subsequent mortality (Marguerat et al., 1999; 
Teshima et al., 2003). Consistently, we observed that MHCII-/-àWT chimeras 
carrying predominantly naïve CD4+ T cells exhibited gradually decreasing body 
weight, while WTàMHCII-/- chimeras carrying predominantly IMP CD4+ T cells 
were able to maintain normal body weight (Figure 5-2 a). Upon further analysis, we 
found that as a measure of the severity of intestinal inflammation, the proportion of the 
weight of the small intestine over body weight is highly correlated with the observed 
body weight loss (Figure 5-2 b). Furthermore, IELs in MHCII-/-àWT chimeras 
exhibited a significantly higher percentage of CD8αβ and lower percentage of 
CD4/CD8αα αβ T cells than WTàWT controls, while WTàMHCII-/- chimeras 
maintained comparable composition of these cell types (Figure 5-2 c&d). Decreases 
in CD4/CD8αα IELs during intestinal inflammation has been attributed to a lack of 
regulatory T cell function in murine models of inflammatory bowel disease (Cheroutre 
and Lambolez, 2008; Das et al., 2003; Yu et al., 2008). CD4+ and CD8+ αβ IELs have 
been reported to be producers of IFN-γ in MHCII-/-àWT bone marrow chimeras 
(Marguerat et al., 1999), and we found that these cells produce both IFN-γ and TNF-α, 
two highly inflammatory cytokines, which was not the case with these cells from 
WTàMHCII-/- chimeras (Figure 5-2 e&f). These data suggest that the severe weight 
loss observed in the MHCII-/-àWT chimeras is associated with increased 
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proinflammatory cytokines by CD4+ and CD8+ αβ IELs.  
  
  159 
 
Figure 5-2. Gut inflammation and pro-inflammatory IELs in mice lacking IMP 
CD4+ T cells. Bone marrow chimeras were generated as indicated, and analyzed 8-10 
weeks post transplantation. (a) Significant weight loss by chimeric mice lacking IMP 
CD4+ T cells. n = 5. Data represent results of > 3 independent experiments. P values 
were generated by two-way ANOVA, comparing groups connected. (b) Percent of 
small intestine or colon weight as a fraction of body weight. Data were combined from 
3 independent experiments. (c) Expression of CD8αα	   and CD8αβ (upper) and 
CD4/CD8αα	   (lower) by TcR	   αβ	   IELs. (d) Percentages of CD8αβ	   and 
CD4/CD8αα	  TcR	  αβ	  IELs. (e) Expression of IFN-γ and TNF-­‐α	  by CD4+ and CD8+	  
αβ	  IEL. (f) Percentages of IFN-γ/TNF-α	  producing CD4+ and CD8+	  αβ	  IELs. In (b-f), 
data were representative or combined results of 3 independent experiments; P values 
were generated by Student’s t test; NS = not significant. 
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Defective T cell regulatory function in the absence of IMP CD4+ T cells  
To investigate potential regulatory function of these T cell populations, we 
compared the composition and regulatory function of T cells in the spleens of 
WTàWT, MHCII-/-àWT and WTàMHCII-/- bone marrow chimeras. Conventional 
regulatory CD4+ T (Treg) cells expressing FoxP3 are well known suppressors of 
multiple autoimmune diseases in both human and mouse (Brusko et al., 2008; Hori et 
al., 2003; Sakaguchi et al., 2008). We found that MHCII-/-àWT chimeric mice with 
severe gut inflammation had significant reductions in FoxP3+ Treg cells as a 
percentage of total CD4+ T cells, while this percentage was significantly higher in 
WTàMHCII-/- chimeras (Figure 5-3 a). Surprisingly however, despite the higher 
percentage of FoxP3+ CD4+ T cells, the number of Treg cells in the WTàMHCII-/- 
chimeras was the same as that seen in MHCII-/-àWT chimeras that developed disease 
(Figure 5-3 b). Furthermore, the IMP CD4+ T cells in the WTàMHCII-/- chimeras 
produced IL-10, a critical immunosuppressive cytokine (Barnes and Powrie, 2009) 
(Figure 5-3 c&d). We also examined other T cell-derived cytokines that may be 
altered between the MHCII-/-àWT chimeras and the WTàMHCII-/- chimeras, 
compared to WTàWT controls, and that correlated with disease occurrence. 
However, aside from the significant reduction in IL-10 and increase in TNF-α 
production in MHCII-/-àWT chimeras (Figure 5-3 e), we did not find any patterns 
among Th1/Th2/Th17 type cytokines examined (Supplemental Figure 5-2). These 
data suggest that in the MHCII-/-àWT chimeras, there is a collapse in the regulatory 
compartment, however, the type of immunosuppressive T cell defect or collapse in 
these mice is unclear. Indeed, while the MHCII-/-àWT chimeras have reduced 
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percentage and number of FoxP3+ Treg cells compared to WT mice, the number of 
these cells is comparable to that seen in the WTàMHCII-/- chimeras which do not 
develop disease, suggesting alternate or additional regulatory T cell components 
responsible for prevention of cGVHD.  
We further analyzed the transcriptomes of IMP CD4+ T cells and found that 
they exhibit elevated expression of multiple master transcription factors for T helper 
sub-lineages, including AhR/c-MAF (driving IL-10 expression in Tr1), T-bet (Tbx21, 
Th1), FoxP3/Helios (Foxp3/Ikzf2, nTreg), and PU.1 (Sfpi-1, Th9), and slight increase 
in GATA3 (Th2) and RORγt (Rorc, Th17) (Figure 5-3 f). Correspondingly, IMP 
CD4+ T cells carry a mosaic T helper cytokine profile at the transcriptional level, with 
equal expression of IL-4 (Th2) and IFN-γ (Th1), slightly enhanced IL-17A/IL-21 
(Th17), and significantly increased IL-10 (Tr1), albeit in the absence of TGF-β 
(Figure 5-3 g). Thus the IMP population of CD4+ T cells likely includes memory and 
memory-like cells for a number of different lineages, but prominent among them, are 
cells that have a regulatory phenotype, suggesting a mechanism for their effect in vivo. 
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Figure 5-3. Systemic collapse of regulatory T cell function in mice lacking IMP 
CD4+ T cells. Bone marrow chimeras were as described in Figure 2. (a) FoxP3 
expression by donor CD4+ T cells in spleens of indicated chimeric mice. (b) 
Percentages and numbers of conventional FoxP3+ regulatory T cells of donor origin. 
In (c-e), splenocytes were stimulated with anti-CD3ε/CD28 antibodies for 3 days, 
followed by PMA/Ionomycin/Brefeldin A treatment for 6-8 hours prior to analysis. (c) 
Expression of IL-10 by CD44hi CD4+ T cells. (d) Percentages of CD44hi IL-10 
producing CD4+ T cells induced by activation. (e) IL-10 and TNF-­‐α	   secreted by 
splenocytes from the indicated chimeric mice stimulated anti-CD3ε/CD28 antibodies 
for 3 days. Data represent results from more than 3 independent experiments; P values 
were generated by Student’s t test; NS = not significant. (f) Expression of CD4+ T 
helper subset master transcription factors. (g) Expression of CD4+ T helper subset 
cytokines. 
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IMP CD4+ T cells but not conventional T regulatory cells rescue MHCII-/-àWT 
chimeras from cGVHD  
As shown in Figure 5-1, IMP CD4+ T cells make up the majority of the CD4+ 
population in WTàMHCII-/- chimeras that do not develop disease, and there are 
significantly more IMP CD4+ T cells in these mice compared to MHCII-/-àWT 
chimeras that do develop disease. In addition, although the IMP CD4+ T cell 
population includes cells that express FoxP3, suggesting the presence of conventional 
Treg cells, they also include features of a Tr1 phenotype. We therefore hypothesized 
that the lack of regulatory IMP CD4+ T cells, rather than Treg cells, was responsible 
for the autoimmune disorder in the MHCII-/-àWT chimeras. To investigate this, we 
sort-purified conventional Treg cells (CD4+TCRβ+CD25hi) and IMP CD4+ T cells 
(CD4+TCRβ+CD44hiCD62Llo) from WT mice and transferred them into MHCII-/-
àWT chimeras to determine whether they could affect disease progression. Transfer 
of IMP CD4+ T cells one-week post BMT significantly reduced weight loss of MHCII-
/-àWT chimeras, confirmed by analysis ratio of small intestine weight:body weight. 
By contrast, transfer of equal numbers of Treg cells (from the same donors) did not 
(Figure 5-4 a&b). However, a single transfer of IMP CD4+ T cells at the early stage 
did not completely abrogate disease, as MHCII-/-àWT chimeric recipients eventually 
started losing significant amounts of weight by eight weeks. Transfer of cells 4 weeks 
post bone marrow transplantation did not have any effect on the disease progression 
(Supplemental Figure 5-3). These data suggest that IMP CD4+ T cells and not 
conventional Treg cells are likely regulators of disease progression in these mice, 
requisitely effective from early stage. 
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Our previous work indicated that IMP CD4+ T cells have a half-life of ~14 
days in vivo (Hu and August, 2008) and so it was possible that incomplete rescue was 
due to turnover of the transferred IMP CD4+ T cells. We therefore transferred IMP 
CD4+ T cells once a week consecutively for 8 weeks to ensure the continuous 
presence of IMP CD4+ T cells in the MHCII-/-àWT chimeras. We found that this 
protocol prevented the progression of disease in these mice (Figure 5-4 c&d). 
Additionally, analysis of the proportion of active CD8αβ αβ IELs, which is strictly 
required for intestinal epithelial barrier disruption (Zufferey et al., 2009), in the 
recipient mice 9 weeks post bone marrow transplantation revealed that this was also 
reduced by the transfer of IMP CD4+ T cells, although regulatory CD4/CD8αα IELs 
were not induced (Figure 5-4 e&f). Of note, the ratio of CD8αβ to CD8+ αβ IELs in 
MHCII-/-àWT chimeric recipients was restored to levels seen in the WTàWT 
chimeras level in the continuous presence of IMP CD4+ T cells (Figure 5-4 f upper 
panel). More importantly, the transferred IMP CD4+ T cells suppressed IFN-γ/TNF-α 
production by both αβ CD4+ and CD8+ IELs, even when a single transfer was 
performed during the early stage post BMT (Figure 5-4 g&h). The complete rescue 
and reversion of the CD8αβ to CD8+ αβ IEL ratio, along with suppression of IFN-
γ/TNF-α production suggests an important role for IMP CD4+ T cells in suppressing 
cGVHD, allowing for successful syngeneic bone marrow transplantation. 
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Figure 5-4. IMP CD4+ but not conventional regulatory T cells suppress 
development of disease. (a) Bone marrow chimeras were generated as described, and 
0.2 - 0.3 × 106 conventional regulatory T cells (+ Treg) or IMP CD4+ T cells (+ IMP 
CD4) were retro-orbitally injected one week post bone marrow transplantation. n = 5. 
P values generated by two-way ANOVA. *P < 0.05 by Student’s t test, comparing “+ 
IMP CD4” to non-rescue group of matched time point. (b) Percent of small intestine 
weight as a function of body weight at time of sacrifice of mice in (a). (c) Bone 
marrow chimeras were generated as described, and cell transfers carried out by weekly 
retro-orbital injection of 0.2 - 0.3 × 106 IMP CD4+ T cells (one dose each week), until 
sacrifice. n=5. P values were generated by two-way ANOVA. (d) Percent of small 
intestine weight over body weight of MHCII-/-àWT mice with different IMP CD4+ 
rescue protocols. Late IMP: single dose 4 weeks post transfer (from Supplemental 
Figure 5-3); Early IMP: single dose 1 week post transfer (from Figure 5-4 c); 
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Multiple IMP: one dose each week from 1 week post transfer. (e) Expression of 
CD8αα	   and CD8αβ	   (upper) and CD4/CD8αα	   (lower) by TcR	   αβ	   IELs. (f) 
Percentages of CD8αβ	  and CD4/CD8αα TcR	  αβ	  IELs. (g) Expression of IFN-­‐γ	  and 
TNF-α	  by CD4+ and CD8+	  TcR αβ	  IEL. (h) Percentages of IFN-γ/TNF-α	  producing 
CD4+ and CD8+ TcR αβ IELs. In (b,d,f&g), P values were generated by Student’s t 
test; NS = not significant. 
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Dendritic cell expression of MHCII is sufficient to allow IMP CD4+ T cell 
development and prevents disease progression 
Dendritic cells (DC) are the major expressers of MHCII among hematopoietic 
cells and enforce clonal deletion of self-reactive T cells, as well as the induction of T 
regulatory cells (Proietto et al., 2008). DCs defective in MHCII-CD4 interaction fail to 
maintain peripheral tolerance (Muth et al., 2012) and tolerogenic CD8α+ plasmacytoid 
precursor DCs can enhance bone marrow engraftment through induction of regulatory 
T cells in vivo (Huang et al., 2011). It is possible that DC-MHCII also contributes to 
the development of IMP CD4+ T cells, which are protective in syngeneic bone marrow 
chimeras. We therefore used a MHCII transgenic model where MHCII is re-expressed 
in MHCII-/- mice solely on CD11c+ DCs (Tg(CD11c-MHCII)/MHCII-/-, referred to as 
MHCIIDC hereafter) (Lemos et al., 2003), as donors to investigate whether DC-
restricted MHCII is important for the development of IMP CD4+ T cells and 
prevention of disease following bone marrow transplantation. We found that MHCII 
expression by DCs did not induce significantly more IMP-like CD4+ T cells compared 
to complete MHCII deficiency, however, DC-restricted expression of MHCII licensed 
functional IMP CD4+ T cells to become potent IFN-γ producers (Supplemental 
Figure 5-4 a&b). Furthermore, transfer of bone marrow from DC-restricted MHCII 
transgenic mice to WT mice (MHCIIDCàWT), led to complete prevention of body 
weight loss (Figure 5-5 c), reversion of ratios of intestine/body weight (Figure 5-5 d), 
CD8αβ:CD8+ αβ IEL ratio, CD4/CD8αα population (Figure 5-5 e&f), and αβ IEL 
IFN-γ/TNF-α production (Figure 5-5 g). This was associated with development of 
IMP CD4+ T cells similar to that seen when MHCII is expressed in the complete 
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hematopoietic compartment (WTàMHCII-/- chimeras) (Figure 5-5 a&b). In addition, 
a significantly higher percentage of CD4+ T cells in the MHCIIDCàWT chimeras 
were capable of producing IL-10 upon T cell receptor activation (Figure 5-5 h). While 
there was some variation in T cell-derived TNF-α by cells from the MHCIIDCàWT 
chimeras, there was significantly enhanced IL-10 production (Figure 5-5 j). Note that 
while DC-MHCII also rescued conventional FoxP3+ regulatory T cells to similar 
levels as in WTàWT controls (Supplemental Figure 5-5 a&b), there were 
significantly higher numbers of IMP CD4+ T cells (Figure 5-5 b, right panel). 
Combined with the inability of conventional Treg cells to prevent disease 
development, we conclude that the ability of CD4+ T cells from MHCIIDCàWT 
chimeras to produce IL-10 may be attributed to regulatory function of DC MHCII-
licensed IMP CD4+ T cells.  
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Figure 5-5. DC-restricted expression of MHCII is sufficient to rescue IMP CD4+ 
T cells and suppress development of disease. Bone marrow chimeras were generated 
as indicated, and were sacrificed for analysis 8-9 weeks post bone marrow 
transplantation. (a) Expression of CD44, CD62L and IFN-γ	  by CD4+ T cells of donor 
origin. Data represent results from more than 2 independent experiments. (b) 
Percentages (left) and numbers (right) of IMP CD4+ T cells in indicated chimeras. (c) 
DC-restricted expression of MHCII on donor bone marrow prevents weight loss. n = 
5. Data represent 2 independent experiments. P values were generated by two-way 
ANOVA. (d) Percent of small intestinal weight as a function of body weight at time of 
sacrifice of mice in (c). (e) Expression of CD8αα	  and CD8αβ and CD4/CD8αα by 
TcR	   αβ	   IELs. (f) Percentages of CD8αβ	   and CD4/CD8αα TcR  αβ	  IELs. (g) 
Expression of IFN-­‐γ	  and TNF-­‐α	  by CD4+ (upper) and CD8+ (lower) TcR αβ IEL. In 
(h-j), splenocytes were stimulated with anti-CD3ε/CD28 antibodies for 3 days, 
followed by PMA/Ionomycin/Brefeldin A for 6-8 hours prior to analysis. (h) 
Expression of IL-10 by CD44hi CD4+ T cells. (i) Percentages of CD44hi IL-10 
producing CD4+ T cells induced by TcR activation. (j) IL-10 and TNF-α secretion. 
For (b,d,f,i&j), data represent results of 2 independent experiments. P values were 
generated by Student’s t test; NS = no significance. 
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The absence of Tec kinase Itk leads to development of IMP CD4+ T cells that can 
attenuate development of disease  
In the absence of the non-receptor tyrosine kinase Itk, the percentage of 
functional (ability to produce IFN-γ) IMP CD4+ is significantly increased (Hu and 
August, 2008) (Supplemental Figure 5-4 c), and the combined absence of Itk and 
MHCII-/- also leads to significantly increased numbers of IMP CD4+ T cells, however, 
these cells now have the capability to produce IFN-γ, unlike those seen in the absence 
of MHCII-/- (Supplemental Figure 5-4 c&d). This suggests that Itk plays a role in 
regulating the development, licensing or function of IMP CD4+ T cells. We therefore 
used these Itk-/-MHCII-/- mice as bone marrow donors to determine the role of Itk in 
the development and function of IMP CD4+ T cells, as well as on the development of 
disease due to the lack of hematopoietic MHCII. We found that the absence of Itk in 
MHCII-/- bone marrow rescued the development of IMP CD4+ T cells (Figure 5-6 
a&b). In addition, the weight loss observed in the MHCII-/-àWT mice is significantly 
attenuated in the WT mice that receive Itk-/-MHCII-/- bone marrow (Itk-/-MHCII-/-
àWT), and compared to WTàWT control, this weight loss is delayed (Figure 5-6 c). 
Nevertheless, the intestine/body weight ratio and the ratio of CD8αβ to CD8+ IELs 
were fully reversed to the control levels in the Itk-/-MHCII-/-àWT chimeric mice 
(Figure 5-6 d, and 5-6 e, upper panel). However, the absence of Itk failed to rescue 
regulatory CD4/CD8αα IELs (Figure 5-6 e, lower panel). Note that, Itk deficiency 
also restored the ability of splenic CD4+ T cells to produce IL-10 (Figure 5-6 g&h). 
Thus Itk plays a regulatory role in the development and function of IMP CD4+ T cells.  
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Figure 5-6. The absence of Itk rescues IMP CD4+ T cell development and 
suppresses disease. Bone marrow chimeras were generated as indicated, and were 
sacrificed for analysis 9 weeks post bone marrow transplantation. (a) Expression of 
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CD44, CD62L and IFN-­‐γ	  in CD4+ T cells of donor origin. (b) Percentages (left) and 
numbers (right) of IMP CD4+ T cells in indicated chimeras. (c) Absence of Itk in 
MHCII-/- bone marrow reduced severity of body weight loss of WT recipients. n = 5. P 
values were generated by two-way ANOVA. (d) Fraction of small intestinal weight 
over body weight at time of sacrifice of mice in (c). (e) Expression of	  CD8αα	  and 
CD8αβ and CD4/CD8αα in	   αβ	   IELs. (f) Percentages of CD8αβ	   and 
CD4/CD8αα αβ	  IELs. In (g&h), splenocytes were stimulated with anti-CD3ε/CD28 
antibodies for 3 days, followed by PMA/Ionomycin/Brefeldin A for 6-8 hours prior to 
analysis. (g) Expression of IL-10 by CD44hi CD4+ T cells. (h) Percentages of CD44hi 
IL-10 producing CD4+ T cells induced by activation. (i) IL-10 and TNF-α secreted by 
splenocytes from the indicated chimeric mice stimulated anti-CD3ε/CD28 antibodies 
for 3 days. For (b,d,f,h&i), P values were generated by Student’s t test; NS = no 
significance.	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Discussions 
BMT of bone marrow lacking expression of MHCII into sub-lethally irradiated 
syngeneic WT recipients results in systemic cGVHD with lethal colitis (Marguerat et 
al., 1999). The cellular mechanism of onset of this disease is not yet elucidated. 
Nevertheless, this syngeneic MHCII-/-àWT transplant-induced cGVHD provides an 
excellent model to investigate factor(s) involved in the failure of “perfect-match” bone 
marrow grafts. Onset of disease may be due to reduced regulatory mechanisms in the 
periphery (Marguerat et al., 1999), or unfettered autoreactive T cells caused by failure 
of hematopoietic-MHCII mediated thymic negative selection (Teshima et al., 2003). 
The latter mechanism has been proposed since although WTàMHCII-/- chimeras fail 
to generate normal number of conventional T regulatory cells (Bensinger et al., 2001), 
they do not develop GVHD. Furthermore thymectomy of WT recipients, which 
eliminates positive selection, prevented GVHD induced by transplant of MHCII-/- 
bone marrow (Denning et al., 2003). However, these findings do not fully support the 
explanation that cGVHD in MHCII-/-àWT chimeras is due to the lack of negative 
selection, and it is likely that this is coupled with a lack of regulatory system. Our data 
support the view that reduced development of the regulatory compartment 
significantly contributes to the development of cGVHD in MHCII-/-àWT BMTs, and 
that IMP CD4+ T cells are dominant over Treg cells as a significant component of this 
regulatory system. This provides an explanation for the previous findings that in 
allogeneic BMT, donor naïve but not CD44hiCD62Llo IMP CD4+ T cells were 
responsible for the onset of GVHD (Zheng et al., 2008), and that chimeras with 
comparable number of Treg cells to healthy control chimeras, still developed severe 
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cGVHD (Sakoda et al., 2007).  
Type 1 regulatory (Tr1) T cells are IL-10 producing CD4+ T cells that play 
essential roles in preventing inflammation, autoimmunity and GVHD (for review see 
(Pot et al., 2011; Roncarolo et al., 2006)). Tr1 cells may be a mixture of multiple Th 
lineages producing IL-10, as IL-10 and IL-10-inducing factors have been found co-
expressed with master regulators of Th1/2/17 as well as by conventional T regulatory 
cells (Tregs) (for review see (Zhu and Paul, 2010)). The ability of Tr1 cells to produce 
IL-10 relies on the expression of c-Maf and the Aryl hydrocarbon receptor (AhR) 
(Apetoh et al., 2010), and is orchestrated by IL-27 producing tolerogenic DCs 
(Toscano et al., 2011). Our finding that the IMP population expressed transcription 
factors that can regulate IL-10 suggests a mechanism for the function of these cells in 
preventing cGVHD, although it is clear that the IMP population includes other cell 
types as well, including Tregs, our data suggest that Tregs are insufficient to prevent 
cGVHD in this model.  
Bone marrow derived DCs play critical roles in the development of self-
tolerance (Hawiger et al., 2001; Probst et al., 2003), including inducing negative 
selection of developing thymocytes (Brocker et al., 1997), and the development of 
Foxp3+ T regulatory cells (Sela et al., 2011). Ablation of DCs in donor marrow leads 
to CD4+ T cell infiltration into multiple peripheral organs in syngeneic WT recipients 
(Ohnmacht et al., 2009), and bone marrow with DCs that are defective in cognate 
CD4+ T-cell recognition resulted in impaired peripheral tolerance with fatal CD8+ T 
cell cytotoxicity in syngeneic WT recipients (Muth et al., 2012). Moreover, we 
identified DCs as the primary hematopoietic cell expressing MHCII required for 
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selection and/or licensing of functional IMP CD4+ T cells. Previous studies using a 
MHCII transgenic mouse model where MHCII is re-expressed in MHCII-/- 
background driven by CD4 promoter and enhancer showed that MHCII expression on 
CD4 expressing cells can contribute to selection of CD4+ T cells with a similar 
memory-like phenotype (e.g., CD44hi (Li et al., 2005; Qiao et al., 2012)). These 
memory-like CD4+ T cells have been defined as thymocyte-selected CD4+ T cells, 
however, it is difficult to rule out that the CD4 promoter/enhancer does not also result 
in expression of MHCII on at least a subset of DCs since DCs have been reported to 
also express CD4 (Vremec et al., 2000). The properties of these cells in BMT have not 
been evaluated and so it is not clear if these cells are the same population of IMP 
CD4+ T cells described here, as it is quite possible that there are alternative pathways 
for the development of IMP CD4+ T cells. Nevertheless, we showed that DC 
expression of MHCII is requisite and sufficient for IMP CD4+ T cell development, T-
cell derived IL-10 production, and prevention of cGVHD in MHCII-/-àWT BMT 
model. Donor T cell derived TNF-α is detrimental and required in the development of 
GVHD (Borsotti et al., 2007; Schmaltz et al., 2003), whereas in humans, IL-10 
promoter polymorphisms are associated with protection in transplantation between 
HLA-identical siblings (Lin et al., 2003). Our data recapitulated this reciprocal 
relationship. Thus MHCII expression by DCs is required for IMP CD4+ T cell 
functional development, and the ability for CD4+ T cells in the transplanted mice to 
produce IL-10, suggesting that DCs may function through antigen presentation to 
license CD4+ T cells with an innate regulatory program, allowing them to suppress T 
cell-mediated GVHD.  
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The absence of Itk leads to reduced naïve CD4+ T cells, but preserved numbers 
of IMP CD4+ T cells (Hu and August, 2008). When Itk is deleted from MHCII-/- donor 
bone marrow, we observed rescued IMP CD4+ T cell development, along with partial 
suppression of cGVHD. This partial response may be related to the role of Itk in T cell 
receptor signaling (Andreotti et al., 2010), trafficking (Xia et al., 2010) and/or survival 
(Qi et al., 2012). Nevertheless, targeting Itk can potentially serve as an in vivo 
supplement to generate IMP CD4+ T cells, or in vitro to enrich IMP CD4+ T cells for 
infusion therapy, thus reducing cGVHD.  
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Supplemental Figure 5-1. Functional development of IMP CD4+ T cells is 
independent of the thymus. (a) Expression of CD44, CD62L and IFN-γ by WT and 
Nude splenocytes. (b) Percentages (left) and number (middle) of IMP CD4+ T cells 
and percentage of CD44hi IFN-γ producing CD4+ T cells (right) in WT and Nude mice 
splenocytes. (c) Bone marrow chimeric mice were generated as indicated, and 
splenocytes of 9-week old chimeras were analyzed for CD44, CD62L and IFN-γ 
expression. (d) Percentages (left) and number (middle) of IMP CD4+ T cells and 
percentage of CD44hi IFN-γ producing CD4+ T cells (right) in indicated chimeric 
mice. P values were generated by Student’s t test; NS = no significance.  
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Supplemental Figure 5-2. Secretion of multiple T cell-derived cytokines by TcR 
stimulated splenocytes lacking either naïve or IMP CD4+ T cells. Splenoctes from 
indicated chimeric mice were stimulated by anti-CD3e/CD28 antibodies for 3 days, 
and supernatants were subjected to multiplex analysis to determine level of secreted 
cytokines. Data combined from 2 independent experiments, n ≥ 5, P values were 
generated by Student’s t test; NS = no significance. 
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Supplemental Figure 5-3. Pathogenesis due to lack of IMP CD4+ T cells is 
irreversible. Bone marrow chimeras were generated as indicated, and 4 weeks post 
bone marrow transplantation, 0.2-0.3×106 conventional regulatory T cells (+ Treg) or 
IMP CD4+ T cells (+ IMP CD4) were injected retro-orbitally. (a) Body weight curves 
of indicated groups. P values were generated by two way-ANOVA. (b) Small 
intestinal weight over body weight at the time of sacrifice of mice in (a). NS = no 
significance by Student’s t test. n ≥ 3 in each group. 
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Supplemental Figure 5-4. DC-restricted MHCII expression or Itk deficiency 
promotes IMP CD4+ T cell functional development in the absence of MHCII-/-. (a) 
Expression of CD44, CD62L and IFN-γ by WT, MHCII-/- and MHCIIDC splenocytes. 
(b) Percentages (left) and number (middle) of IMP CD4+ T cells and percentage of 
CD44hi IFN-γ producing CD4+ T cells (right) in WT, MHCII-/- and CD11c/MHCII 
splenocytes. (c) Expression of CD44, CD62L and IFN-γ by WT, Itk-/-, MHCII-/- and 
Itk-/-MHCII-/- splenocytes. (b) Percentages (left) and number (middle) of IMP CD4+ T 
cells and percentage of CD44hi IFN-γ producing CD4+ T cells (right) in WT, Itk-/-, 
MHCII-/- and Itk-/-MHCII-/- splenocytes. Data represent results from ≥ 2 independent 
experiments. P values were generated by Student’s t test; NS = no significance.  
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Supplemental Figure 5-5. DC-restricted MHCII re-expression or Itk deficiency 
rescues conventional regulatory T cell development in MHCII-/-àWT chimeras. 
Bone marrow chimeric mice were generated as indicated. CD4+ T cells of donor origin 
were analyzed for expression of FoxP3 (a&c) to determine percentages and numbers 
of conventional regulatory T cells (b&d). Data represent results from 2 independent 
experiments. P values were generated by Student’s t test; NS = no significance. 
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CHAPTER SIX 
 
ITK and BTK negatively regulate LPS-induced mast cell-derived TNF-α 
production and septic hypothermiag  
                                                
g Weishan Huang, J. Luis Morales, Victor P. Gazivoda, and Avery August. ITK and BTK 
negatively regulate LPS-induced mast cell-derived TNF-α production and septic 
hypothermia. Manuscript in preparation. 
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Abstract 
Mast cells are indispensible for LPS induced septic hypothermia, in which 
TNF-α plays an essential role to initiate sepsis. Tec kinases ITK and BTK regulate 
mast cell-derived TNF-α in response to allergic antigen, but their role in LPS induced 
TNF-α production by mast cells and related pathology is unclear. We sought to 
investigate the role(s) of ITK and BTK in mast cell response to septic condition. We 
found that the absence of ITK and BTK leads to exacerbation of LPS induced septic 
hypothermia, and enhanced TNF-α production by peritoneal mast cells. Sash mice 
reconstituted with Itk-/-Btk-/- BMMCs develop more severe LPS induced septic 
hypothermia than those reconstituted with WT BMMCs. Itk-/-Btk-/- mast cells exhibit 
hyperactive preformed and LPS-induced TNF-α production, along with enhanced NF-
κB, Akt and p38 activation, compared to WT cells. Blockage of PI3K, Akt or p38 
downstream MNK1 activation significantly suppresses TNF-α hyper-production by 
Itk-/-Btk-/- mast cells in response to LPS, and attenuated septic hypothermia in Itk-/-Btk-/- 
mice. Thus we conclude: ITK and BTK regulate the recovery of thermal homeostasis 
post septic response through mast cell function in mice. They share regulatory 
function downstream of TLR4/LPS in mast cells, through regulating the activation of 
PI3K/Akt, canonical NF-κB and p38 signaling pathways. 
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Introduction 
TNF-α plays a major role in the thermal and cardiovascular disorders 
associated with sepsis (Berry et al., 2004; Meldrum, 1998). Mast cell derived TNF-α is 
a critical initiator in heart failure (Levick et al., 2008) and production of pro-
inflammatory cytokines in ischemia reperfusion (Gilles et al., 2003; Reil et al., 2007). 
Administration of LPS in mice or humans causes sepsis-like symptoms, whereas mast 
cell derived TNF-α rapidly triggered by LPS is indispensible for septic hypothermia in 
mice (Nautiyal et al., 2009). Injection of TNF-α resembles late phase pathogenesis of 
LPS administration (Fairchild et al., 2009). Steroids inhibiting cytokine synthesis can 
blunt, but not eliminate, the severity of endotoxemea, which might be due to the 
incomplete blocking of the initial increase of provoking cytokine(s), or the release of 
preformed cytokine independent of transcriptional control (Alvarez et al., 2007; 
Fairchild et al., 2009). However, mast cell derived TNF-α can also exhibit a protective 
role in reducing mortality in a model of acute septic peritonitis (cecal ligation and 
puncture, CLP) (Echtenacher et al., 1996), and in modulating neutrophil influx during 
bacterial clearance (Malaviya et al., 1996). The crucial role of mast cell derived TNF-
α in local infection, sepsis and myocardial dysfunction is not a novel observation, 
however, how mast cell derived TNF-α production is modulated, remains largely 
unexplained.  
Tec family kinases Tec, ITK and BTK are non receptor tyrosine kinases acting 
downstream of numerous receptors, and have been shown to modulate mast cell 
responses downstream of FcεRIα (Iyer and August, 2008; Iyer et al., 2011; Kawakami 
et al., 1994; Kawakami et al., 1995; Schmidt et al., 2009). In mast cells, ITK and BTK 
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have redundant functions, which might be attributed to structural homology and 
shared substrates (Hata et al., 1998). Neither ITK nor BTK is required for mast cell 
development, but the absence of both leads to impaired FcεRIα-mediated 
degranulation and cytokine secretion, including TNF-α (Iyer and August, 2008; Iyer et 
al., 2011; Kawakami et al., 1994; Kawakami et al., 1995; Schmidt et al., 2009). 
However, the roles of ITK and BTK in mast cell responses to septic condition are 
unclear.  
In mast cells, LPS was shown to activate BMMCs through TLR4 to activate 
MAPKs (Masuda et al., 2002) and NF-κB (Nigo et al., 2006), and induced PI3K/Akt 
activation that regulates NF-κB activation. BTK is shown as a TLR4 binding protein 
involved in NF-κB activation (Jefferies et al., 2003). In monocytic cells BTK 
phosphorylates TLR4 downstream MyD88-adaptor like protein (MAL), leading to 
MAL degradation (Gray et al., 2006). Although some reports suggest that BTK is a 
positive mediator in TLR4 signaling (Doyle et al., 2005; Gray et al., 2006; Jefferies et 
al., 2003; Mansell et al., 2006; Semaan et al., 2011), others suggest that BTK is 
dispensable, as LPS induced TNF-α and IL-6 was slightly increased in 129/Sv 
BMMCs lacking BTK. Recently, BTK was further identified as a negative regulator in 
human primary hematopoietic cell TLR4 signaling through degradation of MAL 
(Marron et al., 2012). This suggests that the role of BTK in TLR4 signaling might be 
cell type specific or strain dependent (Zorn et al., 2009). The role of ITK in mast cell 
response to LPS is not yet investigated.  
In this study, we investigated the function of ITK and BTK in LPS-induced 
mast cell-mediated septic hypothermic response, and report an overall regulatory 
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function for these kinases in suppressing this pro-inflammatory response though 
regulation of NF-κB, PI3K/Akt, p38 and MNK1 signaling activity.   
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Materials and Methods 
 
Mice.  
All mice were on a C57BL/6 background. Itk-/-Btk-/- mice were generated as previously 
described (Iyer et al., 2011). Tnfa-/- (B6.129S-Tnftm1Gkl/J) and Sash (KitW-
sh/HNihrJaeBsmJ) mice were from The Jackson Laboratory (Bar Harbor, ME). All 
experiments were approved by the Office of Research Protection’s IACUC at The 
Pennsylvania State and Cornell Universities. 
 
Generation of BMMCs and reconstitution of BMMCs in Sash mice. 
Bone marrow cells collected from mouse femur were culture in complete DMEM with 
10 ng/ml recombinant murine (rm) IL-3 (Cell Sciences, Canton, MA) and 50 ng/ml 
rmSCF (Rocky Hill, NJ) in ~106 cells/ml, with medium changed every other day. 
After 4 to 6 weeks in culture, BMMCs with purity (c-Kit+FcεRIα+) > 96% were used. 
For in vitro stimulation, 2×106/ml BMMCs were starved in complete DMEM without 
IL-3/SCF overnight, followed by indicated stimulation for indicated time-points. Sash 
mice received 5×106 BMMCs through retro-orbital (intravenous, i.v.) injection and 
5×106 BMMCs though intraperitoneal (i.p.) injection to reconstitute mast cells, 12 
weeks prior to experiment.  
 
LPS induced hypothermia. 
Mice were i.p. injected with 1 mg/kg (compound weight/body weight) LPS, and core 
body temperature (non-invasive measure of central abdomen) was measured at 
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indicated time-points using an infrared thermometer (Reed ST-8812, 
Tequipment.NET, Long Branch, NJ).  
 
Microarray analysis. 
BMMCs were starved for overnight, and treated with PBS or 100 ng/ml LPS for 1 
hour. mRNA from treated cells was extracted with RNeasy Plus Mini Kit (Qiagen, 
Valencia, CA), followed by amplification and array assay (Whole Mouse Genome 
Microarray Kit, 4x44K, Agilent Technologies, Clara, CA) at the Cornell University 
Life Sciences Core Laboratories Center. Microarray data were analyzed using 
GeneSpring GX software (Agilent). Quantile-normalized gene values were used to 
identify genes with significant change (≥ 2 fold change, P < 0.05) in between at one 
pair of “WT+PBS”, “WT+LPS”, “Itk-/-Btk-/-+PBS”, and “Itk-/-Btk-/-+LPS” groups. The 
significantly changed genes are further classified based on the Gene Ontology 
annotation. Those identified as “immune cytokine/chemokine” associated genes were 
used to screen for NF-κB targets (listed http://bioinfo.lifl.fr/NF-KB/NM-mouse.txt, 
derived from (Pahl, 1999)). Selected genes were clustered and presented by 
GeneSpring GX software.  
 
Antibodies and reagents. 
FITC conjugated anti-c-Kit, Phycoerythrin conjugated anti-FcεRIα, and PerCP-eFluor 
710 conjugated anti-TNF-α antibody were from eBioscience (San Diago, CA). Anti- 
phospho- or total p65, p38, ERK, JNK and AKT, anti-phospho-IκBα, anti-p100/p52 
and GAPDH antibodies were from Cell Signaling (Danvers, MA). Anti-IκBα antibody 
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was from Santa Cruz. Horseradish peroxidase (HRP) conjugated anti mouse/rabbit 
IgG secondary antibodies (Jackson ImmunoResearch Laboratories, Inc., West Grove, 
PA) were detected by ECL system (GE Healthcare Biosciences, Pittsburgh, PA). LPS 
(Escherichia coli 0111:B4) was from Sigma-Aldrich (St. Louis, MO). The protein 
transportation blocker Brefeldin A was from Sigma, and used at 10 µg/ml. ITK/BTK 
cross-reactive inhibitor CNX584 was a kind gift from Akt inhibitor Akti1/2 (Santa 
Cruz Biotechnology, Dallas, TX) was used at 10 or 20 µM in vitro, and 5.5 mg/kg in 
vivo. PI3K inhibitor LY294002 (Cayman Chemical, Ann Arbor, MI) was used at 10 or 
20 µM in vitro, and 6.86 mg/kg in vivo. MAP-kinase interacting kinase-1 inhibitor 
CGP57380 (Tocris, Bristol, United Kingdom) was used in 20 µM in vitro, and 9.8 
mg/kg in vivo. 
 
Confocal microscopy and Flow cytometry. 
To determine p65 nuclear translocation, BMMCs were stimulated with 1 µg/ml LPS 
for 15 minutes, fixed and permeabilized with FoxP3 staining buffer kit (eBioscience), 
and stained with Alexa Fluor 488 conjugated anti-p65 antibody (Santa Cruz 
Biotechnology Santa Cruz, CA), in the presence of Fc block (anti-CD16/32, 
eBioscience, San Diego, CA). Following staining, cells were treated with Prolong 
Gold anti-fade reagent with DAPI (Invitrogen, Carlsbad, CA), and imaged on a TCS 
SP5 (Leica Microsystems, Inc., Buffalo Grove, IL) confocal microscope within 24 
hours. Images were processed by ImageJ software (NIH) to calculate the fraction of 
nuclear p65 fluorescence over total. To determine mast cell TNF-α production, cells 
were stained with surface markers in the presence of Fc block, fixation with 4% 
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paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA), permeabilization 
and staining of cytokine antibodies using PBS containing 0.4% saponin (Sigma). All 
flow cytometry data were acquired on LSRII (BD Biosciences), and analyzed in 
FlowJo (Tree Star, Ashland, OR). 
 
Detection of TNF-α mRNA and secretion. 
RNA extracted using RNeasy Plus Mini Kit (Qiagen, Valencia, CA) was converted to 
cDNA with You Prime First-Strand beads kit (GE Healthcare, Piscataway, NJ). 
Quantitative real-time PCR (qRT-PCR) was carried out using Taqman probe sets 
(Applied Biosystems, Foster City, CA). Secreted cytokine in supernatant of indicated 
cells was measured using a Millipore multiplex system (Millipore, Billerica, MA) 
following manufacturer’s instruction. 
 
Statistical analysis. 
Two-tailed Student’s t test (referred to as “t test”) and two-way ANalysis Of VAriance 
between groups (ANOVA) were performed using GraphPad Prism v5.00 (GraphPad, 
San Diego, CA), with p < 0.05 considered statistically significant.   
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Results 
 
ITK and BTK negatively regulate LPS induced hypothermia and mast cell-derived 
TNF-α 
Mast cells have been shown to be responsible for the LPS induced 
hypothermic response, which is mediated by LPS induced TNF-α (Nautiyal et al., 
2009). To determine whether ITK and BTK play roles in mast cell response to LPS 
and thus regulate this the hypothermic response to LPS-induced sepsis, we injected 
WT, Itk-/-, Btk-/- and Itk-/-Btk-/- mice with 1 mg/kg LPS to induce septic hypothermia. 
We found that Itk-/- and Btk-/- mice did not exhibit significantly worse hypothermic 
response compared to WT mice (Supplemental Figure 6-1), however, Itk-/-Btk-/- mice 
suffered significantly exacerbated LPS-induced hypothermia (Figure 6-1 A). 
Furthermore, primary mast cells from mouse peritoneum lavage (PLMCs) from these 
mice carry higher level of preformed TNF-α, and responded to LPS stimulation with 
significantly higher TNF-α production (Figure 6-1 B). These data suggest that, ITK 
and BTK limit the drop in body temperature from the homeostatic levels, and 
contribute to the recovery of thermal homeostasis post exposure to bacterial 
endotoxin. In the absence of ITK and BTK, mast cells are hyperactive to LPS-induced 
TNF-α production, which may be responsible for the exacerbation of hypothermic 
response in murine models. 
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Figure 6-1. The absence of ITK and BTK enhances LPS-induced hypothermia 
and mast cell-derived TNF-α. (A) Change in core body temperature induced by LPS. 
n = 3, p value by ANOVA. (B) Representative plots and average MFI of TNF-α 
expression by peritoneal mast cells treated with PBS or LPS. n ≥ 3, p value by t test. 
 
 
  
WT
Itk-/-Btk-/-
B 
%
 o
f m
ax
im
al
 
TNF-!"
WT+PBS 
WT+LPS 
Itk-/-Btk-/-
+PBS 
Itk-/-Btk-/-
+LPS 0
1000
2000
3000
4000
p = 0.01
p = 0.04
PBS LPS
TN
F-
!
 M
FI
A 
0 30 60 90 12
0
15
0
18
0
21
0
24
0
27
0
30
0
33
0
36
0
39
0
42
0
45
0
48
0
51
0
54
0-4.0
-3.5
-3.0
-2.5
-2.0
-1.5
-1.0
-0.5
0.0
WT
Itk-/-Btk-/-
Time post injection of LPS (min)
p = 0.0298
Change of core body temperature (°C)
 
  201 
Itk-/-Btk-/- BMMCs exhibit hyperactive TNF-α production and exacerbate LPS 
induced hypothermia 
To confirm the role of mast cell-derived TNF-α in LPS-induced hypothermia 
in the absence of ITK and BTK, we aimed to generate a murine model with the loss of 
ITK and BTK only in mast cells. Reconstituting mast cell deficient Sash mice with 
bone marrow derived mast cells (BMMCs) is a potent tool to do so (Grimbaldeston et 
al., 2005). We characterized the effect of the absence of ITK and BTK in TNF-α 
production by the BMMCs. Very intriguingly, we found that in the absence of ITK 
and BTK, BMMCs carry higher amounts of preformed TNF-α transcripts (Figure 6-2 
A), and spontaneously generate and secrete low amounts of TNF-α (Figure 6-2 B). 
When stimulated with LPS, Itk-/-Btk-/- BMMCs rapidly secreted significantly higher 
amounts of TNF-α compared to WT BMMCs, and the more LPS used, the more 
profound this effect was (Figure 6-2 C). This hyperactive TNF-α producing 
phenotype in Itk-/-Btk-/- BMMCs is consistent with what we observed in primary 
PLMCs, suggesting that this was a conserved phenotype between mast cells 
differentiated in vitro and in vivo. We thus used these BMMCs to reconstitute Sash 
mice, and used the “BMMC+Sash” model to examine the function of ITK and BTK in 
LPS-induced mast-mediated hypothermic response. We found that Sash mice 
reconstituted with Itk-/-Btk-/- BMMCs exhibited more severe hypothermic response 
(Figure 6-2 D), suggesting that the lack of ITK and BTK in mast cells only is 
sufficient to cause exacerbated hypothermic response in LPS-induced sepsis. Thus, 
ITK and BTK regulate murine thermal homeostasis in LPS-induced septic response 
through mast cell function.  
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Figure 6-2. ITK and BTK negatively regulate LPS-induced hypothermia via mast 
cells. (A) Relative mRNA expression of preformed TNF-α mRNA in BMMCs. n =6, p 
value by t test. (B) Representative plots of TNF-α synthesis in the steady state by 
BMMCs, of 2 independent experiments. (C) LPS-induced TNF-α mRNA and 
secretion. p values by ANOVA, represent results of 3 experiments. (D) LPS-induced 
hypothermia in BMMC reconstituted Sash mice. Data represents result of 2 
independent experiments. p by ANOVA.  
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ITK and BTK negatively regulate LPS induced canonical NF-κB activation in mast 
cells 
LPS signaling emanating through TLR4 can trigger both canonical and non-
canonical NF-κB pathways. The former is dependent on the phosphorylation and 
release of IκBα from p65 that can translocate into the nuclear compartment, while the 
latter triggers the processing of p100 to generate p52 that can form activating 
complexes to turn on target gene expression (see review (Oeckinghaus et al., 2011)). 
In order to find genes that are significantly altered by the absence of ITK and BTK in 
mast cell response to LPS, we stimulated WT and DKO BMMCs with PBS or LPS for 
1 hour, and assay for gene expression using microarray. We screened for genes with 
significant change due to the lack of ITK and BTK function, and found those 
annotated by Gene Ontology database as immune response-associated. These genes 
were then compared to the reported NF-κB transcriptional targets (Pahl, 1999). We 
noticed from microarray analysis that, along with TNF-α, other NF-κB target genes 
are highly activated in the absence of ITK and BTK in mast cell response to LPS 
(Figure 6-3 A). Thus we examined the activation status of BMMCs stimulation with 
LPS. We found that the canonical NF-κB signaling is highly active in the absence of 
ITK and BTK: IκBα exhibited higher basal phosphorylation, which was increased and 
persisted in response to LPS; meanwhile, p65 phosphorylation is significantly higher 
than that in WT BMMCs in response to LPS (Figure 6-3 B, top four panels). In 
contrast, little conversion of p100 into p52 was observed in either WT or Itk-/-Btk-/- 
BMMCs in both steady state and LPS stimulated state (Figure 6-3 B, top 5&6 panel). 
To further verify that p65 is activated and translocated to the nucleus, we examined 
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the subcellular translocation of p65 following LPS stimulation, and in comparing WT 
and Itk-/-Btk-/- BMMCs, we found that, LPS-induced p65 translocation is more efficient 
in the absence of ITK and BTK (Figure 6-3 C). This suggests that ITK and BTK 
function in mast cells is to negatively regulate the activation of the canonical NF-κB 
signaling pathway, and accordingly suppress LPS-induced mast cell-derived TNF-α 
production. 
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Figure 6-3. Hyperactive canonical NF-κB signaling in Itk-/-Btk-/- BMMC response 
to LPS. (A) Significant change in of NF-κB targeted cytokine/chemokine associated 
gene expression by microarray. (B) LPS induced activation of key components of the 
NF-κB pathway. Data represent results of ≥ 2 experiments. (C) LPS-induced p65 
nuclear translocation. p values by t test. NS: p > 0.05. 
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ITK and BTK regulate LPS induced Akt and p38 signaling activity in mast cells 
LPS induced PI3K/Akt (Song et al., 2012) and MAPK (Avila et al., 2012) 
activation has been shown to regulate the activity of NF-κB pathway in mast cells. To 
determine whether the activation of these signaling pathways are altered in mast cell 
response to LPS in the absence of ITK and BTK, we examined the activation status of 
Akt and MAPKs (including p38, ERK and JNK). We found that Akt phosphorylation 
was enhanced in the absence of ITK and BTK in BMMCs stimulated with LPS along 
the time course (Figure 6-4). In mast cells lacking of ITK and BTK, p38 exhibited 
enhanced basal phosphorylation, and was further significantly induced by stimulation 
of LPS, in contrast, activation of ERK and JNK was impaired (Figure 6-4). This is 
consistent with very recent findings that p38 critically regulates LPS-induced TNF-α 
production in BMMCs, while ERK activation is dispensable (Hochdorfer et al., 2013). 
Thus, MAPKs are differentially regulated by ITK and BTK in the mast cell response 
to LPS. While ITK and BTK negatively regulate p38 activation, they are required for 
optimal activity of ERK and JNK in this process.  
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Figure 6-4. Hyperactive Akt and p38 signaling in Itk-/-Btk-/- BMMC response to 
LPS. LPS induced activation of Akt and MAPKs. Data represent results from ≥ 2 
independent experiments. 
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PI3K/Akt signaling activity is required for LPS induced TNF-α hyper-production 
and exacerbated hypothermia in the absence of ITK and BTK 
The lack of ITK and BTK expression in BMMCs led to hyperactive Akt in 
response to LPS. PI3K has been well characterized as a major activator up-stream of 
Akt (Franke et al., 1997). To test whether PI3K and Akt can be attributed to the 
hyperactive TNF-α production and associated septic hypothermia due to the mast cells 
response to LPS in the absence of ITK and BTK, we used PI3K inhibitor LY294002 
(Vlahos et al., 1994) and Akt inhibitor Akti1/2 (Barnett et al., 2005) to treat BMMCs 
and PLMCs, and measured the LPS-induced TNF-α production. Blocking PI3K or Akt 
activation resulted in impairment of LPS induced TNF-α mRNA production in both 
WT and Itk-/-Btk-/- BMMCs, and of note, the Itk-/-Btk-/- BMMCs TNF-α transcript level 
was severely blunted to the level of that observed in WT cells in response to LPS 
(Figure 6-5 A). WT primary PLMCs exhibited weak dependence on PI3K and Akt 
activation in early TNF-α production in response to LPS stimulation (6 hours, Figure 
6-5 B), however, primary mast cells lacking the expression of ITK and BTK strongly 
depended on the PI3K and Akt activation to execute the hyperactive TNF-α 
production induced by LPS (Figure 6-5 B). These data suggest that PI3K and Akt 
activation is required for the LPS-induced TNF-α production by mast cells, and 
contributes to the hyperactive TNF-α production in the absence of ITK and BTK. This 
hyperactive Akt responsiveness to LPS might be critical for the exacerbation of septic 
hypothermia induced by LPS in Itk-/-Btk-/- mice observed (Figure 6-1 A). We hence 
used Akti1/2 and LY294002 to pretreat Itk-/-Btk-/- mice 30 minutes prior to LPS 
exposure, and found that the inhibition of Akt or PI3K activation significantly 
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attenuated LPS-induced hypothermia Itk-/-Btk-/- mice (Figure 6-5 C). The requisite role 
of PI3K and Akt activation in LPS-induced hyper-production of mast cell-derived 
TNF-α and exacerbated hypothermic response suggests that ITK and BTK regulate 
PI3K and Akt activity to regulate LPS-induced mast cell-mediated pro-inflammatory 
response and associated thermal homeostasis in mice. Furthermore, this is likely 
through the regulation on NF-κB target gene transcription. 
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Figure 6-5. PI3K/Akt activity is required for hyperactive TNF-α production and 
enhanced hypothermia in the absence of ITK and BTK. Effects of Akt and PI3K 
inhibitors on LPS-induced (A) TNF-α mRNA in BMMCs and (B) TNF-α protein 
expression in PLMCs. (C) Akt and PI3K inhibitors attenuated LPS-induced 
hypothermia in the absence of ITK and BTK. n ≥ 3, p by t test between columns, by 
ANOVA between curves. NS: p > 0.05. 
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MNK contributes to the LPS induced TNF-α hyper-production and exacerbated 
hypothermia in the absence of ITK and BTK 
Two major factors regulate the rate of its biosynthesis post TNF-α mRNA 
translation: the stability of TNF-α mRNA and rate of translation of TNF-α mRNA into 
protein, both of which were shown to be regulated by p38 activity. TNF-α mRNA 
contains an Adenylate-uridylate-rich element (ARE) in its 3’, which can be bound be 
ARE-binding and -destabilizing factor tristetraprolin (TTP) (Lai et al., 1999). In 
macrophages, p38 activates MK2, which further phosphorylates TTP to reduce TTP 
binding affinity on the ARE, thus stabilizing TNF-α mRNA (Tiedje et al., 2012). 
However, in mast cells, LPS-induced TNF-α is dependent on p38 and independent of 
TTP (Hochdorfer et al., 2013; Kotlyarov et al., 1999), suggesting that TNF-α mRNA 
stabilization by p38/MK2/TTP signaling axis does not play a major role in TNF-α 
production by WT mast cells. If this p38/MK2/TTP axis played a role, then TNF-α 
mRNA should be significantly more stable in the Itk-/-Btk-/- BMMCs. We tested this by 
comparing the stability of LPS-induced TNF-α mRNA by blocking mRNA 
transcription/production using Actinomycin D, starting 1 hour after LPS-induced 
TNF-α mRNA production, and compared the rate of TNF-α mRNA degradation 
between WT and Itk-/-Btk-/- BMMCs. We found that this rate is significantly higher in 
Itk-/-Btk-/- BMMCs indicated by a significantly shorter half-life (Supplemental Figure 
6-2), suggesting that the hyperactive TNF-α production in the absence of ITK and 
BTK is not a result of p38 mediated TNF-α mRNA stabilization. It is therefore likely 
that the enhanced p38 activation in mast cells lacking ITK and BTK contributes to 
TNF-α production through mRNA translation. p38 mediated activation of MNK1 
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phosphorylates and reduces the binding affinity of eukaryotic initiation factor 4E 
(eIF4E) to the 5’ cap structure of cytoplasmic mRNA, to ease eIF4E sliding and so 
facilitate cap-dependent translation (Scheper et al., 2002). This p38/MNK1 mediated 
initiation of TNF-α mRNA translation can be inhibited by > 75% by a MNK1 
selective inhibitor CGP57380 (Buxade et al., 2005). To examine whether the 
hyperactive p38 signaling in LPS stimulated mast cells is responsible for the hyper-
production of TNF-α through MNK1 mediated initiation of mRNA translation, we 
treated WT and Itk-/-Btk-/- BMMCs with MNK1 inhibitor CGP57380, found that, 
MNK1 inhibitor significantly reduced LPS-induced TNF-α mRNA production, and 
brought the level of TNF-α mRNA in the long run (12 hours) in Itk-/-Btk-/- BMMCs 
similar to that observed in WT cells (Figure 6-6 A), suggesting that, MNK1 mediated 
translation contributed to the hyperactive production of LPS-induced TNF-α in mRNA 
level in the absence of ITK and BTK. Itk-/-Btk-/- primary mast cells treated with MNK1 
inhibitor failed to turn on the LPS-induced hyperactive immediate synthesis of TNF-α 
protein (Figure 6-6 B). These data suggest that MNK1 mediated TNF-α translation is 
required for the LPS-induced hyperactive TNF-α production observed in mast cell 
lacking the ITK and BTK, and is probably mediated by p38 hyperactivity. We also 
found that targeting MNK1 in vivo resulted in attenuation of the severe LPS-induced 
hypothermia in mice lacking ITK and BTK (Figure 6-6 C), suggesting that MNK1 
activity contributes to exacerbate LPS-induced mast cell mediated septic hypothermic 
response, likely through initiating TNF-α translation. 
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Figure 6-6. MNK is required for hyperactive TNF-α production and enhanced 
hypothermia in the absence of ITK and BTK. Effects of MNK inhibitor on LPS-
induced (A) TNF-α mRNA in BMMCs and (B) TNF-α protein expression in PLMCs. 
(C) MNK inhibitor attenuated LPS-induced hypothermia in the absence of ITK and 
BTK. n ≥ 3, p by t test between columns, by ANOVA between curves. NS: p > 0.05. 
 
  
B 
0 1 12
0
5
10
15
20
25
30
35
40
45 WT + DMSO
WT + CGP57380
Itk-/-Btk-/- + DMSO
Itk-/-Btk-/- + CGP57380
p < 0.05
NS
Time post LPS (hour)
R
ela
tiv
e m
R
N
A
DMSO
CGP57380
0 1 2 3 4 5 6 7 8
-6
-5
-4
-3
-2
-1
0
1
2
DMSO
CGP57380
Time post injection of LPS (hour)
p < 0.0001
Change of core body temperature (°C)
 
0
1000
2000
3000
4000
5000
p < 0.05
NS
WT Itk-/-Btk-/-
TN
F-
!
 M
FI
C 
A 
  214 
Discussions 
We show here that ITK and BTK share redundant role(s) in negatively 
regulating mast cell-mediated inflammatory response to gram-negative endotoxin 
LPS. In the absence of both ITK and BTK, mice suffered exacerbated LPS-induced 
hypothermia. Mast cells lacking ITK and BTK exhibited elevated preformed TNF-α 
and LPS-induced production, and contributed to enhance LPS-induced hypothermia in 
mice. ITK and BTK kinase activity is involved in executing this regulatory role. Mast 
cells lacking ITK and BTK also exhibited significantly enhanced LPS-induced 
signaling activity in canonical NF-κB, PI3K/Akt and p38 pathways. Blocking 
PI3K/Akt and p38-associated MNK activity dampened LPS-induced mast cell-derived 
TNF-α production and septic hypothermic response due to the absence of regulation 
by ITK and BTK.  
Unlike macrophages that use both MAL/MyD88 and TRAM/TRIF adaptor 
complexes immediately downstream of TLR4, WT murine BMMCs use only MyD88 
dependent signaling, with very low levels of TRIF and CD14 expression (Keck et al., 
2011). We also excluded the possibility that TRAM/TRIF signaling complex is 
expressed in Itk-/-Btk-/- mast cells to contribute to the observed hyperactive TNF-α 
production in response to LPS, as we did not observe similar hyper-production of 
IFNβ that lies downstream of TRAM/TRIF (Juang et al., 1998). BTK has been shown 
to be a regulatory mediator of MyD88/MAL signaling axis downstream of TLR4, by 
phosphorylating MAL for MAL degradation, in monocytic cell lines (Gray et al., 
2006). However, it has been shown that in Btk-/- BMMCs, MAL stability is not altered 
(Zorn et al., 2009), and our observation is consistent with this: we did not find MAL 
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accumulation in Itk-/-Btk-/- mast cells in the steady state nor in response to LPS 
(Supplemental Figure 6-3), suggesting that the hyperactive pro-inflammatory 
response in mast cells lacking ITK and BTK is not due to the MAL stabilization. Thus, 
ITK and BTK function as regulatory component of MyD88/MAL signaling axis 
downstream of TLR4/LPS in mast cells through an alternative mechanism other than 
MAL degradation. In the absence of BTK, LPS induced p38 activity is similar to that 
in WT cells, with moderate increase in TNF-α and IL-6 production (Zorn et al., 2009). 
However, the additional absence of ITK leads to a significant enhancement in LPS-
induced p38 activation, and TNF-α and IL-6 (Supplemental Figure 6-4, as well as 
CXCL2 and IL-1β) production, suggesting that ITK and BTK share redundant 
function in negatively regulating LPS-induced p38 activation and associated pro-
inflammatory cytokine production. Furthermore in mast cells lacking ITK and BTK, 
p38 may function to promote TNF-α protein translation, as its downstream effector 
MNK is an essential component in the hyper-production of TNF-α in LPS-stimulated 
mast cells. Our previous work suggested that the absence of ITK and BTK resulted in 
enhanced ERK activation in mast response to IgE-mediated antigen, without affect 
p38 activation (Iyer et al., 2011). While in the mast response to LPS, we observed 
impaired ERK and enhanced p38 activation, suggesting that the function of ITK and 
BTK in mast cells might be pathway specific.  
ITK has been shown to interact with PI3K in T cells, and both ITK and BTK 
are directly downstream of PI3K, requiring PI3K activity for their activation (Fruman, 
2004; Kuehn et al., 2008; Lu et al., 1998). However, BTK has been shown to 
differentially regulate B cell receptor signaling, distinct from PI3K immediately 
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downstream of the receptor, but share a common target in activating NF-κB further 
downstream (Suzuki et al., 2003). In IgE-mediated antigen induced signaling activity 
in mast cells, AKT activation, which lies downstream of PI3K, was not affected in the 
absence of BTK, while blocking PI3K activity by Wortmannin or LY294002 
dampened BTK activation, in support of the previous findings that PI3K is upstream 
of BTK in mast cell antigenic response (Kuehn et al., 2008). However, the relationship 
between ITK/BTK and PI3K in cellular response to LPS remained largely undefined. 
Activation of PI3K pathway increases LPS-induced TNF-α production in mast cells 
(Hochdorfer et al., 2011). Our finding that LPS induced better activation of Akt in 
mast cells lacking ITK and BTK suggested a reciprocal regulation between ITK/BTK 
and PI3K.  
The activation of lymphocytes and certain myeloid lineages in autoimmune 
diseases and hypersensitivity require the activation of ITK and BTK, making Tec 
kinase inhibitors promising selective targets for therapy (Di Paolo et al., 2010; 
Hendriks, 2011; Sahu and August, 2009). However, given the overall regulatory role 
of ITK and BTK in the mast cell response to LPS, these same inhibitors might 
exacerbate mast cell mediated diseases such as septic hypothermia. Due to the high 
homology structure of ITK and BTK, specific targeting may be difficult, hence mast 
cell function might be a critical issue in drug specificity and efficacy of those targeting 
Tec family kinases.  
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Supplemental Figure 6-1. The absence of ITK or BTK does not exacerbate LPS-
induced hypothermia. (A) Change in core body temperature induced by LPS. n = 3.  
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Supplemental Figure 6-2. TNF-α mRNA is significantly less stable in Itk-/-Btk-/- 
BMMCs compared to WT cells. BMMCs were stimulation with LPS for 1 hour, 
followed by addition of DMSO or Actinomycin D (ActD). TNF-α mRNA was 
measured every 0.5 hour, and normalized to the level in time 0 (1 hour post LPS). 
Half-life indicated was calculated based on the trend line generated by linear 
regression in the region where 50% mRNA falling in. 
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Supplemental Figure 6-3. No MAL accumulation is observed in the absence of 
ITK and BTK. The same membrane used in Figure 6-4 was used to measure MAL 
expression. Control loading is GAPDH shown in Figure 6-4. Data represent results 
from ≥ 2 independent experiments. 
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Supplemental Figure 6-4. ITK and BTK negatively regulate LPS-induced pro-
inflammatory cytokine expression. BMMCs were stimulated with 1 µg/ml LPS for 
indicated time. LPS-induced cytokine mRNA (upper panel) and secretion (lower 
panel) are presented. n = 2. p values by ANOVA. 
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CHAPTER SEVEN 
 
Final discussion 
 
 
  
  228 
Tec family kinase, ITK, has been one of significant interest during the past 
decade, in the fields of immunology and pharmacology, mainly because of its critical 
role in T cell development and function. In the absence of ITK, Th2- and Th17-
mediated diseases such as allergic asthma and EAE are significantly attenuated 
(Douhan et al., 2008; Ferrara et al., 2006; Gomez-Rodriguez et al., 2009; Kannan et 
al., 2013a; Kannan et al., 2013b; Mueller and August, 2003), thus inhibition of ITK 
has been proposed as a therapeutic strategy against such inflammatory diseases. 
However, despite the defect in the development of pathogenic conventional Th2 and 
Th17 cells, innate memory phenotype (IMP) T cells are selectively developed in the 
absence of ITK (Hu and August, 2008; Hu et al., 2007). Hence it is urgent and 
necessary to understand the function of IMP T cells to achieve a comprehensive 
evaluation of the advantages and disadvantages of targeting ITK as a treatment 
strategy for inflammatory diseases.  
Work presented in this dissertation shows that IMP CD8+ T cells are very 
potent players in “primary” response to antigenic stimulation, with rapid IFN-γ and 
TNF-α secretion, which might be essential for clearance of infection ((Huang et al., 
2013) as in chapter two); and that IMP CD4+ T cells can suppress autoimmune graft-
versus-host disease due to loss of donor MHCII function in syngeneic bone marrow 
transplantation (chapter five). These findings suggest that using inhibitors of ITK as a 
strategy can potentially increase the frequency of IMP T cells, to enhance IMP CD8+ 
T cell-mediated immunity against infection and IMP CD4+ T cell-mediated regulatory 
immune function, depending on the specific pathogenic conditions. One practical aim 
of interest in medicine would be to generate a protocol to enrich IMP T cells to be 
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used in, for example, infusion therapy. IL-4 was suggested to be responsible, in vivo, 
in inducing IMP CD8+ T cells in the absence of ITK, in a T cell-extrinsic manner 
(Weinreich et al., 2010). However, we found that ITK intrinsically suppresses IMP-
like CD8+ T cell enrichment, in the presence of IL-4 (chapter three). Of note, the 
absence of ITK without IL-4 is not sufficient for development of IMP CD8+ T cells. It 
is the combination of the absence of ITK and the presence of IL-4 that promotes IMP 
CD8+ T cell enrichment. Mostly importantly, this combination significantly enhances 
IMP-like CD8+ T cell enrichment in vitro, suggesting the possibility of using ITK 
inhibitors in the presence of IL-4 to differentiate IMP CD8+ T cells in vitro, as a 
source of donor cells for infusion therapy. Similar cell-intrinsic effects of ITK on 
CD4+ IMP T cell development have also been shown by a previous study (Hu and 
August, 2008). However, whether cytokines play any roles in collaboration with the 
lack of ITK to promote IMP CD4+ T cell enrichment is not yet clear, and our work in 
progress (Huang and August, unpublished data) suggests that IL-4 is less critical in 
IMP CD4+ T cell development, as Itk-/-Il4ra-/- mice retain the high frequency of IMP 
CD4+ T cells, whereas Itk-/-Stat6-/- mice carry normal level (similar to WT) of IMP 
CD4+ thymocytes. It is likely that other cytokines that utilize STAT6 signaling are 
involved in coupling with ITK deficiency to promote IMP CD4+ T cell enrichment. It 
may be other Th2 cytokines such as IL-5 and IL-13 in the place of or in combination 
with IL-4 that can be candidates for future investigation. Nevertheless, the T cell-
intrinsic function of ITK in suppressing IMP T cell differentiation, and potency of IL-
4 in inducing CD8+ T cell memory feature in vitro, suggest a promising cell culture 
protocol for clinical practice.  
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To a greater extent, the T cell-intrinsic function of ITK in suppressing CD8+ T 
cell memory differentiation seems to be a general property, also applicable to 
memory-like CD8+ T cell anti-tumor immunity development during lymphopenia-
driven homeostatic proliferation (chapter four). This potentially expands the clinical 
spectrum for applications of ITK inhibitors. Infusion of tumor-reactive cells (derived 
and enriched against tumor antigen in vitro) following lymphodepletion induces 
marked tumor regression in metastatic melanoma patients, mainly because of the rapid 
repopulation of anti-tumor CD8+ T cells in the lymphopenic condition (Dudley et al., 
2002). In addition to the potential in vitro protocol in enriching memory-like CD8+ T 
cells described above, ITK inhibition may also contribute to a more rapid expansion of 
the tumor-reactive infused cells in vivo through homeostatic proliferation in 
lymphopenic condition. More intriguingly, the lack of ITK function actually enhances 
HP CD8+ anti-tumor immunity, independently of CD4+ T cell help. CD4+ T cells are 
critical helpers for CD8+ T cells to acquire protective function in during homeostatic 
proliferation (Hamilton et al., 2006), but paradoxically, they also increase the of risk 
of developing autoimmunity in the lymphopenic or immunodeficient recipients 
(Dudley et al., 2002; Morrissey et al., 1993). In infusion therapy, inhibiting ITK may 
allow the exclusion of CD4+ T cells in the donor composition (as CD4+ T cells are not 
longer required to help the development of HP CD8+ T cell anti-tumor immunity, in 
the absence of ITK), to develop effective HP CD8+ T cell anti-tumor immunity against 
CD4+ T cell-mediated autoimmunity.  
Most of the ITK inhibitors that were reported or under investigation were 
designed to target the ITK kinase activity (Sahu and August, 2009; Vargas et al., 
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2013). IMP T cell enrichment in the absence of ITK is mainly due to the lack of ITK 
kinase activity (Hu and August, 2008; Hu et al., 2007), thus ITK kinase inhibitors can 
serve to promote IMP T cell enrichment in the proposed protocol. Regarding HP CD8+ 
T cell-related application, more research is required to determine whether ITK kinase 
activity is a proper target to ablate its T cell-intrinsic suppressive function in HP CD8+ 
T cell expansion and anti-tumor immunity development. There are potential tools for 
investigating this, such as the murine model that expresses ITK kinase defective 
mutant (in T cells) on Itk-/- background. However, CD8+ T cells developed in the 
absence of active ITK kinase function, acquire memory-like phenotype (Hu et al., 
2007), which causes the same problem as Itk-/- mice do (insufficient number of naïve 
CD8+ T cells can be isolated for related studies). Alternatively, naïve CD8+ can be 
isolated from the Itk-/- OTI-Rag-/- mice, and transduced to re-express ITK mutants of 
the domain function of interest, including the kinase activity, although this approach is 
tedious and might introduce other interfering factors due to the transduction process. 
Currently, some work in progress is aiming to develop a murine model in which ITK 
kinase defect can be conditionally induced. Preliminary data show normal CD8+ T cell 
composition in these mice, and operatable induction of ITK kinase defect to a 
satisfactory degree (Kannan and August, unpublished data). This model may serve as 
a critical tool in the near future to investigate the involvement of ITK kinase function 
in the development of various diseases, and to help better assess the value of targeting 
ITK as a treatment strategy.  
In addition to the careful assessment of ITK kinase activity in T cell function 
and related diseases, developing ITK inhibitors with desired potency and specificity 
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against other kinases is also very important. Based on the ITK kinase domain crystal 
structure (bound with a potent broad-spectrum kinase inhibitor), it should be possible 
to design small molecules capable of distinguishing ITK from Src family kinases 
(SFKs), as both the size and shape of the ITK kinase pocket are distinct from those in 
SFKs (Brown et al., 2004). However, three of ITK kinase pocket-associated residues 
are highly conserved between ITK and BTK, while only one is unique for ITK (termed 
as ITK kinase gatekeeper or blocker) (Brown et al., 2004). Theoretically, this single 
gatekeeper would allow the development of ITK specific inhibitors (compared to BTK 
for example), however in fact, this is extremely difficult as other Tec kinases’ covalent 
inhibitors may exploit ITK kinase pocket through hydrogen bonding interaction or 
hydrophobic binding (Brown et al., 2004; Lo, 2010; Sahu and August, 2009; Vargas et 
al., 2013). In addition, biological and biomedical tools to evaluate the specificity of 
ITK inhibitors are also quite limited, due to the high homology of Tec family kinases 
and their differential expression (in different cell types, as well as at different levels 
when expressed in the same cells).  
ITK and BTK are expressed at similar levels in mast cells (Evans et al., 2009), 
and neither of them is required for mast cell differentiation in vivo and in vitro, 
making mast cell as an excellent model to evaluate kinase inhibitor specificity 
between ITK and BTK. We have used this system and described the regulatory 
function that is redundant between ITK and BTK in negatively regulating LPS 
induced TNF-α production and septic hypothermia (chapter six). Given the highly 
pro-inflammatory property of TNF-α and detrimental consequence of severe septic 
hypothermia, it is clearly important that kinase inhibitors developed are able to 
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distinguish ITK and BTK. However, with current progress in Tec kinase inhibitor 
development, it may be a bit much to expect the availability of inhibitors highly 
specific against ITK or BTK in a near future. Alternative strategies may be developed 
to compensate for the potential risk due to the simultaneous absence of ITK and BTK 
kinase activity. In mast cells, we showed that in the absence of ITK and BTK, PI3K, 
Akt and MNK1 inhibitors could reverse the LPS-induced TNF-α production and 
hypothermic response toward WT levels, and so might be considered as candidates to 
develop combinatorial treatment with ITK/BTK inhibitors to target T or B cell-
mediated diseases.  
It should be mentioned that we also have observed some distinct cell type-
specific effects of the simultaneous absence of ITK and BTK in innate immune cell 
response to LPS (Huang and August, unpublished data), which may be due to the 
differential expression pattern of these kinases as well as the cell-specific signaling 
downstream of LPS/TLR4 ligation. For example, dendritic cells express BTK in 
significantly higher level compared to that of ITK (see Immunological Genome 
Project database: http://rstats.immgen.org/comparative/comparative_search.php) and 
use both MyD88 and TRIF-dependent signaling downstream of TLR4 (see review 
(Buer and Balling, 2003)); while mast cells carry ITK and BTK expression at similar 
level (Evans et al., 2009), and use only MyD88-dependent signaling (Keck et al., 
2011). A more comprehensive understanding of the function of ITK and BTK in the 
innate immune system requires further investigation of other innate cells, such as 
macrophages, neutrophils, eosinophils and basophils.  
Although ITK and BTK are highly conserved between mouse and human, 
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there could be differences in their associated immune functions in human compared to 
those in mice. Murine models are critical, but might not be sufficient to provide 
preliminary data to ensure an accurate clinical assessment on the therapeutic potential 
of ITK inhibition. For example, murine and human mast cells exhibit some species-
specific differences (Bischoff, 2007; Bischoff and Kramer, 2007). Thus it is important 
to extend the study to human models to indicate whether pharmacological inhibition of 
ITK and/or other TFKs is of promise in clinical medicine.   
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